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Abstract 
Background: The burden of stroke in low-and middle-income countries (LMICs) has risen 
sharply in recent years and the rate of increase is set to accelerate due to socio-demographic 
and lifestyle changes related to the industrialization and a rise in many modifiable vascular 
disease risk factors.  
Aims: The first aim was to establish, for countries like Rwanda, how much stroke is a major 
problem. The second aim was to explore whether the existing stroke services were well 
prepared. The third aim was to develop and implement a relevant service improvement in 
Rwanda.   
Methods: First, I conducted systematic reviews of the literature on the epidemiology and 
impact of stroke, and the available stroke services in Africa. Second, I conducted a systematic 
review of the literature and analyzed the INTERSTROKE study data to identify the stroke key 
performance indicators (KPIs) that have been described in stroke care and assessed their 
association with patient outcomes. Finally, I selected the stroke unit care KPIs relevant to 
Rwandan and other LMIC settings, and used several strategies including site champions, 
provision of educational materials, feedback on usual care, training hospital staff on stroke 
KPIs, consensus discussions on service improvement by local staff, and discussions with the 
hospital directors to promote the implementation of the selected KPIs in two hospitals in 
Rwanda. 
Results: Stroke was found to be common and important in Africa. However, the provision of 
stroke care was below the recommended standards. After adjustment for case mix and stroke 
onset-hospital arrival interval, I found a consistent trend of associations between my 
implementation intervention and improved delivery of stroke KPIs and patient outcomes.  
Conclusion: Several common KPIs of stroke unit care can be implemented in hospitals in 
Rwanda. However, there are some major challenges that need to be addressed for optimal 
implementation of stroke unit care. 
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Chapter abstracts 
Chapter 1: Epidemiology and impact of stroke in Africa: a systematic review of the 
literature 
Background: Stroke is the second most common cause of death, and the third most common 
cause of disability-adjusted life-years (DALYs) worldwide, but there is limited information on 
the stroke burden in Africa. 
Aim: To describe the epidemiology (incidence, prevalence, mortality, one month-case-
fatality) and impact (disability, quality of life, and cost) of stroke in Africa. 
Methods: I performed a systematic review which included full-text manuscripts published 
between January 1980 and June 2017 that described the epidemiology or impact of stroke. I 
searched Medline, Embase, PubMed, and African Journals Online (AJOL) databases, and 
screened references from bibliographies. There was no language restriction. To determine the 
estimates of stroke epidemiology and impact variables in Africa, the overall means with 
standard deviation (SD) were calculated.  
Results: I identified 44 eligible studies among which 21 were hospital based and 23 were 
community based. The majority (30/44) of the studies were conducted in urban settings. 
Overall, the crude mean per 100,000 population was 122.4 (SD: 68.1) for the incidence, 539.1 
(SD: 381.5) for the prevalence and 84.7 (SD: 30.15) for mortality. The age-adjusted mean per 
100,000 population was 162.7 (SD: 117.5) for incidence, 788.3 (SD: 536.7) for the prevalence 
and 192.7(SD: 155.2) for mortality. The overall mean rate for stroke one-month case fatality 
was 30.4% (SD: 11.7%). It was also reported that 30.6% of stroke survivors had moderate or 
severe disability at one-year post stroke, and at 29 months post stroke, the stroke survivors in 
general had neither poor nor good quality of life (the mean for the health-related quality of life 
was 71%). The overall mean for the in-hospital care cost was found to be 1971 (SD: 1108) 
United States Dollars (USDs).  
Conclusions: This review provides an overview of the epidemiology and impact of stroke in 
Africa, despite the paucity of available data. I found that stroke was common and important in 
Africa. Robust high-quality studies are needed to help policy makers and health care 
professionals to control the stroke burden in Africa. Appropriate preventive and therapeutic 
measures should be promoted to decrease the incidence of stroke, improve the outcomes, and 
maintain the survivors’ quality of life in Africa. 
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Chapter 2: Stroke care in Africa: a systematic review of the literature 
 Background: Appropriate systems of stroke care are important to manage the increasing 
death and disability associated with stroke in Africa. Information on existing stroke services in 
African countries is limited. 
Aim: To describe the status of stroke care in Africa.  
Methods: I undertook a systematic search of the published literature to identify recent 
(January 1
st
, 2006-June 20
th
, 2017) publications that described stroke care in any African 
country.  
Results: My initial search yielded 838 potential papers, of which 38 publications were eligible 
representing 14/54 African countries. Across the publications included for my review, the 
proportion of stroke patients reported to arrive at hospital within three hours from stroke onset 
varied between 10─43%. The median time interval between stroke onset and hospital 
admission was 31 hours. The reported proportions of stroke patients who received brain 
imaging within three hours of stroke onset varied between 0% and 13%, and the overall 
proportion of patients who received brain imaging varied between 13% and 36%. Only 
twenty-three stroke units in Africa were reported, and two studies indicated that stroke unit 
admission was associated with a decrease in in-patient case fatality rate of 17-30%. Access to 
in- and out-patient rehabilitation services was reported to be very low. Poor awareness of 
stroke signs and symptoms, shortages of medical transportation, health care personnel, and 
stroke units, and the high cost of brain imaging, thrombolysis, and outpatient physiotherapy 
rehabilitation services were reported as major barriers to providing best-practice stroke care in 
Africa. 
Conclusions: This review provided an overview of stroke care in Africa and highlighted the 
paucity of available data. Stroke care in Africa usually fell below the recommended standards 
with variations across countries and settings. Combined efforts from policy makers and health 
care professionals in Africa are needed to improve, and ensure access to organised stroke care 
in as many settings as possible. Mechanisms to routinely monitor usual care (i.e. registries or 
audits) are also needed to inform policy and practice. 
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Chapter 3: Key performance indicators of quality stroke care and their association with 
patient outcomes: a systematic review of the literature and meta-analysis 
Background: Translating research evidence into clinical practice often uses key performance 
indicators (KPIs) to monitor quality of care. However, information on KPIs for stroke care is 
limited. 
Aims: To identify the stroke KPIs used in large registries, and to estimate their association 
with patient outcomes. 
Methods: I sought publications of recent (January 2000-May 2017) national or regional stroke 
registers reporting the association of KPIs with patient outcome (adjusting for age and stroke 
severity). I searched Ovid Medline, Embase and PubMed and screened references from 
bibliographies. I used an inverse variance random effects meta-analysis to estimate 
associations (odds ratio; 95% Confidence Interval) with death or poor outcome (death or 
disability) at the end of follow up. 
Results: I identified 30 studies (324,409 patients) eligible for the qualitative review. Among 
these, only 22 were eligible for the meta-analysis. The commonest KPIs were 
swallowing/nutritional assessment, stroke unit admission, antiplatelet use for ischemic stroke, 
brain imaging, anticoagulant use for ischemic stroke with atrial fibrillation, lipid management, 
deep vein thrombosis prophylaxis and early physiotherapy/mobilization. Lower case fatality 
was associated with swallow/nutritional assessment (OR: 0.78; 0.66-0.92), stroke unit 
admission (OR: 0.79; 0.72-0.87), antiplatelet use for ischemic stroke (OR: 0.61; 0.50-0.74), 
anticoagulant use for ischemic stroke with atrial fibrillation (OR: 0.51; 0.43-0.64), lipid 
management (OR: 0.52; 0.38-0.71), and early physiotherapy or mobilization (OR: 0.78; 0.67-
0.91). Reduced poor outcome (death or disability) was associated with adherence to 
swallowing/nutritional assessment (OR: 0.58; 0.43-0.78) and stroke unit admission (OR: 0.83; 
0.77-0.89). Adherence to several KPIs appeared to have an additive benefit. 
Conclusions: I found that the most frequently reported KPIs for stroke care were swallowing 
assessment, stroke unit admission, antiplatelets for ischemic stroke, brain imaging, 
anticoagulants for ischemic stroke with atrial fibrillation, lipid management, deep vein 
thrombosis (DVT) prophylaxis, and early mobilization. Adherence to common KPIs was 
consistently associated with a lower risk of death or disability after stroke. Policy makers and 
health care professionals should implement and monitor those KPIs supported by good 
evidence. 
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Chapter 4: Stroke services in African and other low and middle-income countries in an 
international study  
Background: Stroke key performance indicators (KPIs) have been used to monitor service 
improvement in high-income countries (HICs), but information regarding their utility in low 
and middle-income countries (LMICs) is limited. 
Aims: To explore the association of recording of stroke KPIs with patient outcomes in 
LMICs, generally and African settings in particular. 
Methods: I analysed data collected from the INTERSTROKE case control study (conducted 
between January 2007 and August 2015). I had full data for 12343 participants and analysed 
9766 from LMICs. I calculated the odds ratios (OR) with 95% confidence intervals (CI) for 
the associations of KPIs with 30-day patient outcomes using univariate and multivariate 
regression analyses to account for patient casemix. I also used the Bonferroni correction 
method to control the familywise error rate and considered 0.006 as the p-value of 
significance. 
Results: In LMICs, availability of a stroke unit (OR: 0.71, 0.60-0.83; p<0.0001) or a stroke 
specialist (OR: 0.74, 0.64-0.85; p<0.0001), receiving antiplatelet therapy for ischemic stroke 
(OR: 0.69, 0.56-0.85; p=0.001), and the availability of acute (OR: 0.70, 0.57-0.87; p=0.001) 
and post-discharge (OR: 0.41, 0.34-0.48; p<0.0001) rehabilitation were independently 
associated with lower risk for 30-day case fatality. Early brain imaging (OR: 0.71, 0.58-0.88; 
p=0.001) and stroke unit availability (OR: 0.62, 0.55-0.71; p<0.0001) were independently 
associated with lower risk of death or severe disability at 30 days. There was a dose dependent 
relationship of number of KPIs recorded with a better outcome. For the African countries 
alone, I had no enough evidence to show an association between any of the stroke KPIs 
investigated and patient outcomes. 
Conclusions: In LMICs, achieving several common KPIs was associated with a statistically 
significant reduction in post-stroke death or disability. Policy makers and health care 
professionals should be encouraged to implement the commonly established stroke KPIs even 
in settings with limited resources. 
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Chapter 5: Implementing stroke unit care in Rwanda: a two-hospital before and after 
implementation trial  
Background: Stroke unit care has become established as the central component of a modern 
stroke service to improve patient outcomes, but it requires several resources. This raises the 
question of whether stroke unit care is feasible and applicable to low and middle-income 
country settings. 
Aims: To explore the feasibility and effectiveness of implementing stroke unit care in selected 
hospitals in Rwanda. 
Methods: I used a before and after implementation trial design. The clinical intervention 
consisted of 11 key stroke unit care elements that were identified from the results of chapters 
three and four, the World Stroke Organisation (WSO) recommendations and the Rwandan 
clinical guidelines. The implementation intervention consisted of identification of site 
champions, provision of educational materials, face-to-face educational seminar (including 
feedback on usual care, training on stroke KPIs and local consensus discussions), and 
discussions with the study hospital directors. 
Results: Overall, after case mix adjustment for stroke severity (using six simple variables), 
stroke type and stroke onset-hospital arrival interval, I found a consistent trend of associations 
between the intervention and an increase in participants who received the KPIs investigated 
and an increase in better patient outcomes. However, the results were statistically significant 
for only the use of standardized assessment tools (OR: 2.98, 1.36-6.51; p=0.006), swallowing 
assessment recorded (OR: 5.73, 2.08-15.74; p=0.001), mobilization recorded (OR: 2.30, 1.16-
4.56; p=0.017) and multidisciplinary team meetings recorded (OR: 9.04, 2.74-29.86; 
p<0.0001). Survival in hospital (OR: 2.97, 1.25-7.05; p=0.014) and at three months post stroke 
(OR: 2.30, 1.10-4.78; p=0.026) significantly improved. 
Conclusions: Several common KPIs for stroke unit care can be implemented in two selected 
hospitals in Rwanda although there were limited resources, and some important KPIs such as 
geographic stroke unit and thrombolysis could not be implemented. The data also suggested 
that there may be improved patient outcomes. There is a need for combined efforts to continue 
improving the implementation of stroke KPIs including those that are not yet initiated like a 
geographic stroke unit.   
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Chapter 6: Final discussion  
In this final chapter, I aim to discuss to what extent the aims of the thesis have been achieved, 
the contributions made by this thesis and future work. 
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0. General introduction 
Stroke is the second most common cause of death (Lozano et al., 2010), and the third most 
common cause of disability-adjusted life-years (DALYs) lost worldwide (Murray et al., 2012). 
In contrast to high income countries (HICs) where stroke mortality rates have declined, the 
burden of stroke in developing countries has risen in recent years and is expected to accelerate 
(Feigin et al., 2014). Eighty-six percent of all stroke deaths around the world take place in 
African and other low and middle-income countries (LMICs) (Feigin, 2005). Further, African 
and other LMICs account for over 87% DALYs lost from stroke, which is about seven times 
the DALYs lost in HICs (Johnston et al., 2009). In the absence of significant international 
public health responses, projections based on the current trends, incidence velocity, risk factor 
prevalence, population-attributable risks, and relative risk for risk factors, indicate that by 
2030, stroke will be the first leading cause of death in middle-income countries and the third 
in low-income countries, especially in Africa (Owalabi et al., 2015).  
Many African countries are undergoing progression of the epidemiological transition driven 
by socio-demographic and lifestyle changes, related to unchecked industrialisation, and a rise 
in many modifiable, lifestyle-related vascular disease risk factors (Kabudula et al., 2017). 
These include smoking, harmful use of alcohol, physical inactivity and unhealthy diets 
resulting in an increased prevalence of obesity and hypertension, precursors for heart disease, 
diabetes and stroke (Connor et al., 2007; Owolabi et al. 2014). Consequently, the burden of 
non-communicable diseases (NCDs) in Africa is growing (Owolabi et al. 2014). A systematic 
review (Owolabi et al., 2015) of community-based studies revealed an age-standardised 
annual stroke incidence rate of up to 316 per 100,000 population, and age-standardised 
prevalence rates of up to 981 per 100,000 in Africa.  
Despite the available evidence regarding the burden of stroke in Africa, health systems in 
many African countries are characterised by geographical and financial inaccessibility, rapid 
turnover of people in key positions, lack of continuity in policy, lack of resources, poor 
management of available resources and poor implementation (Sambo, 2012). Specifically, the 
lack of functional stroke units, neurologists, health workers, cranial computed tomography 
(CT) scans, magnetic resonance imaging (MRI) and echo-doppler machines, among many 
others, has negatively affected stroke outcomes (Chin, 2012). Additionally, the high cost of 
medical care in a relatively low-income African society without universal health care coverage 
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could have contributed to high stroke fatalities (Johnston et al., 2009). Moreover, some 
patients with stroke in Africa prefer to patronise traditional healers because they still believe 
that stroke is related to bad spiritual forces (Mapoure et al., 2014). 
It is recommended that appropriate systems of stroke care be established in Africa and other 
LMIC regions to control the increasing death and disability associated with stroke (Feigin et 
al., 2009; Langhorne et al., 2012). Stroke units can provide one of the most effective and 
generally applicable interventions to reduce the risk of death and disability for patients 
admitted to hospital after stroke. A stroke unit is a complex intervention that entails a 
combination of medical and rehabilitation interventions that are delivered by a 
multidisciplinary team of stroke specialists who work in a focussed and coordinated way to 
provide care for patients with stroke in hospital (Stroke Unit Trialists’ Collaboration; 2013).  
 
Stroke units have become established as the central component of a modern stroke service 
(Langhorne and Rudd, 2009). However, since stroke unit implementation requires a range of 
health professional resources, co-location of beds and clinical leadership, most service 
developments have taken place in high income countries (Langhorne et al., 2012). This raises 
the question of whether stroke unit care is feasible and applicable to LMIC settings like 
Rwanda. My thesis aimed to establish, for countries like Rwanda, how much stroke is a major 
problem (chapter 1), if services are well prepared (chapter 2), what are the key indicators of 
successful implementation of stroke unit care (chapters 3-4), and then how to develop and 
implement a relevant service improvement (chapter 5). The findings and future implications of 
my thesis are summerized in chapter 6. 
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Chapter 1: Epidemiology and impact of stroke in Africa: a systematic review of 
the literature 
1.1 Introduction 
Globally, about 16 million new cases of stroke and 62 million stroke survivors were estimated 
in 2005, with deaths from stroke accounting for 9.7% of all global deaths. In the absence of 
significant international public health responses, this is expected to increase to over 23 million 
new stroke cases and 7.8 million stroke deaths by 2030 (World Health Organization [WHO], 
2004; Strong et al., 2007). 
Within HICs, adequate health services and strategies for stroke prevention and care such as 
smoking cessation, control of hypertension, and acute stroke units appear to have contributed 
to the decline in stroke incidence, mortality, mortality-to-incidence ratios, and DALYs since 
1940 (Whisnant, 1984; Feigin et al., 2014). A systematic review of population-based studies 
of stroke incidence (Feigin et al., 2009) showed that while there was 42% decrease in 
incidence in HICs in the previous four decades. However, in African and other LMIC 
countries, the incidence of stroke is increasing (Feigin et al., 2009).  
Between 2002 and 2004, estimates revealed an increasing incidence and prevalence with 8% 
of new stroke cases and 5% of stroke survivors occurring in Africa (Truelsen, 2010). The 
Global Burden of Disease (GBD) 2010 data also revealed an increase in age-standardised 
ischaemic stroke incidence from 1990 to 2010 which ranged between 5.2% (South Africa) and 
27.8% (Democratic Republic of Congo) (Owolabi et al., 2015). Overall, in Africa, there was 
significant mean increase in age-standardised ischaemic stroke incidence of 14.8% between 
1990 and 2010. Similarly, the increase in age-standardised haemorrhagic stroke incidence 
from 1990 to 2010 ranged between 13.0% (Gambia) and 45.7% (Burundi). Overall, in Africa, 
there was significant mean increase in age-standardised haemorrhagic stroke incidence of 
28.7% between 1990 and 2010.  
Accurate, up-to-date information on stroke burden is necessary for the development and 
evaluation of effective and efficient preventative, acute care, and rehabilitation programmes 
for stroke patients (Owolabi et al., 2015). Information on the current burden of stroke in Africa 
is however limited. In an attempt to fill the gap of lack of data on stroke burden in developing 
countries, there have been global reviews of stroke with a few studies of African populations 
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included (Aho et al., 1980; Feigin et al., 2003; Feigin et al., 2009).  For example, a systematic 
review (Feigin et al., 2003) which was confined to stroke epidemiology included population-
based studies only. This criterion refers to the most vigorous design but is challenging for 
most African countries. Also, only the Medline database was consulted, and papers in English 
only were considered, and there was no single study from Africa that was eligible for 
inclusion. 
In a subsequent systematic review of 56 population-based studies globally (Feigin et al., 
2009), only one African site (Ibadan, Nigeria) was included. The result from this survey may 
not necessarily reflect the overall burden of stroke in Africa (Adeloye, 2014). The Global 
GBD collaborators (Krishnamurthi et al., 2013; Feigin et al., 2014), using multi-state models, 
published data on the burden of stroke and stroke subtype in various countries across the globe 
but without specific focus on Africa (Owolabi et al., 2015).   
Some systematic reviews have been published on the burden of stroke in Africa, but I believe 
their literature searching methodology may have resulted in them missing some relevant 
information on stroke in Africa. For example, a meta-analysis by Adeloye (2014) was limited 
to the prevalence and incidence of stroke in Africa, though with pooled data of uneven quality 
(Owolabi et al., 2015). Furthermore, this meta-analysis (Adeloye, 2014) searched three 
databases only (Medline, Embase and Global Health), and I believe that not considering the 
African Journals Online (AJOL) database could have resulted in missing some important 
information on stroke in Africa. A systematic review by Owolabi et al. (2015) aimed to 
examine the burden and epidemiological trends of stroke in Africa but was limited to 
searching publications indexed in PubMed and AJOL databases only. Additionally, this 
review was confined to studies published in English while some of the African researchers are 
more likely to publish in French. A recent meta-analysis (Ezejimofor et al., 2016) on stroke in 
LMICs in different continents including Africa provided estimates on the prevalence of stroke 
survivors and secular trends only. This analysis pooled data from uneven quality studies, while 
data on stroke incidence and stroke-related mortality, disability, quality of life and cost were 
not included. These are also important for health care planning. This review also divided 
Africa in two regions including North Africa and Sub-Saharan Africa and combined data from 
North Africa with those from Middle East.  
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With this background, and evidence of changing stroke epidemiology and impact (Feigin et 
al., 2003, Ezejimofor et al., 2016), I aimed to conduct an updated systematic literature review 
on the epidemiology (incidence, prevalence, mortality, one month-case-fatality) and impact 
(disability, quality of life, and cost) of stroke in Africa. I hope this review will increase our 
current knowledge of epidemiology and impact of stroke and inform policy makers and health 
care professionals about appropriate responses and health system interventions across many 
African countries. 
1.2 Methods 
This review was performed according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2015), and I used the 
following methods: 
1.2.1 Search strategy  
Studies for this review were identified by searches of Medline, Embase, PubMed, and AJOL 
databases. There was no language restriction, but the search was limited to full-text 
manuscripts published from January 1
st
, 1980 to June 8
th
, 2017.  
I used Medical Subject Headings (MeSH) and all subheading terms including “stroke”, 
“cerebrovascular accident”, “cerebrovascular disease”, “cerebrovascular disorders”, 
“epidemiology”, “burden”, “incidence”, “mortality”, “case fatality”, “prevalence”, “impact”, 
“disability”, “quality of life”, “cost”, and “Africa”. Additional searching was conducted on 
reference lists of relevant studies to identify publications that could have been omitted in the 
database searches. For further details of the search strategy, see the Appendix 1.1.  
1.2.2 Inclusion criteria 
The inclusion criteria were of studies that:  
 Were conducted in an African country 
 Described the epidemiology or impact of stroke 
 Used a prospective quantitative study design 
 Had full text available for review 
 Used stroke case ascertainment by the WHO clinical criteria (WHO MONICA Project 
Principal Investigators, 1988) and/or CT or MRI scan 
 For stroke case fatality, only those reporting a one-month case fatality were considered 
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 Followed the guidelines of the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) Statement (von Elm et al., 2007) for the items below: 
a. Providing an informative and balanced summary of what was done and what was 
found (STROBE criterion 1b) 
b. Describing the study setting, locations and relevant dates (STROBE criterion 5) 
c. Giving the eligibility criteria for the participants (STROBE criterion 6) 
d. Giving stroke diagnostic criteria (STROBE criterion 7).  
e. Giving details of methods of assessment (measurement) (STROBE criterion 8).  
f.    Describing any efforts to address potential sources of bias (item number 9) 
g. Explaining how the study size was arrived at (STROBE criterion 10) 
h. Providing information on the follow-up time (item number 14c) 
1.2.3 Exclusion criteria 
 Exclusion criteria included: 
 Review articles 
 Duplicate publications  
1.2.4 Screening and quality assessment 
The study selection involved three consecutive stages. In stage 1, I screened the retrieved 
publications for potential eligibility based on their titles and abstracts. In stage 2, I determined 
eligibility for further assessment based on the availability of full text. Stage 3 consisted of 
further assessment of eligibility and involved a full review of the publications using the 
inclusion criteria. After the initial screening process, the eligibility for 20 articles was unclear, 
and my primary supervisor and I independently performed a full review to determine if those 
20 articles met the inclusion criteria. We then discussed them and reached a consensus about 
their eligibility. However, the quality appraisal for the studies included in the review was not 
undertaken. 
1.2.5 Data extraction 
After screening the articles identified and assessing them for quality, those which qualified for 
the review were categorized into seven themes: incidence, prevalence, mortality, case fatality, 
disability, quality of life and cost of stroke as shown in tables 1.1-1.7.  
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A data extraction form for each of the seven variables for the review was drafted and tested 
with extraction of data from two studies for further refinement. Thereafter, I systematically 
extracted data from each study in discussion with my primary supervirsor and recorded the 
data on the corresponding final extraction form as indicated in tables 1.1-1.7.   
1.2.6 Data analysis 
For the studies on incidence, prevalence or mortality rates of stroke in Africa, data were 
presented either per 1,000 or per 100,000 population. During the analysis, all the data were 
presented per 100,000 population.  
For case fatality, all studies which reported stroke case fatality for 28 days (four weeks) or 30 
days were all considered for one-month stroke case fatality outcomes.  
Disability post stroke was anticipated to use outcome measures such as the modified Rankin 
Scale (mRS) and the Glasgow Outcome Scale (GOS). For easy interpretation and comparison, 
I planned to present findings on disability of stroke survivors under three categories. These 
include mild disability (mRS=0-2 and GOS=5), moderate disability (mRS=3 and GOS=4), and 
severe disability (mRS=4-5 and GOS=2-3). 
For the data on cost of stroke care, an average for ischemic and hemorrhagic stroke costs in 
the Cameroonian study (Mapoure et al., 2014) was calculated and used for further 
interpretation. Because the reviewed studies were conducted in different years and in different 
currencies, the data on cost of stroke care was converted to 2016 United States Dollar (USD) 
currency values using a web-based tool (CCEMG-EPPI-centre cost converter) and using the 
International Monetary Fund (IMF) for the purchasing power parity (PPP) values. 
A Tanzanian study (Walker et al., 2000) provided separate data for males and females 
regarding both crude and age-adjusted stroke mortality rate. For these data, averages were 
calculated for easy further analysis and interpretation. 
To determine the overall estimates of stroke epidemiology and impact variables in Africa, the 
overall means with standard deviation (SD) were calculated. 
 
1.3 Results 
The search results and review profile are shown in Figure 1.1. I identified a total of 466 
references from which 44 studies were eligible for my review. 
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Figure 1. 1: Review profile showing selection of studies reporting on epidemiology or 
impact of stroke in Africa 
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Table 1. 1: Studies reporting the incidence of stroke in Africa 
Study  
Reference 
Country Location Rural/  
Urban 
Data collection  
Period 
Sample size Age 
group 
First ever 
or 
Recurrent 
N. of 
cases 
Crude 
incidence 
/100,000 
Age-
adjusted 
incidence  
/100,000 
Hospital-based studies 
Ashok et al., 1986 Libya  Benghazi Urban Nov 1983-Oct 1984 518,745 All First ever 329 63  
Rosman, 1986 SA Pretoria  Urban  May 1984-Apr 1985 114,931 ≥ 20 All 116 101  
Matenga, 1997 Zimbabwe Harare Urban Jan-Dec 1991 887,768 All First ever 273 30.7 68 
Damasceno et al., 2010 Mozambique Maputo Urban Aug 2005-Jul 2006 2007 Census* ≥ 25 All 651 148.7 260.1 
Community-based studies 
Kandil et al., 2006 Egypt Sohag Mixed 1992 20,900 All All 39 186.6  
Walker et al., 2010 Tanzania Hai  
D-e-S 
Rural   
Urban 
Jun 2003-Jun 2006 159,814       
56,517 
All All 453   
183          
94.5  
107.9  
108.6  
315.9   
Farghaly et al., 2013 Egypt Al Kharga Mixed Jan-Dec 2007 62,583 All All 156 250  
El Tallawy et al., 2013 Egypt Al Quseir Urban Jul 2009 – Jan 2012 19,848 ≥ 20 All 36 181  
Okon et al., 2015 Nigeria Akure  Urban Nov 2010-Oct2011 491,033 All First ever 298 60.69 60.67 
Abbreviations: D-e-S, Dar-es-Salaam; N., Number; SA, South Africa 
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There were four hospital-based and five community-based studies on incidence of stroke in 
Africa. The hospital-based studies provided a crude incidence mean of 85.9 (SD: 
50.8)/100,000 population. The age-adjusted stroke incidence mean from two hospital based 
studies was 164.1 (SD: 135.8)/100,000 population. Regarding the community-based 
studies, the crude stroke incidence mean was 146.8 (SD: 70.81)/100,000 population. The 
community-based age-adjusted stroke incidence mean from three African settings was 
161.7 (SD: 135.7)/100,000 population. For all the studies on incidence in Africa, the crude 
incidence mean was 122.4 (SD: 68.1)/100,000 population while the age-adjusted incidence 
mean was 162. 7 (SD: 117.5) /100,000 population.    
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Table 1. 2: Studies reporting the prevalence of stroke in Africa  
Study 
Reference 
Country Location Rural/  
Urban  
Data collection period Sample 
size 
Age 
group 
N. of 
cases 
Crude 
prevalence 
/100,000 
Age-adjusted 
prevalence 
/100,000 
Osuntokun et al., 1987 Nigeria Igbo-Ora Urban 1982-1983 18954 All 11 58  
The SASPI Project Team, 2004 SA Agincourt subdistrict Rural Aug-Nov 2001 42 378 ≥15 103 243 330 
Kandil et al., 2006 Egypt Sohag Mixed Jan 1992-Apr 1993 25000 All 127 508  
Danesi et al., 2007 Nigeria Lagos Urban Jun 2005-May 2006 13,127 All  15 114 114 
Cossi et al., 2012a Benin Cotonou Urban Sept 2008- May 2009 15,155 ≥ 15  70 460 870 
El Tallawy et al., 2013 Egypt  Al Quseir  Urban Jul 2009 – Jan 2012 19,848 ≥20 130 655  
Farghaly et al., 2013 Egypt Al Kharga Mixed Jun 2005-May 2008 62,583 All 351 560  
Khedr et al., 2013 Egypt  Assiut Governorate  Urban Jan-Dec 2010 5920 ≥15 57 963 980.9 
Khedr et al., 2014 Egypt Qena Governorate Mainly Rural Sept 2011-Aug 2013. 8027 All 74 922  1221.7  
Engels et al., 2014 Morocco Rabat-Casablanca Mixed Nov 2008-Apr 2009 44742 ≥15 127 284  
Enwereji et al., 2014 Nigeria Ukpo  Rural 2011 6,150 All 10 163 100 
Onwuchekwa et al., 2014 Nigeria Niger Delta Rural July 2008 1057 ≥18 9 851 1230 
El Tallawy et al., 2015 Egypt Upper Egypt Mixed Jan 2006-Jan 2012 55,664 ≥20 470 844   
Sanya et al., 2015 Nigeria Kwara state Semi-urban Oct 2009- Aug 2010 12,992 ≥18 17 131  
Ezejimofor et al., 2017 Nigeria Niger Delta Rural June-Sept 2014 2028 ≥18 27 1331 1460 
Abbreviations: N., Number; SA, South Africa, SASPI: Southern Africa Stroke Prevention Initiative 
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Fifteen studies in total reported on the prevalence of stroke in Africa, and they were all 
community-based. One study in Egypt (El Tallawy et al., 2015) included seven transient 
ischemic attack (TIA) cases. These were removed and a total of 470 stroke cases only were 
considered in the current review. The highest crude prevalence was reported in Nigeria 
(1331/100,000 population) and the lowest was reported in Nigeria (58/100,000 
population). The crude prevalence mean is 539.1 (SD: 381.5)/100,000 population. 
Some studies determined the age-adjusted prevalence of stroke which ranges between 100 
(Ukpo, Nigeria) and 1460 (Niger Delta, Nigeria) /100,000 population, an age-adjusted 
prevalence mean of 788.3 (SD: 536.7)/100,000 population. 
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Table 1. 3: Studies reporting the mortality of stroke in Africa  
Study 
Reference 
Study Location Rural/ 
Urban 
Data collection period Sample 
size 
Age 
group  
N. of deaths 
due to stroke 
Crude Rate/ 
100,000 
Age-standardized 
rate /100,000 
Osuntokun et al., 1987 Nigeria Igbo-Ora Urban Jan1982-Jun 1983 18,954 All   - 70  
Kahn and Tollman, 1999 SA Agincourt District Rural 1992 -1995   - ≥35 55 127  
Walker et al., 2000 Tanzania Dar-es-Salaam Urban Jun 1992-May 1995 65,826 ≥15 104 79.5* 368.5*  
  Hai  Rural  142,414  235 99.5*  134.5*  
  Morogoro Rural  99,672  82 47.5*  75*  
Abbreviations: N., Number; SA, South Africa 
* Numbers are averages from original separate data for females and males  
 
There were three community-based studies that repored on stroke mortality in Africa. With regard to crude mortality, the highest rate was found in 
South Africa (127/100,000 population) and the lowest was reported in Morogoro District of Tanzania (47.5/100,000). The overall crude mortality 
mean rate was 84.7 (SD: 30.15)/100,000 population.  
The study in Tanzania (Walker et al., 2000) determined the age-standardized mortality rate ranging between 75/100,000 population in the rural 
setting of Morogoro District and 368.5/100,000 population in the urban setting (Dar-Es-Salaam). The age-adjusted mortality mean rate was 
192.7(SD: 155.2)/100,000 population. 
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Table 1. 4:  Studies reporting one-month stroke case fatality rate in Africa 
Study 
Reference 
Country Location Rural/ 
Urban  
Data collection period N. of stroke 
cases 
First ever/ 
Recurrent 
Age 
group 
N. of stroke 
deaths  
CF rate 
(%) 
 Hospital-based studies 
Ashok et al., 1986 Libya  Benghazi Urban Nov 1983-Oct 1984 329 First ever All 57 17.3 
Rosman, 1986 South Africa  Pretoria  Urban  May 1984-Apr 1985 116 All ≥ 20 - 33.6 
Walker et al., 2003 Gambia  Banjul Urban 1990-1991 106 All All 29  27 
Garbusinski et al., 2005 Gambia  Banjul Urban Feb 2000-Feb 2001 148 All ≥15 - 46 
Komolafe et al., 2008 Nigeria  Ile-Ife Urban 2000-2005 135 All All 21 15.6 
Longo-Mbenza et al., 2008 DRC Kinshasa Urban 1989-1992 212 All All 94 44 
Damasceno et al., 2010 Mozambique  Maputo Urban Aug 2005-Jul 2006 651 All ≥ 25 - 49.6 
Musa et al., 2012 Nigeria  Maiduguri Urban 2005-2009 91 First ever All 18 19.78 
Alkali et al., 2013 Nigeria  Abuja Urban Jan 2010 –Jun 2012 272 All ≥25 51 18.8 
Owolabi and Nagoda, 2013 Nigeria  Kano Urban Jun 2007-Jun 2010 273 All All 102 37 
Kwarisiima et al., 2014 Uganda  Mulago Urban Jul 2010-Jan 2011. 128 All ≥18 56 43.8 
Ekeh et al., 2015 Nigeria  Jos Urban Jan-Dec 2006 120 All ≥16 40 33.3   
Nakibuuka et al., 2015 Uganda  Kampala Urban Feb-July 2014 127 All All 34 26.8 
 Community-based studies 
Walker et al., 2011 Tanzania  Hai District Rural Jun 2006- Jun 2009 353 All All 95 26.9 
Danesi et al., 2013 Nigeria  Lagos Urban Jan-Dec 2007 160 First ever All 26 16.2  
Abbreviations: CF, case fatality; N., Number; %, percentage 
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Almost all the studies on one-month stroke case fatality in Africa (86.7%) were hospital 
based and showed that stroke case fatality in Africa for one month varies between 15.6% 
and 49.6%. The case fatality mean rate in one-month post stroke as reported by hospital-
based studies in Africa was 31.7% (SD: 11.8%). The community-based studies found that 
one-month fatality rate was 16.2% in Nigeria and 26.9% in Tanzania, with a mean equal to 
21.6% (SD: 7.6%). Overall, the one-month case fatality mean rate for stroke in African 
studies was 30.4% (SD: 11.7%). 
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Table 1. 5: Studies reporting the disability of stroke survivors in Africa 
Study 
Reference 
Country Location Rural/ 
Urban 
Data collection 
period 
Sample 
size 
Age 
group  
Assessment 
Tool 
Period post 
stroke  
Disability categories (%) 
         Mild Moderate Severe 
Komolafe et al., 2008 Nigeria Ile-Ife Urban 2000-2005 111 All GOS 30 days 7.2 66.7 26.1 
Damasceno et al., 2010 Mozambique Maputo Urban Aug 2005-July 2006 370 ≥25 mRS 28 days 35.6 27.8 36.6 
de Villiers et al., 2011 South Africa Cape Town Urban Aug 2004- Jan 2006 117 All mRS  6 months  52 26 22 
Heikinheimo et al., 2012 Malawi Blantyre Urban Feb 2008 -Apr 2009 96 ≥18 mRS 6 weeks 33.3 31.3 35.4 
     81   6 months 59.3 24.7 16.0 
     72   1 year 69.4 15.3 15.3 
Owolabi and Nagoda, 2012 Nigeria Kano Urban Jun 2008-Jun 2010 106 All mRS 6 months  66 11 23 
Abbreviations: GOS, Glasgow Outcome Scale; mRS, modified Rankin Scale; %, percentage 
 
Most of the studies conducted on disability in Africa included in the review used the modified Rankin Scale. As shown in table 1.5, it was found 
that at one-month post stroke, 64.4% (Mozambique) and 92.8% (Nigeria) of stroke survivors have moderate or severe disability.  
At 6-month post stroke, many stroke survivors (34% in Nigeria, 40.7% in Malawi, and 48 % in South Africa) have moderate or severe disability. 
At one-year post stroke, 30.6% of stroke survivors have moderate or severe disability. 
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Table 1. 6: Studies reporting the quality of life among stroke survivors in Africa  
Study 
Reference 
Country Location Rural/ 
Urban  
Data collection period Sample 
size 
Age 
group 
Tool Post-stroke duration Mean 
score 
Owolabi and Ogunniyi, 2009 Nigeria Ibadan Urban 2002-2004 100  HRQOLISP 28.5 months 73.5% 
Donkor et al., 2014a Ghana  Accra and Tema Urban Jan 2012-Sept 2013 156 All HRQOLISP 29 months (Mean) 69% 
Heikinheimo and Chimbayo, 
2015 
Malawi  Blantyre Urban Aug 2008-Apr 2010 25 ≥18 NEWSQOL 6 months a 78% b 
Abbreviations: NEWSQOL, Newcastle Stroke-specific Quality of Life Measure; HRQOLISP; Health Related Quality of Life in Stroke Patients 
a: Seven interviews were conducted at 12 months post stroke. 
b: The mean was calculated using the reported mean scores for all NEWSQOL domains 
 
Three studies only were included in my review, and they were all community-based. One study measured the level of quality of life of 25 
participants at six or 12 months post stroke using the NEWSQOL and showed that the score across the QoL domains was ranging between 70%-
88%, with a mean of 78%, meaning good QoL. The other ones in Ghana (Donkor et al., 2014a) and Nigeria (Owolabi and Ogunniyi, 2009) 
assessed the quality of life post stroke at an average of 29 months post stroke using the HRQOLISP and revealed that the participants had neither 
poor nor good QoL (69% and 73.5%, mean=71%). 
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Table 1. 7: Studies reporting the cost of stroke in Africa 
Study  
Reference 
Country Location Rural/ 
Urban 
Data collection 
period 
Sample 
size 
Age 
group 
Estimation 
procedure 
Length  
of care 
Currency Mean Mean* in 
USD-2016   
Adoukonou et al., 2013 Benin Parakou Urban Jun 210-May 2011 78 All Bottom up 14.4 days CFA-2011 316,810.3  1588.21 
Gnonlonfoun et al., 2013 Benin Cotonou Urban Feb-Sept 2001 122 ≥20 Bottom up    - USD-2011 1030 1105.17 
Mapoure et al., 2014 Cameroon Douala Urban Apr 2012-Apr 2013 71 >15 Bottom up  
        In hospital care cost 
        10 days CFA 2013 718,970 3220.47 
        After discharge care cost 
        9 months CFA 2013 1,031,888 4622.12 
Abbreviations: CFA, Communauté financière d'Afrique (Financial Community of Africa) franc 
* The cost data were converted to 2016 USD currency values using a web-based tool (CCEMG-EPPI-centre cost converter) 
 
Three studies were considered for review about the cost of stroke care in Africa. All the included studies focused on the direct cost, being medical 
or non-medical. Considering the in-hospital care cost, the mean of the estimates as reported in the three studies was 1971 (SD: 1108) USD. A 
single study conducted in Cameroon (Mapoure et al., 2014) showed a higher cost for the post-discharge period (4622.12 USD). 
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1.4 Discussion 
1.4.1 Incidence of stroke in Africa 
In total, nine studies on the incidence of stroke in Africa were identified. Eight of the nine 
studies were conducted over a period of one year, and the remaining study (Walker et al., 
2010) was conducted for a period of three years. Four out of the nine studies were hospital-
based, and most of them were conducted between 1983 and 1991. The hospital-based studies 
are subject to several limitations and their results must be interpreted with caution. First, 
hospital-based data cannot provide reliable incidence estimates because the population at risk 
(i.e. the denominator) is not well known (Owolabi et al. 2015). Second, hospital-based studies 
underestimate stroke incidence as a result of exclusion of fatal or mild cases who do not 
present to hospital. For instance, transport problems and large distances to hospital from some 
patients’ homes in Africa mean that a significant number of patients with stroke die before 
reaching the hospital. Third, hospital-based studies do not capture patients who patronise 
traditional healers or those who don’t go to hospital at all because of financial problems. Five 
studies reporting on stroke incidence in Africa were community or population-based and most 
of them were conducted between 2003 and 2011, indicating that in Africa there has been a 
progressive shift from hospital-based to community or population-based studies on stroke 
incidence.  
The case ascertainment was achieved by a clinical examination mainly based on WHO clinical 
criteria (WHO, 1988) and confirmed by CT or MRI scan, except for one study (Matenga, 
1997) where the diagnosis was determined based on the WHO clinical criteria alone. 
However, case ascertainment for stroke in Africa is very difficult due to several challenges 
such as difficulties resulting from the very large study populations with limited resources, and 
because of non-inclusion of those who patronise traditional healers (Osuntokun et al., 1979; 
Owolabi et al., 2015). 
The hospital-based studies on incidence of stroke in Africa provided a crude incidence mean 
of 86/100,000, and an age-adjusted stroke incidence mean from two studies (Matenga, 1997; 
Damasceno et al., 2010) of 164/100,000 population. There was a wide range of results from 
the hospital-based studies of crude stroke incidence: 30.7 per 100,000 population in 
Zimbabwe, 63 in Libya, 101 in South Africa, and 148.7 in Mozambique. Although not all the 
studies provided the age-adjusted stroke incidence to allow easy comparison, the variation in 
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the results may be partly explained by the methodological differences across the four hospital-
based studies. For instance, studies with higher crude stroke incidence (Rosman, 1986; 
Damasceno et al., 2010) not only included both first ever and recurrent incidences, but also 
they recruited participants aged 25 years and above in Mozambique (Damasceno et al., 2010), 
20 years and above in South Africa (Rosman, 1986), while other studies (Ashok et al., 1986; 
Matenga, 1997) considered first ever stroke incidents only and included all age groups. 
Different studies have shown that the risk of stroke increases with age (Feigin et al., 2003; 
Connor et al., 2007). 
The current crude stroke incidence mean is higher than the pooled estimate (77.4/100,000 
population) found in a meta-analysis of hospital-based studies (Adeloye, 2014), the observed 
difference may be because the meta-analysis included a study with a low rate of 48.0/100,000 
population which did not meet my inclusion criteria because its full text was not available for 
my current review. Community-based studies yielded higher crude incidence mean rate 
(147/100,000 population). It has been noted that hospital-based studies underestimate the 
incidence rates because they are affected by referral bias as patients who die quickly from 
stroke or those with mild stroke do not present in hospitals (Owolabi, 2011). Furthermore, in 
African cultures, stroke can be attributed to a supernatural force requiring intervention by a 
traditional healer (Mshana et al., 2008), and some people with stroke symptoms may not 
present to hospitals, leading to the underestimation of stroke incidence. 
However, the community-based age-adjusted incidence mean rate (162) was slightly lower 
than the hospital-based one (164/100,000 population). In fact, one (Damasceno et al., 2010) of 
the two hospital-based studies that reported the adjusted incidence rates included only 
participants of 25 years old and above while the community-based studies (Walker et al., 
2010, Okon et al., 2015) included all age groups. This could have resulted in higher hospital-
based rates since we know that the risk for stroke increases with age (Feigin et al., 2003; 
Connor et al., 2007).  
The current community or population-based studies review results are higher than the results 
from previous similar reviews which revealed the population-based crude incidence of 73-165 
(Feigin et al., 2009) and 112.94 (Adeloye, 2014) per 100,000 population. Some factors may 
have contributed to the lower rates reported by these reviews: two studies with low incidence 
rates (25.2 and 26.0/100,000 population) were considered in the review by Adeloye (2014) but 
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which were not included in my review on community-based stroke incidence. One of the two 
studies was published in 1979 while the other one did not include persons who died from 
stroke before presenting to hospital. The rate reported by Feigin et al. (2009) is for LMICs 
among which only one African country (Nigeria) was included. In addition, the rate as 
reported by Feigin et al. (2009) is for the period from 2000 to 2008. After the year 2008, there 
may have been increasing incidence.  
The results from the community-based Tanzanian study (Walker et al., 2010) showed that the 
age-adjusted stroke incidence in Dar-es-Salaam (316) is higher than the rates for HICs 
(246.32; 221.19; and 217.26 in 1990; 2005; and 2010 respectively) and the rates for all LMICs 
in general (251.93; 277.48; 281.12 in 1990; 2005; and 2010 respectively) (Feigin et al., 2014). 
The recent GBD 2016 estimates indicate that while the age-standardised incidence declined 
from 1990 to 2016 globally (–8.1% [–10.7 to –5.5]), it increased for 1.9% (–0.5 to 4.7) in 
southern sub-Saharan Africa (GBD 2016 Stroke Collaborators, 2019). Urbanisation, growing 
industrialisation, and other socio-demographic and lifestyle changes in Africa, are increasing 
rapidly and, in the absence of effective preventive measures, this is likely to lead to further 
substantial increases in stroke incidence. 
1.4.2 Prevalence of stroke in Africa 
All 15 studies on stroke prevalence in Africa included in this review were community or 
population-based. Community or population-based studies constitute the best way to 
determine the true prevalence of stroke, although they are very rare in Africa due to lack of the 
required resources (Owolabi et al., 2015). The observed crude prevalence rates of stroke 
survivors varied between 58 (in Igbo-Ora, Nigeria) and 1331 (in Niger Delta, Nigeria) with a 
mean rate of 539 per 100, 000 population.  
The low prevalence rate that was recorded in Nigeria in 1982-1983 (Osuntokun et al., 1987) 
may be attributed to various factors. It may be due the high case fatality rates from stroke, 
which has generally been reported in many parts of Africa (Bonita and Truelsen, 2003). The 
result is also likely an underestimate because the study was a broad door-to-door survey of 
neurological disorders in the community, which could imply that active case recognition of 
specific stroke cases may be less rigorous. Furthermore, the reported prevalence rate is a point 
prevalence as the new stroke cases which occurred after the reference date (15 February 1982) 
were not included (Osuntokun et al., 1987). The study period could be another factor. The 
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survey was done in 1980’s, and after that period the stroke incidence and prevalence could 
have increased as suggested by the literature (Feigin et al., 2003; Ezejimofor et al., 2016). 
Finally, because of Nigerian cultural attitudes, some stroke survivors may have been hidden 
and not made available to interviewers during the survey (Osuntokun et al., 1987). In fact, 
some interviewers were strangers in their data collection areas, and subjects tend to be 
unwilling to offer information to unfamiliar faces about their relatives suffering from stroke 
which is sometimes regarded as a social stigma in Africa (Osuntokun et al., 1987) 
The crude prevalence mean rate of 539/100,000 population is higher than the previous pooled 
prevalence rate of 388/100,000 population from a meta-analysis (Adeloye, 2014) which 
included two studies from Ethiopia (Tekle-Haimanotet al., 1990) and Tunisia (Romdhane et 
al., 1993) reporting low prevalence rates (15 and 42/100,000 population respectively), but did 
not meet the inclusion criteria for my review as their full texts were not available. 
The age-adjusted mean prevalence of 788 found in this current review was higher than the 
rates of 546; 676 and 715 for HICs in 1990; 2005 and 2010 respectively, and higher than the 
rates for all LMICs in general (360; 387; and 393 in 1990, 2005 and 2010 respectively) 
(Feigin et al., 2014). The high age-adjusted prevalence of stroke as revealed by the current 
review may reflect the increased exposure to risk factors for stroke in Africa due to ongoing 
epidemiological and demographic transitions (Owolabi et al., 2015). 
 
1.4.3 Mortality rate of stroke in Africa 
It is very difficult to estimate the mortality burden of stroke in Africa as the relevant studies 
are rare. Three studies only (Nigeria, Tanzania and South Africa) which were community-
based have been included in my review. The highest crude mortality rate was found in South 
Africa (127/100,000 population) and the lowest was reported in Morogoro District of 
Tanzania (47.5/100,000). The crude mortality rate mean is 85/100,000 population. The high 
mortality rate in South Africa was likely influenced by considering a population of at least 35 
while the study in Nigeria included all age groups and the study in Tanzania included the 
population of 15 years and above. The low rate reported in Morogoro, a rural area of Tanzania 
is probably due to lower exposure to stroke risk factors, and consequently lower stroke 
incidence. 
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It is a challenge to compare the results on stroke mortality rate in Africa as only one study 
conducted in three different areas of Tanzania including Dar-es-Salaam (urban), Hai 
(prosperous rural) and Morogoro (impoverished rural) provided the age-adjusted mortality rate 
ranging between 369/100,000 population in the urban setting (Dar-Es-Salaam) and 75/100,000 
population in the rural setting of Morogoro District, with an overall mean rate 193/100,000 
population. This age-adjusted mortality rate is higher than the rates in HICs (96; 72; and 61 
per 100,000 person years in 1990, 2005 and 2010 respectively) (Feigin et al., 2014). The 
higher stroke mortality in Africa may be attributed to the high stroke incidence rate associated 
with poor health care services. As the African population is undergoing epidemiological and 
demographic transitions leading to risk factors for stroke, mortality rate for stroke is expected 
to increase in the absence of relevant preventive, curative and rehabilitative interventions to 
mitigate the burden. 
1.4.4 One-month case fatality rate of stroke in Africa 
Thirteen out of 15 studies (87%) reporting one-month stroke case fatality rate (CFR) in Africa 
were hospital-based, and provided rates ranging from 16% and 50% with a mean rate of 32%. 
The results are however biased towards urban settings (with reasonably better resourced 
health-care systems) than rural settings. This hospital-based CFR mean observed in my review 
is higher than the one-month CFR of 22% in the African countries as shown by the hospital-
based INTERSTROKE study (O’Donnell et al., 2010). The lower rate reported by the 
INTERSTROKE study might be due to having involved five African countries only and 
selected patients for inclusion in the study.   
The variations in CFR across African countries can be attributed to both study methodologies 
and differences in quality of stroke care. Most of the studies with lower case fatality did not 
include patients with high risk of death. For instance, in the study in Maiduguri, Nigeria with a 
CFR of 19.8%, patients with diagnosis of subarachnoid hemorrhage, subdural hematoma, 
those with a past history of stroke, and those who died within 24 hours of admission were 
excluded. The CFR found in Ile-Ife, Nigeria (15.6%) was lower than the rate of 17% identified 
from the Oxfordshire community stroke study in UK. The Nigerian study was hospital-based 
and showed that some patients presented to the hospital very late, up to two weeks after the 
onset. It is most likely that patients with severe stroke died before reaching the hospital, thus a 
low in-hospital CFR. 
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The observed high CFRs in Maputo, Mozambique (50%) and Banjul, Gambia (46%) have 
been attributed to the scarce human, technical, and pharmacological resources; patients are 
cared for in a general medical ward and not in stroke units, thrombolysis is not available for 
acute management of stroke, and there is poor access to secondary and tertiary prevention 
(Damasceno et al., 2010). The study in Gambia also showed that the high CFR for stroke is 
associated with poor accessibility to hospital care, swallowing difficulties, lung infection, 
fever, bed sores, and absence of aspirin treatment (Garbusinski et al., 2005).  
By contrast, lower CFRs were reported in settings with better health care systems. For 
example, in Benghazi (Libya) with a rate of 17% (Ashok et al., 1986), the medical 
organisation was reported to be efficient and comprehensive. Patients were referred from the 
walk-in polyclinics to the four university hospitals and to a rehabilitation centre for persons 
with disabilities. The health care was public and free, patients with neurological problems 
were referred from the medical clinics and university hospitals to the neurology outpatient 
clinics. In addition, there was a Neurology Unit in Benghazi with three qualified neurologists, 
and neuro-radiological investigations were facilitated by the availability of two computed 
tomography scanners in Benghazi. All the stroke cases were personally examined by one of 
the neurologists (Ashok et al., 1986). 
Post-stroke CFRs should ideally be calculated using community-based studies because of the 
likelihood that many patients are not admitted to hospital (Connor et al., 2007). This review 
identified two community-based studies which provided a one-month CFR of 16% and 27% in 
Nigeria and Tanzania respectively, with a mean equal to 22%. The mean community-based 
CFR found in the current review falls within the rate range of 18-35% for all LMICs reported 
previously (Feigin et al., 2009), but is lower than the median hospital-based rate found. Case 
fatality rates may be higher in hospital-based than community-based studies (as was found in 
the current review) because the hospital-based studies may be affected by referral bias. In fact, 
often only those with moderate to severe stroke, consequently with higher risk for death, tend 
to present to hospital. However, I believe the findings from the two community-based studies 
provided an underestimated CFR. The study in Nigeria (Danesi et al., 2013) determined the 
CFR based on hospitalized patients only, and the limitations of such a data collection approach 
were discussed earlier. The findings from the study in Tanzania (Walker et al., 2011) are also 
likely to be underestimates because data was collected by verbal autopsy (VA) and the 
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information being gathered retrospectively, relies heavily on the recall of those interviewed for 
the VA and, therefore, may be inaccurate (Walker et al., 2011). 
Despite the limitations I discussed above for the underestimation of CFRs, the overall one-
month mean CFR for stroke in Africa from both hospital and community-based studies of 30% 
is higher than the CFR in High Income Countries (HICs) (21.5%, 22.2% and 19.8% in 1980–
89, 1990–99, and 2000–2008, respectively) (Feigin et al., 2009). This difference could be due 
to variations in stroke severity or co-morbidities but it seems more likely that it can be 
explained by poorer management of stroke in Africa compared with the management in HICs 
(Ingall et al., 2000). 
1.4.5 Disability post stroke in Africa 
Five studies were included in this review for disability among stroke survivors in Africa, but 
none of them assessed DALYs due to stroke. Rather, they assessed levels of activity 
limitations and participation restrictions using the mRS (Damasceno et al., 2010; de Villiers et 
al., 2011; Heikinheimo et al., 2012; Owolabi and Nagoda, 2012) and Glasgow outcome scale 
(GOS) (Komolafe et al., 2008).  
At one-month post stroke, 64% and 93% of stroke survivors in Mozambique (Damasceno et 
al., 2010) and Nigeria (Komolafe et al., 2008), respectively, were reported to have moderate or 
severe disability. The percentage in Nigeria may be high because the study used a different 
outcome measure (GOS), and patients corresponding to score 1 (No significant disability 
despite symptoms) and score 2 (Slight disability) of the mRS could have been classified as 
having moderate disability. Therefore, results from the two studies should be compared with 
caution. 
At six-month post stroke, the proportion of stroke survivors left with moderate or severe 
disability in Nigeria, Malawi and South Africa, ranged from 34 to 48%. The differences in 
proportion of patients with moderate or severe disability at six months could be due to the 
quality of care and rehabilitation post discharge.  The management of stroke patients in the 
rehabilitation centers in Nigeria was in accordance with Aminu Kano Teaching Hospital 
guideline on stroke management which is a modification of American Heart 
Association/American stroke association (AHA/ASA) guidelines (Owolabi and Nagoda, 
2012). In Malawi, some patients were transferred to a residential rehabilitation unit and others 
continued getting outpatient physiotherapy, but no information was provided about the 
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structure and process of the rehabilitation post discharge (Heikinheimo et al., 2012). The study 
in South Africa however, was conducted in a socio-economically disadvantaged community 
where poor housing was found to be an independent predictor of poor functional outcome, and 
there were limited rehabilitation resources (de Villiers et al., 2011).  
The study in Malawi (Heikinheimo et al., 2012) indicated that at one-year post stroke, 31% of 
stroke survivors have moderate or severe disability. The decrease in percentages of stroke 
survivors with moderate to severe disability from one month to six and 12 months post stroke 
may reflect improvement from rehabilitation services and secondary prevention of stroke 
(Owolabi and Nagoda, 2012). However, some of the patients lost to follow-up across the 
studies included in this review could be as a result of unreported death at home as disability 
was found to be an independent predictor of death post stroke. In addition, some stroke 
survivors with severe disability may have been hidden by family members and not made 
available for assessment due to the stigma attached to disability. 
Stroke is estimated to be the seventh leading cause of DALYs (Feigin et al., 2009). Estimates 
indicated there were 102.2 million DALYs in 2010 with 78% of them attributed to LMICs 
only (Feigin et al., 2014). Direct studies of DALYs due to stroke are very rare in Africa. The 
burden of disease due to stroke in South Africa (2008) was 564 000 DALYs, and of this, 17% 
was contributed by years lived with disability (Bertram et al., 2013). The estimated proportion 
of DALYs due to stroke was in 2002 (Johnston et al., 2009) 1,230 per 100,000 in Angola 
(Africa), compared to 200 per 100,000 in Switzerland (Europe).  
It was not possible to compare the current results on disability in Africa with the results from 
international studies which used the common DALYs approach. Future researchers on 
disability post stroke in Africa are therefore encouraged to adopt the common international 
approaches. Despite the limitations, the studies included in this review indicate that disability 
post stroke is common in Africa. Disability, as manifested by limitations in activities of daily 
living and restrictions in involvement in social life, is a burden not only to the survivor but 
also to his or her family and society in general. There is therefore a need for appropriate 
strategies for the prevention and rehabilitation of post-stroke disability. 
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1.4.6 Quality of life among stroke survivors in Africa 
Assessment of QoL could help both in understanding the areas in which a patient is most 
affected by a disease and in planning effective therapeutic and rehabilitative interventions 
(Owolabi and Platz, 2008). Studies on QoL post stroke in Africa are however very rare. Only 
three studies were available and met inclusion criteria for my review. Referring to the guide 
for score interpretation provided by Ali et al. (2013), one study (Heikinheimo and Chimbayo, 
2015) reported that stroke survivors had good quality of life (the mean score was >75%) at 6 
to 12 months post stroke while the remaining two studies (Owolabi and Ogunniyi, 2009; 
Donkor et al., 2014a) reported moderate quality of life (the mean score was 71%) at 29 months 
post stroke. 
Although those three studies used standardized instruments with good validity and reliability 
(Buck et al., 2004; Owolabi and Ogunniyi, 2009), they have some limitations that raise 
concerns about the external validity of the results. Firstly, the study samples were not 
representative because stroke survivors with very poor quality of life do not participate in 
study interviews. For instance, out of 81 stroke survivors at six months (Heikinheimo and 
Chimbayo, 2015), 23 of them with severe expressive or receptive dysphasia and four who 
were severely ill or bed-ridden did not participate to the NEWSQOL interview. The study in 
Ghana (Donkor et al., 2014a) recruited participants attending two major urban hospitals for 
rehabilitation only, and who developed stroke at least one month before the time of interview 
in order to exclude acute cases of stroke. Secondly, the majority of the stroke survivors in the 
study in Ghana (52.6%) had experienced mild stroke. Finally, responses for some stroke 
survivors with communication problems were provided by their caregivers (Donkor et al., 
2014a), and I believe that the information provided by a caregiver may not represent the real 
life experiences of the stroke survivor. 
1.4.7 Cost of stroke in Africa 
The cost of the disease comprises both direct and indirect cost. Direct cost encompasses 
medical treatment and various mobilized resources in order to improve and stabilize the 
disease (hospitalization cost in acute stage, rehabilitation care, ambulatory care, care from 
relatives and next of kin) (Mamoli et al., 1999). Estimating indirect cost is pretty complex as it 
globally comprises the socio-professional effects on the disease (loss of productivity, 
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absenteeism, work or activity cessation, social aid, adjustment to social life, incentives in com- 
pensation to the disability etc.) (Claesson et al., 2000).  
Measuring cost of stroke in Africa is very difficult. Due to limited resources, estimating the 
lifetime costs of a stroke from its onset to its termination, especially the follow-up after 
discharge from hospital, is a major challenge, and the available relevant studies provide only a 
snapshot of costs at a particular point in time. Aditionally, some patients in Africa spend more 
money by consulting traditional healers because they still believe that stroke is related to bad 
spiritual forces (Mapoure et al., 2014), and capturing such costs is a big challenge. Poor 
documentation in Africa is another problem. For instance, a pilot study (Kabadi et al., 2013) 
that was conducted in Tanzania did not include the costs of physiotherapy services for one of 
the study settings because they were not available. Regarding the indirect cost of stroke, the 
productivity losses are likely to be undervalued in the estimation process for patients without 
formal employment from which actual monetary losses can be precisely estimated. 
Furthemore, actual productivity losses can be underestimated due to recall bias and/or the 
difficulty in documenting and valuing all gainful activities patients were involved in before 
stroke (Kabadi et al., 2013). 
Three studies (Adoukonou et al., 2013; Gnonlonfoun et al., 2013; Mapoure et al., 2014) were 
considered for review about the cost of stroke in Africa. All the included studies focused on 
the direct cost. The in-hospital care mean cost per patient was found to be 1,971 USD. It was 
also reported that length of hospitalization, hemorrhagic stroke, and stroke initial severity 
(Adoukonou et al., 2013; Gnonlonfoun et al., 2013) are the most powerful factors influencing 
the cost of stroke.  
The cost variations are not surprising if we consider the differences in research methodologies, 
hospital levels and the management systems across and within countries. The Benin study 
(Gnonlonfoun et al., 2013) conducted in Cotonou (cost mean: 1,105 USD) aimed to determine 
factors associated with direct cost of stroke hospitalization while the other Benin study 
(Adoukonou et al., 2013) in Parakou (cost mean: 1,588 USD) aimed at determining the direct 
cost of in-hospital stroke care, which could imply that recording the cost for stroke patients 
may be more rigorous. 
The highest cost in Cameroon of USD 3,220 per person could be due to several reasons. First, 
the study in Cameroon was conducted in a specialized hospital that has neurologists, 
physiotherapists, speech therapists and occupational therapists, and various diagnostic 
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procedures like CT scanning, electrocardiogram, trans-thoracic echocardiogram, and the 
supra-aortic duplex ultrasound among others, and those resources are not or are rarely found in 
other settings. Secondly, the Cameroonian setting was a specialized hospital in Douala, the 
richest city in the whole Economic and Monetary Community of Central Africa (CEMAC) 
region, and the prices of goods and services are likely to be high. Additionally, it was reported 
that since 2008 in Cameroon, there was an increase of salaries for the employees including the 
health care professionals (Mapoure et al., 2014).  Finally, the aim of the study was to find the 
data to serve as an evidence to advocate for the financial support from the Government of 
Cameroon for the management of stroke patients (Mapoure et al., 2014). Consequently, the 
recording of stroke costs may have been more rigorous than in other studies.  
It appears that stroke patients in Africa have less spent on them than patients in HICs do for 
example 70,330 USD per patient in Sweden (Jorgensen et al., 1997), £15,306 per patient in 
UK (Beech et al., 1999), and €17,799 per patient in France (Launois et al., 2004). In reality 
however, they spend a greater proportion of income than patients from HICs if we consider 
their low purchasing power. For instance, the ratio cost/gross domestic product (GDP) per 
inhabitant in Benin (Gnonlonfoun et al., 2013) shows that the direct cost per patient represents 
in Benin 1.3 times the GDP per inhabitant. Accordingly, most people from Benin cannot 
access specialized neurology care for a stroke. 
To sum up, the cost of stroke constitutes a high economic burden in Africa, but the available 
data appears to underestimate the real total cost. In fact, most of the studies did not include the 
cost of care post discharge, and all the studies did not include the indirect cost associated with 
changes in productivity resulting from stroke, including productivity gains or resulting from 
patient time spent in treatment or healthcare facilities.  
Strengths and weaknesses 
Several systematic reviews on stroke in Africa have been published previously but, to the best 
of my knowledge, this review on the epidemiology and impact of stroke in Africa seems to be 
more up-to-date and comprehensive. My review was systematic, and I searched many relevant 
databases including Medline, Embase, PubMed, and AJOL, with no language restriction. In 
addition, the STROBE guidelines were used to assess the identified publications while the 
PRISMA ones were used to write the review report. However, my review may well be subject 
to publication bias as only the electronic databases and references were considered. 
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Furthermore, the investigators of the identified studies were not contacted to confirm data, and 
two persons (GU and PL) only were involved in screening and quality assessment of the 
identified studies. The studies included for the review had various limitations and the results 
need to be interpreted with caution. Last but not least, most of the studies reviewed were 
conducted in urban settings and therefore might not show the situation in rural areas. 
1.5 Conclusion 
This systematic review showed that stroke is common and important in Africa. It also showed 
that robust high-quality studies are needed to help policy makers and health care professionals 
to control the stroke burden in Africa. More attention should be put on community or 
population-based studies with large sample size, in both urban and rural settings. Appropriate 
preventive and therapeutic measures should be promoted to decrease the incidence of stroke, 
improve the outcomes, and maintain the survivors’ quality of life in Africa. 
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Chapter 2: Stroke care in Africa: a systematic review of the literature  
2.1 Introduction 
The previous chapter raised a question on the availability, accessibility and quality of stroke 
services in Africa. In contrast to high income countries (HICs) where stroke mortality rates 
have declined, the burden of stroke in developing countries has risen in recent years and is 
expected to accelerate (Feigin et al., 2014). Eighty-six percent of all stroke deaths around the 
world take place in LMICs (Feigin, 2005). Further, LMICs account for over 87% DALYs 
from stroke, which is about seven times the DALYs in HICs (Johnston et al., 2009).  
African countries are undergoing an epidemiological transition driven by socio-demographic 
and lifestyle changes related to unchecked industrialization and a rise in many modifiable 
vascular disease risk factors. These include smoking, harmful use of alcohol, physical 
inactivity and unhealthy diets resulting in an increased prevalence of hypertension, diabetes 
and obesity (Owolabi et al., 2014). Consequently, the burden of NCDs including stroke is 
growing (Owolabi et al., 2014). A systematic review (Owolabi et al., 2015) of community-
based studies revealed an age-standardised annual stroke incidence rate of up to 316 per 
100,000 population, and age-standardised prevalence rates of up to 981 per 100,000 in Africa. 
However, health systems in many African countries are characterised by geographical and 
financial inaccessibility, rapid turnover of people in key positions, lack of continuity in policy, 
lack of resources, poor management of available resources and poor implementation (Sambo, 
2012). 
It is recommended that appropriate systems of stroke care be established in Africa and other 
LMIC regions to control the increasing death and disability associated with stroke (Feigin et 
al., 2009; Langhorne et al., 2012). However, we need information about the existing resources 
and current practices for stroke care in Africa. There have been some international reviews 
and surveys (not offered in languages other than English) on stroke care, but few studies 
included Africa. Several have relied on self-reported information which may be biased or had 
a very narrow focus (Brainin et al., 2007; Langhorne et al., 2012; Giruparajah et al., 2015; 
Wintermark et al., 2015). This motivated me to conduct a systematic literature review on 
systems of stroke care in Africa to inform policy makers and health care professionals about 
areas for improvement across the whole stroke care pathway. 
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2.2 Methods 
This review was performed according to the PRISMA guidelines (Moher et al., 2015). 
2.2.1 Search strategy  
Studies for this review were identified by searches of Ovid Medline, Embase, Amed, 
CINAHL, PubMed, and AJOL databases. There was no language restriction, but the search 
was limited to contemporary full-text publications (from January 1
st
, 2006 to June 20
th
, 2017). 
I used Medical Subject Headings (MeSH) and all subheading terms including “awareness”, 
“health care delivery”, “health care”, “health care system”, “health care facility”, “health 
service”, “health care access”, “rehabilitation”, “therapy”, “stroke unit”, “patient referral”, 
diagnosis, “secondary prevention”, and “Africa”.  
Additional searching was conducted on reference lists of relevant studies to identify 
publications that could have been omitted in the database searches. The search strategies 
through different databases as detailed in Appendix 2.1 were developed in consultation with a 
medical literature search specialist. 
2.2.2 Inclusion criteria 
The inclusion criteria were of studies that:  
 Were conducted in an African country 
 Reported on any of the six phases of the continuum of stroke care as conceptualized in 
the WSO Stroke Services Framework (Lindsay et al., 2014): systems for stroke 
recognition and response, hyperacute stroke care, acute inpatient care, stroke 
rehabilitation, secondary stroke prevention, and longer-term stroke recovery. 
 Due to the paucity of data, any study design was allowed. 
2.2.3 Exclusion criteria 
Exclusion criteria included: 
 Publications reviewing other studies 
 Clinical trial publications 
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2.2.4 Screening and quality assessment  
I screened the titles and abstracts of all the retrieved articles and assessed them for eligibility 
for narrative analysis using the inclusion criteria. However, the eligibility for 13 articles based 
on the title or abstract was unclear, and I screened them in discussion with my primary 
supervisor. Five of the 13 articles remained uncertain, and we independently performed a full 
review to determine if they met the inclusion criteria. In cases of disagreement, final 
determination was by discussion and consensus. The quality assessment for the studies 
included in the review was not undertaken. 
2.2.5 Data extraction 
Data were extracted using the World Stroke Organisation (WSO) Stroke Services Framework 
(Lindsay et al., 2014) which consists of six phases of the continuum of stroke care: systems for 
stroke recognition and response, hyperacute stroke care, acute inpatient care, stroke 
rehabilitation, secondary stroke prevention, and longer-term stroke recovery.  
The draft form was pilot tested on five studies for further refinement. The final version 
(Appendix 2.2) allowed extracting data regarding the country, study setting, sample, key 
element(s) investigated, and the main results.  
Before extracting the data, I read each publication included for the review three times, but 
there was more reading for any paper which was not easily understood. Thereafter, using the 
data extraction form, I systematically retrieved the data from each publication considered for 
the review. I extracted data about the author(s), publication year, study setting, type of setting 
(rural or urban), study design, sample size, participants, and main findings. Thereafter, I 
reviewed the main findings to identify the stroke care key elements and phase(s) reported. 
This process was done with reference to the stroke care key elements and the six phases of the 
continuum of stroke care as consptualized in the WSO Stroke Services Framework (Lindsay et 
al., 2014). The reported stroke care elements were unclear for 10 of the 38 reviewed 
publications. My primary supervisor reviewed those 10 papers, and we reached a consensus by 
discussion. To ensure accuracy and consistency, I carried out the data extraction processes 
twice.   
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2.2.6 Data analysis 
I anticipated that there would be limited, and heterogeneous data identified. Therefore, I 
planned to use a narrative synthesis to summarise the information from the included studies. 
Information was reported according to the phase of patient journey as conceptualized by the 
WSO framework (Lindsay et al., 2014).   
2.3 Results  
The review profile is shown in Figure 2.1. I identified 838 references from which 38 
publications (16-53) were eligible for my review following de-duplication and screening.  
 
Figure 2. 1: Review profile showing selection of studies reporting on stroke care in Africa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The included publications represent 14/54 African countries from all the main regions (east, 
west, central, north, and south) (Figure 2.2).  
 
Records identified through Embase (231), 
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Figure 2. 2: African map showing countries (in yellow) with included publications on 
stroke care in Africa  
 
Abbreviation: ns, number of studies. 
 *One study (Rhoda et al., 2015) was conducted in three countries including Rwanda, South Africa and Tanzania. 
The data ranged from 2008 to 2017, with most (24/38) published between 2013 and 2017. The 
publications included single and multi-site studies with varying numbers of participants (from 
1 (Ellenga-Mbolla et al., 2013) to 15,155 participants (Cossi et al., 2012b)). Nigeria and South 
Africa provided 10 (27.8%) and 9 (25.0%) of the selected publications, respectively. The 
majority (30/38) of the studies were conducted in urban hospitals or urban communities. Two 
publications (Diagana et al., 2008; Jemaa et al., 2008) were written in French and the 
remainder were in English. The studies included for the review used different study designs 
including cross-sectional survey (n=14), prospective follow up (n=13), retrospective approach 
(n=8), case reports (n=2) and qualitative interviews (n=1). Table 2.1 provides a list of the 
number of publications with information on each stroke care phase from 2008 to 2017.  
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Table 2. 1: Availability of information reported by stroke care phase from the publications by year 
WSO Template 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Total 
Systems for stroke recognition and 
response 
2 2 0 1 3 0 2 3 2 1 16 
Hyperacute stroke care 1 1 0 0 1 2 1 2 2 1 11 
Acute inpatient care 2 2 0 0 1 0 0 1 1 0 7 
Stroke rehabilitation 0 1 0 0 1 2 0 1 0 2 7 
Secondary stroke prevention 0 1 0 0 0 0 0 0 1 2 4 
Longer-term stroke recovery  0 1 0 0 0 0 0 0 0 0 1 
 
Some publications (Jemaa et al., 2008; Wasserman et al., 2009; Adoukonou et al., 2012; Rhoda et al., 2015; Ossou-Nguiet et al., 2016) provided 
information on more than one stroke care phase. Only the first and second phases of stroke care were reported in at least a quarter of the included 
publications. Secondary stroke prevention and longer-term stroke recovery were rarely reported. The reported core elements related to the stroke 
care phases are summarized in Table 2.2. 
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Table 2. 2: Stroke care in Africa 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Systems for stroke recognition and response 
Mshana et al., 2008 Tanzania Rural and urban 
community 
80 people Perception of adequate 
response to stroke signs 
and symptoms 
In rural area (Hai) where stroke was believed to come from natural causes, hospital 
treatment was the first option while in urban area (Dar-es-Salaam) where stroke was 
widely believed to emanate from supernatural causes the first option was traditional 
healers. 
Wahab et al., 2008 Nigeria Urban hospital  225 patients 
with 
hypertension or 
diabetes  
Knowledge of stroke 
signs and symptoms  
The commonest sign identified was sudden unilateral limb weakness (24.4%), and 
136 (60.4%) of the participants had no knowledge of any warning sign. Male sex and 
higher education were independently associated with better knowledge 
      
Akinyemi et al., 
2009 
Nigeria Urban hospital  370 hospital 
workers 
Knowledge of stroke 
signs and symptoms and 
perception of adequate 
response 
Weakness on one side (61.9%) was the most commonly identified warning symptom, 
and 8.6% of the participants could not identify a single warning symptom. Hospital 
treatment (61.1%) was the most preferred option while 13% of the participants 
preferred spiritual healing.   Higher level of education was significantly associated 
with better stroke knowledge and perception. 
Wasserman et al., 
2009 
SA Rural hospital 1 hospital Availability and 
accessibility of stroke 
care resources  
 
 
 
In 2007, at Mosvold Hospital (rural), there were 13 doctors and 59 professional 
nurses, 4 PTs, 1 OT, 1 ST, 1 dietician and 2 social workers only for a municipality 
with a population of 184 049. These staff were responsible for managing 49 000 
outpatients annually, and admitting 9400 patients per year, whose average stay was 7 
days. Basic radiography and ultrasound were available, but no CT scanner. The 
nearest referral facility with a CT scanner was 3 hours’ drive away. 
Gould et al., 2011 Ghana Urban hospital 2 hospitals Initiative to support stroke 
unit establishment 
There was no stroke unit in Ghana, but a collaborative partnership between staff from 
England and Ghana was initiated to review and plan local services and provide 
multidisciplinary education and training with a goal of establishing the Ghana’s first 
stroke unit. 
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Systems for stroke recognition and response 
Adoukonou et al., 
2012 
Benin Urban hospitals 
(n=2) 
2 hospitals Availability and 
accessibility of stroke 
care services 
There were 2 neurologic departments only in Benin (one in Cotonou and the other in 
Parakou) for a population of 9 million. There were 3 CT scanners only, and none of 2 
existing neurologic departments could conduct vascular sequences. In Parakou as 
example, there was also shortage of staff in all healthcare domains, and the costs for 
diagnostic exams such as CT scan ($100 USD) was high, and awareness of early 
stroke symptoms was very poor. For improvement, evidence-based accessible 
multidisciplinary care pathways for stroke management were set up, and there were 
public campaigns related to stroke awareness. 
      
Chin, 2012 Uganda Urban hospital 1 hospital Availability and 
accessibility of stroke 
care services 
Patients were brought to the emergency room by family members. Many patients 
presented to hospital several days or more after stroke onset and travelled long 
distances by public transportation. There was only one government health facility in 
the whole country that had a CT scanner, but there was no MRI unit or equipment for 
contrast angiography. The cost for a brain CT was approximately $60 USD. For those 
who could afford a CT scan, additional diagnostic tests (EKG, carotid ultrasound, and 
echocardiogram) were usually not affordable. Thrombolytics and IV heparin were not 
available. Neurosurgical consultation was available for emergency decompression of 
large intracerebral hemorrhages. Inpatient physical therapy services were very limited 
and basic equipment (quad canes, walkers, wheelchairs) were obtained privately by 
the patient. Long-term rehabilitation facilities did not exist. 
Cossi et al., 2012b Benin Urban community  15155 people 
aged ≥15 years 
Knowledge of stroke 
signs and symptoms and 
perception of adequate 
response 
The most often cited warning signs were paralysis and hemiplegia (34.4%). A 
proportion of 27.2% were unable to cite any stroke symptom. A proportion of 94.1% 
of subjects reported that they would go to a hospital if one of their relatives 
experienced stroke symptoms while 3.5% said they would wait and let the patient 
rest. Older age (>40 years), family history of stroke, higher education level, having 
hypertension, overweight or obesity were independently associated with better 
knowledge and better reaction to stroke symptoms.  
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Systems for stroke recognition and response 
Donkor et al., 
2014b 
Ghana Urban 
Community  
693 people 
between 18 and 
60 years  
Knowledge of stroke 
signs and perception of 
adequate response  
Numbness on one side (44%) was the commonest warning sign cited, and 22% of the 
participants had no knowledge of any warning sign. The majority (77%) of the 
participants believed that stroke requires emergency treatment.  
Obembe et al., 
2014 
Nigeria Urban university  994 (500 
students and 
494 staff) 
Knowledge of stroke 
signs and symptoms and 
perception of adequate 
response 
Weakness (66.2%) was the most commonly identified warning sign, and 12.2% of the 
participants had no knowledge of any warning sign. Predictors for adequate 
awareness were being female, younger age (< 40 years), and higher education level. 
Four hundred ninety-three (49.6%) participants indicated that they would take the 
person to the hospital while 3.2% would seek spiritual attention if a stroke happens 
near them. 
Kaddumukasa et 
al., 2015 
Uganda Rural and urban 
community 
377 adult people Knowledge of stroke 
signs and symptoms 
Paralysis (18.3%) was the most commonly identified warning sign of stroke, and 215 
(57%) had no knowledge of any warning sign. Urban residence and knowing that 
stroke is preventable were independently associated with better awareness of stroke 
warning signs. 
      
Komolafe et al., 
2015 
Nigeria Urban secondary 
schools (n=4) 
703 (589 
students and 
114 teachers) 
Knowledge of stroke 
signs and symptoms and 
perception of adequate 
response 
Weakness (51.9%) was the most commonly identified warning sign of stroke, but 
23.7% of the teachers had no knowledge of any warning sign. Better awareness of 
warning signs was associated with having had stroke in the family and being 
hypertensive. Four hundred ninety-three (41.4%) participants indicated that they 
would take the person to the hospital while 20 (2.8%) participants indicated that they 
would seek spiritual attention if a stroke happens near them. 
Nel and Stassen, 
2015 
SA Four urban 
emergency  
stations  
40 Ambulance 
personnel 
Ability to recognize 
stroke signs and 
symptoms and identify 
stroke 
The combined sensitivity and specificity were 91.5% and 92.0% respectively.  
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
 
Systems for stroke recognition and response 
      
Burton, 2016 SA Nationwide  - Initiative to support stroke 
unit establishment  
Stroke experts from different countries spoke at the meeting sessions organized by 
South African team during October 2014-October 2015, and neurologists and 
neurology registrars with much experience in European stroke units led the scheduled 
training sessions. By December 2015, 17 new stroke units were initiated, and many 
more were expected to join later. There was a challenge whereby the Ministry of 
Health was unwilling to support a project to start stroke units, focusing on a single 
non-communicable disease. Starting up a stroke unit focused on formation of stroke 
teams, distributing post stroke care protocol templates, and trainings on stroke care by 
led by international experts. There was also selection of site champions. These were 
staff enthusiastic about improving care, and who could help organise meetings and 
training sessions. 
Shehata et al., 2016 Egypt Urban Cairo 
University 
Hospitals 
111 hospital 
workers 
Knowledge of stroke 
signs and symptoms and 
perception of adequate 
response 
The most common identified stroke symptoms were slurring of speech (38.5%) and 
elevated blood pressure (38.5%), but 12% of the participants did not know any 
symptom. The most frequent response to an attack of stroke was transferring the 
patients to a hospital (59.8%) while 1.1% preferred calling a religious person. Clinical 
workers were more likely to identify the stroke symptoms compared with nonclinical 
workers. 
Baatiema et al., 
2017 
Ghana Hospital 11 major 
referral 
hospitals 
Availability of stroke care 
services and Health 
policies for stroke care 
One hospital had a stroke unit, but thrombolytic therapy using rtpA for ischemic 
stroke (IS) care was not available in any of the study hospitals. Although eight study 
sites reported having a brain CT scan, only 7 (63.6%) were functional at the time of 
the study. MRI scan services were also limited to only 4 (36.4%) hospitals (only 
functional in three). Acute stroke care by specialists, especially neurologists, was 
found in 36.4% (4) of the study hospitals whilst none of the study hospitals had an 
OT or a ST.  There was no direct health policy support from the state or national level 
for stroke care, or a national stroke policy framework, or national stroke clinical 
guideline existed. There were some broad policies on health care improvement, non-
communicable diseases and staff professional development, but these were not being 
implemented due to lack of funds.  
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
 
Hyperacute stroke care 
 
Jemaa et al., 2008 Tunisia Urban hospital 203 patients Time from stroke onset to 
hospital arrival and time 
from stroke onset to CT 
Scan  
Only 17.3% used medical ambulance transport. Arrival to emergency time mean was 
16h (median=4h), and arrival to emergency within 3h rate was 42.9%. Early arrival to 
emergency was associated with urban residence and having motor deficit or higher 
NIHSS score. Stroke onset-access to CT interval mean was 19h07’ (median= 8h45’), 
and access to CT within 3h and 24 h rate was 13.3% and 77.8% respectively. The 
waiting time mean for CT scan access was 3h. Early access to CT was associated with 
subarachnoid hemorrhage. 
 
Wasserman et al., 
2009 
SA Rural hospital  30 patients Time from stroke onset to 
hospital arrival and access 
to CT scan 
Mean delay of almost 2 days from symptoms onset to presentation at hospital; only 4 
(13.3%) had CT brain scans. 
Owolabi and 
Nagoda, 2012 
Nigeria Urban hospitals 
(n=2) 
273 patients Time from stroke onset to 
hospital arrival and access 
to CT/MRI Scan 
Only 20.1% and 28.9% of the participants presented before 3h and within 6h of stroke 
onset respectively. The main reasons for delay included delay referral from private 
hospital (49.1%), transportation problem (32.2%), prior visit to traditional homes 
(10.6%) and treatment at home (7%). Only 36.3% and 2.2% had CT and MRI scans 
respectively, and of these, only 32.3% had imaging within 24 hours. 
Ellenga-Mbolla et 
al., 2013 
Congo 
Brazzaville 
Urban hospital  1 patient The first ever 
thrombolysis 
The first ever thrombolysis with tenecteplase in Congo Brazzaville was indicated and 
performed by a neurologist and the CT scan performed at 24 hours did not show 
bleeding. 
Ossou-Nguiet et al., 
2013 
CAR Urban hospital  1680 patients Access to CT scan and its 
impact  
Between 2006 and 2011, there was a significant increase in CT scan completion rate 
which was 5.81% in 2006 versus 93.68% in 2011 (OR: 15.4, CI: 8.2-29.4), a 
significant increase in cases of cerebral hemorrhage between 2006 and 2011 (OR: 
5.21, CI: 2.6-17.3), and a decrease in mortality (OR: 2.41, CI: 1.4-8.2).  
Ekeh and Isamade, 
2014 
Nigeria Urban hospital 128 patients Time from stroke onset to 
hospital arrival 
Only 10.2% presented in 3h; 17.2% presented more than one week after stroke onset. 
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Hyperacute stroke care 
Ogbole et al., 2015 Nigeria Urban hospital 83 patients Time from stroke onset to 
CT Scan 
Mean presentation time for CT scan was 70 h with a median time of 24 hours. None 
presented for CT scan within 3 hours, and only 31.3 % and 54% presented within 12h 
and 24h respectively after stroke onset. IS was associated with higher presentation 
delay.  
Philip-Ephraim et 
al., 2015 
Nigeria Urban hospital  81 patients Time from stroke onset to 
hospital arrival 
Only 17 (21%) of the patients arrived at the hospital within three-hours of stroke 
onset, while 53 (65.4%) patients arrived >24 h after symptom onset. None of the 
patients were brought by ambulance service. Only lack of awareness of the symptoms 
of stroke was independently associated with delayed presentation. 
Chtaou et al., 2016 Morocco Urban hospital 52 patients Stroke onset/door-to-
needle time for 
thrombolysis 
Seventeen of 52 patients were treated within a 3 hours window of stroke onset and 35 
of 52 patients were treated within 3-4.5 h. The mean door-to-needle time was 1h15 
minutes while the mean onset-to treatment time was 3h32 minutes. 
      
Ossou-Nguiet et al., 
2016 
CAR Urban hospital 737 patients  Proportion of IS patients 
treated with thrombolysis 
Twenty six of 464 patients with IS were eligible for IV rt-PA, but none was 
thrombolysed because of the high cost of rt-PA, and Congolese patients had to pay 
themselves before all treatment. 
Napon et al., 2017 Burkinafaso Urban hospital 227 patients Route and time from 
stroke onset to hospital 
arrival, time from stroke 
onset to CT Scan, and 
access to thrombolysis 
 
The time between the stroke onset and the first contact with the first health facility 
ranged between 30 min and 24 h with an average of 6 h and 56 min and the one 
between first health facility and medical emergency ranged between 15 min and two 
weeks.  Patients spent on average 2 days (41 h 48 min) in the first health facilities, 
with no CT scans or neurologist there. After their arrival in medical emergency, 
patients spent on average 21 h and 18 min to achieve the cerebral CT scan. 
Thrombolysis was not available yet while 19% of patients were eligible according to 
the 4h30mn period. 
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Acute inpatient care 
Diagana et al., 2008 Mauritania Urban hospital 82 patients (42 
for neurology 
unit and 40 for 
internal 
medicine and 
cardiology unit) 
Impact of acute admission 
unit  
Stroke onset-CT scan interval: 3.12 for neurology unit versus 3.73 days for internal 
medicine and cardiology unit; stroke onset-hospitalization interval: 2.05 for 
neurology unit versus 1.36 days for internal medicine and cardiology unit; stroke 
onset-rehabilitation start interval:  9.11 for neurology unit versus 19.53 days for 
internal medicine and cardiology unit (p=0.0002); there was more 3-month functional 
independence improvement for the neurology unit admission (59.52%) than the 
internal medicine and cardiology unit admission (25%) (p=0.001). 
Jemaa et al., 2008 Tunisia Urban hospital 203 patients Time from stroke onset to 
admission 
Time onset-admission mean was 29h23’ (median= 15h), and only 1% of patients 
were admitted within 3 h from stroke onset.  
de Villiers et al., 
2009 
SA Urban hospital 195 patients Impact of stroke unit 
admission (n=101) 
compared to general ward 
admission (n=94) 
Inpatient mortality decreased from 33% to 16% (P=0.005); LoS increased from a 
mean of 5.1 days to 6.8 days (P=0.01), referral at discharge to inpatient rehabilitation 
increased from 5% to19% (P=0.04). Number of CT scans performed (13% GW 
versus 16% SU) and the number of referrals to the tertiary academic hospital (7% 
GW versus 4% SU) did not increase significantly.   
Wasserman et al., 
2009 
SA Rural hospital 30 patients Acute admission, family 
education, and discharge 
planning 
Mean duration of hospital stay was 6 days. Two-thirds of all families received no 
stroke education before discharge. All the patients were discharged into family care 
as there was no stroke rehabilitation facility available to the community. 
Adoukonou et al., 
2012 
Benin Urban hospitals 
(n=2) 
122 patients Time from stroke onset to 
admission  
In 2011, only 17.2% of 122 patients were admitted within 3 hours of stroke onset. 
Rhoda et al., 2015 Rwanda, SA 
and 
Tanzania 
Hospitals (n=3) 452 patients  Time from stroke onset to 
admission 
Time onset-admission interval was 6.8, 0.3 and 1.2 days and the length of hospital 
stay (LoS) was 8.2, 7.38 and 12.16 days for Rwanda, SA and Tanzania respectively. 
Ossou-Nguiet et al., 
2016 
CAR Urban hospital 737 patients Impact of stroke unit 
admission  
During the first year (2004) of stroke unit admission, there was 30% mortality rate 
decrease compared to the previous year. 
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
      
    Stroke rehabilitation  
Rhoda et al., 2009 SA Urban 
Community 
Health 
Centres (n=20) 
100 patients  Rehabilitation services 
received 
At two months post stroke, most participants were treated by PT (98.8%) and medical 
doctor (62.5%), and only 25% were treated by OT. At six months also, many 
participants were treated by PT (57.9%) and medical doctor (82.9%), and only 21.1% 
were treated by OT. Surprisingly, at both two and six months, less than 10% of the 
participants were treated by any of other rehabilitation team members including ST, 
home-based carer, nurse, social worker, dietitian, rehabilitation worker, and other 
rehabilitation specialists. By six months post stroke, the majority (68%) of the 
participants received between one and 5 physiotherapy sessions. Almost half (49%) 
of the participants received between one and four hours of physiotherapy. 
Ntsiea et al., 2012 SA Rehabilitation 
facilities  
36 facilities Practice in return to work 
(RTW) intervention 
programmes 
Seventeen clinical settings referred patients to facilities offering RTW services, and 
seven facilities offered RTW services. Of the seven facilities that rendered post stroke 
RTW services, five communicated with the employer to discuss reasonable 
accommodation and four did assessments for potential to RTW. The most common 
reasons given by the 29 facilities for not offering RTW services were that they 
referred patients to other therapists who offered these services, staff shortage, and the 
unemployed status of the patient at the time of having stroke. 
Joseph and Rhoda, 
2013 
SA Urban 
rehabilitation 
centre 
67 patients Rehabilitation services 
received and outcomes 
 
LOS was 52 days. Health professionals seen by patients were nurse (100%), doctor 
(98.48%), PT (98.48%), social worker (96.96%), OT (95.45%), ST (54.54%), 
dietitian (16.66%), psychologist (10.60%). Discharge destination was mainly home 
(82.08%). The mean Barthel Index scores on admission and discharge were 58.85 and 
81.59 respectively (p<0.01). 
Ntamo et al., 2013 SA Rural hospital 103 patients Rate of attendance to 
outpatient physiotherapy 
services 
The majority (86%) of patients did not attend out-patient physiotherapy. The major 
reasons for poor attendance were lack of finances (95%), migration to other areas 
(36%), and living a long distance from the hospital (38%). 
Rhoda et al., 2015 Rwanda, SA 
and 
Tanzania  
Hospitals (n=3) 452 patients  Inpatient PT rehabilitation A proportion of 40%, 68% and 98% of stroke patients in Rwanda, Tanzania and SA 
respectively received PT rehabilitation during acute hospital stay.  
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Stroke rehabilitation 
Olaleye et al., 2017 Nigeria Urban hospitals 
(n=3) 
 
60 patients Satisfaction with 
outpatient physiotherapy 
services 
Nearly all the participants (98.3%) indicated one of good, very good, and excellent 
improvement in their clinical conditions with physiotherapy. Majority expressed 
satisfaction with their physiotherapy care, the modal response being very good 
(59.3%). However, lack of continuity (being treated by different physiotherapists) and 
cost of care were sources of dissatisfaction. 
Olaleye and Lawal, 
2017 
Nigeria Urban hospital 783 patients Inpatient PT rehabilitation The mean LoS was 16.2 days. Referral rate for PT was high (75.8%) and the mean 
time from admission to referral for PT was three days. The majority (63.4%) of 
patients referred utilised PT and the mean number of PT sessions received during in-
patient care was 8.7. Utilisation of in-patient PT was significantly associated with 
reduced LoS.   
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Table 2. 2: Stroke care in Africa                 Continued 
Study reference Country Study setting 
type 
Sample Key element(s) 
investigated 
Main results 
Secondary stroke prevention 
Wasserman et al., 
2009 
SA Rural hospital 30 patients Rate of adherence to 
secondary prevention 
At three months after discharge follow up, all patients claimed to be taking their 
antihypertensive medication but 11 (55%) of those who had been prescribed aspirin 
admitted to defaulting. 
Mugwano et al., 
2016 
Uganda Urban hospitals 
(n=2) 
112 patients Rate of adherence to 
secondary prevention 
Only 17% were highly compliant with anti-hypertensive medications. The main 
reasons for poor drug adherence were lack of knowledge of the chronicity of 
hypertension (73%), cost of the drugs (63%) and access to health care provision 
(15%). However, 19% of the study participants were not able to provide a reason for 
the poor drug adherence. 
Sarfo et al., 2017a Ghana Urban clinic 418 patients Rates and determinants of 
persistent utilization of 
secondary prevention 
therapies 
At one-year post stroke, 92.1% of subjects were persistent on secondary prevention 
medications initiated at enrollment with medication class specific rates of 97.5% for 
antihypertensive, 94.8% for anti-platelets, 94.1% for statins, 85.7% for anti-diabetic 
and 50% for anticoagulants. Abuse of alcohol was significantly associated with non-
persistence, adjusted OR (95% CI) of 3.08 (1.13–8.38). 
Sarfo et al., 2017b Ghana Urban clinic 602 patients Rates and determinants of 
uncontrolled systolic 
blood pressure (SBP)  
At one-year post stroke, up to 35% of subjects had SBP above 140 mmHg during 
follow-up clinic visits. Predictors of uncontrolled SBP were SBP at enrollment into 
clinic, with an adjusted odds ratio (OR [95% confidence interval (CI)]) of 1.31 (1.17-
1.47)/10 mmHg increase, and average number of antihypertensive medications 
prescribed, with an adjusted OR (95% CI) of 1.30 (1.06-1.60). 
Longer-term stroke recovery 
Wasserman et al., 
2009 
SA28 Rural hospital 30 patients Training of home-based 
carers (HBCs)’ and 
patients’ follow-up in 
community 
The HBCs received no specific stroke care training. Each carer travelled about 7 km 
each day on foot or bicycle to conduct home visits.  In three months after discharge, 
only 13 of 20 (65%) surviving patients were visited by home-based carers, nine 
patients were visited by a physiotherapist, and 2 could consult a social worker during 
this period. 
Abbreviations: CAR, Central African Republic; CT, computerized tomography; EKG, electrocardiogram; IV, intravenous; LOS, length of hospital stay; MRI, magnetic resonance imaging; OT, occupational therapy(ist); 
PT, physiotherapy(ist); rtpA, recombinant tissue plasminogen activator; SA, South Africa; ST, speech therapist. 
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2.3.1 Systems for stroke recognition and response 
The main core elements related to systems for stroke recognition and response were 
knowledge of stroke signs and symptoms, perception of adequate response to stroke signs and 
symptoms, availability and accessibility of stroke care policies and services. 
Regarding the awareness about stroke signs and symptoms, the greatest proportion of 
participants who knew any of the established stroke signs and symptoms ranged between 18% 
for paralysis in Uganda (Kaddumukasa et al., 2015) and 66% for weakness in Nigeria 
(Obembe et al., 2014). The most preferred response to stroke signs and symptoms (range: 
41%-94%) was bringing the patient to the hospital (Akinyemi et al., 2009; Obembe et al., 
2014; Donkor et al., 2014b; Komolafe et al., 2015; Shehata et al., 2016), but some participants, 
between 1-13%, identified seeking spiritual intervention as the first option (Akinyemi et al., 
2009; Cossi et al., 2012b; Obembe et al., 2014; Komolafe et al., 2015; Shehata et al., 2016). In 
several studies, higher education level was significantly associated with better knowledge 
(Wahab et al., 2008; Akinyemi et al., 2009; Cossi et al., 2012b; Obembe et al., 2014) of, and 
better response (Akinyemi et al., 2009; Cossi et al., 2012b) to, stroke signs and symptoms.  
 Gaps were reported in the availability of stroke care services with variations across countries 
and settings. The areas in which shortage was commonly reported included medical 
transportation (Jemaa et al., 2008; Chin, 2012; Owolabi and Nagoda, 2012; Philip-Ephraim et 
al., 2015), CT and MRI scanning machines (Wasserman et al., 2009; Adoukonou et al., 2012, 
Chin, 2012; Baatiema et al., 2017), stroke units (Gould et al., 2011; Baatiema et al., 2017), 
thrombolysis (Chin, 2012; Baatiema et al., 2017; Napon et al., 2017), inpatient and long-term 
rehabilitation services (Chin, 2012), and healthcare personnel in overall number and 
specialties (Wasserman et al., 2009; Adoukonou et al., 2012; Baatiema et al., 2017; Napon et 
al., 2017).  
The high cost of infrastructure resources where they exist such as CT scanners (Adoukonou et 
al., 2012, Chin, 2012; Ossou-Nguiet et al., 2013), medications such as thrombolysis (Ossou-
Nguiet et al., 2016), and outpatient physiotherapy rehabilitation services (Olaleye et al., 2017) 
were reported as major barriers for stroke care in Africa.  In addition, a study from Ghana 
(Baatiema et al., 2017) identified the lack of direct regional or national health policy to support 
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stroke care, including a lack of a national stroke policy framework and national stroke clinical 
guidelines. 
2.3.2 Hyperacute stroke care 
The most common elements related to hyperacute stroke care reported included time from 
stroke onset to hospital arrival and patient access to CT/MRI brain imaging (Jemaa et al., 
2008; Wasserman et al., 2009; Owolabi and Nagoda, 2012; Ellenga-Mbolla et al., 2013; 
Ossou-Nguiet et al., 2013; Ekeh and Isamade, 2014; Philip-Ephraim et al., 2015; Ogbole et al., 
2015; Chtaou et al., 2016; Ossou-Nguietet al., 2016; Napon et al., 2017). 
Several publications consistently identified that patients with stroke in Africa were late in 
arriving to hospital. The highest reported proportion of stroke patients who arrived at hospital 
within three hours from stroke onset was 43% in Tunisia (Jemaa et al., 2008) while the lowest 
proportion (10%) was reported in Nigeria (Ekeh and Isamade, 2015).  The reported 
proportions of stroke patients who received CT brain imaging within three hours of stroke 
onset varied between 0% (35) and 13% (Jemaa et al., 2008), and where operational CT/MRI 
scan machines existed, the reported proportion of patients who received CT/MRI brain 
imaging varied between 13% (Wasserman et al., 2009) and 36% (Owolabi and Nagoda, 2012). 
2.3.3 Acute inpatient care  
The main core elements related to acute inpatient care for stroke patients that were reported 
included the time from stroke onset to hospital admission, and access to stroke units (Diagana 
et al., 2008; Jemaa et al., 2008; de Villiers et al., 2009; Wasserman et al., 2009; Adoukonou et 
al., 2012; Rhoda et al., 2015; Ossou-Nguiet et al., 2016). 
The interval between time of stroke onset and hospital admission varied between 7.2 hours and 
6.8 days (Diagana et al., 2008; Rhoda et al., 2015), with a median of 1.3 day.  Few patients, 
1% in Tunisia (Jemaa et al., 2008) and 17% in Benin (Adoukonou et al., 2012), were reported 
to have been admitted within three hours of stroke onset.  Regarding access to stroke units, 
South Africa was reported to have 21 stroke units (Burton et al., 2016), and the only other 
countries reported to have a stroke unit were Ghana (Baatiema et al., 2017) and the Central 
African Republic (Ossou-Nguiet et al., 2016).  Two studies (de Villiers et al., 2009; Ossou-
Nguiet et al., 2016) included in my review reported that stroke unit admission was associated 
with a decrease in inpatient mortality rate of 17-30%. 
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2.3.4 Stroke rehabilitation 
The proportion of patients reported to receive inpatient physiotherapy rehabilitation was 
greatest in South Africa (98%) and smallest in Rwanda (40%) (Rhoda et al., 2015).  A South 
African publication describing access to outpatient physiotherapy rehabilitation (Ntamo et al., 
2013) identified low attendance rates (14%) as being associated with lack of finances (95%), 
patient migration to other areas (36%), and living a long distance from the hospital (38%) 
(Ntamo et al., 2013). In a study from Nigeria (Olaleye et al., 2017) the majority (59%) of 
patients were highly satisfied with outpatient physiotherapy services, however the high cost of 
these services and lack of continuity of care were sources of dissatisfaction.  
Three South African studies (Rhoda et al., 2009; Ntsiea et al., 2012; Joseph and Rhoda, 2013) 
reported information on rehabilitation after discharge from the acute inpatient settings. It 
appeared that patients treated in a specialized rehabilitation facility received a variety of 
rehabilitation services from medical doctors, nurses, physiotherapists, social workers, 
occupational therapists, and speech therapists, although few of them received dietetics (17%) 
or psychology (11%) services (Joseph and Rhoda, 2013).  In contrast, services offered in 
community health centres were mostly limited to physiotherapy and medical rehabilitation 
services (Rhoda et al., 2009).  
2.3.5 Secondary stroke prevention  
A retrospective observational study (Sarfo et al., 2017a) involving 418 stroke survivors 
enrolled into a neurology clinic in Ghana showed that, at one-year post stroke, 92% of subjects 
were persisting with secondary prevention medications. However, in two publications 
(Wasserman et al., 2009; Mugwano et al., 2016) included in my review, evidence of poor 
compliance with secondary prevention medications was reported. In one study (Wasserman et 
al., 2009) of stroke survivors living in a rural South African community who were prescribed 
aspirin for secondary prevention, 9/20 (45%) reported taking this medication at three months 
post stroke. In a similar study conducted in Uganda (Mugwano et al., 2016) which involved 
112 participants, only 17% were adhering to anti-hypertensive medications as prescribed. The 
main reasons for poor drug adherence were lack of knowledge of the chronicity of 
hypertension (73%) and cost of the drugs (63%). Other factors that were reported to be 
associated with poor compliance with secondary prevention medications were alcohol abuse 
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Sarfo et al., 2017a) and average number of antihypertensive medications prescribed (Sarfo et 
al., 2017b).  
2.3.6 Longer-term stroke recovery 
Regarding longer-term stroke recovery, many challenges were identified in a South African 
study (Wasserman et al., 2009). Three months post stroke, 20 survivors living in a rural 
community had no access to a rehabilitation facility and did not get support from government 
or local authorities, leaving the responsibility to some local non-governmental organizations 
which also had limited resources to provide stroke survivors support.  
2.4 Discussion 
Overall, very few studies on stroke care have been published about the vast continent of 
Africa, and only one study (Wasserman et al., 2009) included information on longer-term 
stroke recovery. From the available data, I identified only a small proportion of patients with 
stroke that arrived at a hospital within three hours from symptom onset (Jemaa et al., 2008; 
Ekeh and Isamade, 2014) and, consequently, less than 20% (Jemaa et al., 2008; Adoukonou et 
al., 2012) of patients were admitted within three hours of stroke onset.  Studies from other 
non-African LMICs showed a similar delay (Nandigam et al., 2003; Ghandehari et al., 2009). 
Late presentation to hospital has been reported to be associated with poor awareness of stroke 
signs and symptoms, late referral from private hospitals, transportation problems, visit to 
traditional healers before coming to hospital, and treatment at home (Owolabi and Nagoda, 
2012; Philip-Ephraim et al., 2015). These were also identified in my review. Delays in 
presentation to hospital prevent patients from benefiting from emergency interventions such as 
brain imaging and thrombolysis for IS among others. Also, although diagnostic CT or MRI 
scan imaging is important when antithrombotic treatments are being considered, my review 
showed that the CT/MRI brain imaging services were rare or too expensive for many patients 
in Africa (Wasserman et al., 2009; Owolabi and Nagoda, 2012). My review showed that no 
patients in a Nigerian hospital (Ogbole et al., 2015) and only 13% of stroke patients in Tunisia 
(Jemaa et al., 2008) received a CT scan within three hours of stroke onset. This is a major 
barrier to meet the recommended standard of thrombolysis for IS within four and half hours of 
stroke onset (Lindsay et al., 2014).  
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Despite the evidence that thrombolysis can improve outcome in ischaemic stroke (The IST-3 
collaborative group, 2013), my review indicates that intravenous thrombolysis remains ‘a 
desirable dream’ in many African countries (Ossou-Nguiet et al., 2016; Napon et al., 2017).  
This finding was consistent with the results of a survey (Wintermark et al., 2015) whereby 
none of the African centres surveyed in 2012 administered acute revascularization therapy to 
patients with acute stroke. In another systematic review (Berkowitz et al., 2014) only 3% of 
low-income countries were found to use thrombolysis for acute IS.  The most important barrier 
of thrombolysis therapy in Africa, as in other low-income countries, is reported to be cost 
(Owolabi and Nagoda, 2012; Ossou-Nguiet et al., 2016). This emphasizes the need for 
governments and health systems of developing countries to develop strategies to enhance 
accessibility to thrombolysis. 
Despite the available evidence for the benefits associated with stroke unit admission, the 
stroke unit model for stroke care appeared to be rare in Africa. In fact, collectively I identified 
that there were only 23 stroke units from the available publications I reviewed. Fortunately, 
there is the intention for the establishment of more stroke units in Africa in the next few years 
(Gould et al., 2011; Burton et al., 2016).  
The WSO recommended early adequate rehabilitation to reduce the social and economic costs 
related to long-term care (Lindsay et al., 2014). However, it appeared that only medical and 
physiotherapy rehabilitation services are common in Africa (Joseph and Rhoda, 2013; Rhoda 
et al., 2015; Baatiema et al., 2017), and that the physiotherapy services are accessible to a 
limited number of patients. We need to address the identified barriers for inpatient and 
outpatient physiotherapy rehabilitation including high cost, geographical inaccessibility and 
lack of continuity of care.  
While aspirin and antihypertensive drugs were found to be associated with lower risk for 
stroke recurrence (PROGRESS Collaborative Group, 2001; van Gijn and Algra, 2003), my 
review findings indicated poor compliance with secondary prevention anti-hypertensive 
medications in Uganda (Mugwano et al., 2016) and aspirin in South Africa (Wasserman et al., 
2009) most likely because of cost and lack of knowledge about the risk of stroke recurrence. 
This challenge should be addressed in education sessions for stroke patients and their 
caregivers. 
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Other important challenges that were raised were shortage or high cost of medical 
transportation, brain imaging infrastructure, stroke units, and healthcare personnel (Jemaa et 
al., 2008; Wasserman et al., 2009; Adoukonou et al., 2012; Chin; Owolabi and Nagoda, 2012; 
Ossou-Nguiet et al., 2013; Philip-Ephraim et al., 2015; Baatiema et al., 2017; Napon et al., 
2017). To address this gap, politicians in most African countries need to invest in stroke care 
by developing and implementing direct health policies for stroke, training and staffing key 
rehabilitation professionals, making available and accessible the appropriate infrastructure, 
equipment and medications for quality stroke care, building national insurance systems to 
reduce the cost for care (Mills, 2014), and establishing partnerships with international experts 
to improve stroke care in African countries as they appeared to be effective in South Africa 
(Burton, 2016).   
Strengths and weaknesses 
To the best of my knowledge, this is the first review on delivery of stroke care with focus on 
Africa. It provides a systematic, up-to-date overview of the available data on this topic. I 
searched a range of relevant databases, with no language restriction. Additionally, data from 
eligible publications were extracted and analysed based on the WSO Stroke services 
Framework (Lindsay et al., 2014) while the review report is based on the PRISMA guidelines. 
However, my review may well be subject to publication bias as only the electronic databases 
and references were considered. Furthermore, the investigators of the identified studies were 
not contacted to confirm data. Among the studies that were considered for my review, nine 
were retrospective and the shortcomings of this study design needs to be considered when 
interpreting the results. Furthermore, most of the publications were conducted in cities, and 
some of them were single studies and generalisability to rural settings or whole countries is 
limited. Therefore, national or regional prospective observational studies on the provision of 
stroke care in African countries are needed. The lack of data from many African countries is 
also a limitation and highlights the urgent need to establish systems of routine and reliable data 
monitoring across this continent. Finally, there were limited data on important phases of stroke 
care including secondary prevention and longer-term recovery. More studies about these two 
phases are required. 
 
 
53 
 
2.5 Conclusion 
Overall, the reported provision of stroke care in Africa is below the recommended standards 
with variations across countries and settings. Combined efforts from policy makers and health 
care professionals in Africa are needed to ensure greater access to essential infrastructure such 
as stroke units. More high-quality studies are needed to inform how to establish infrastructure 
in African settings where there are limited resources and diverse socio-cultural contexts. 
Mechanisms to routinely monitor usual care (i.e. registries or audits) would be invaluable to 
inform policy and practice.  
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Chapter 3: Key performance indicators of quality stroke care and their 
association with patient outcomes: a systematic review of the literature and 
meta-analysis 
3.1 Introduction 
The previous two chapters have outlined the increasing burden of stroke in Africa and the need 
to develop services to respond to this burden of disease.  There are major challenges to design 
and deliver service initiatives and also to measure and monitor their progress in improving the 
quality of care.  In recent years there have been concerted efforts to develop and implement 
clinical practice guidelines for the management of patients with acute stroke (Adams et al., 
2003). Clinical guidelines are written to promote diagnostic or therapeutic interventions 
applicable to the majority of patients in most circumstances. However, the use of guideline 
recommendations for individual patients has traditionally been left to the discretion of 
individual clinicians (American Heart Association, 2000). A recognised approach to assist the 
translation of research evidence into clinical practice is to monitor the quality of care using 
standardized performance indicators (Grol and Grimshaw, 2003) also called quality indicators, 
process of care measures or key performance indicators (KPIs). Performance indicators are 
standards of care that imply that health care professionals are providing inadequate care if 
eligible patients do not receive that standard of care. Performance indicators can be used to 
monitor the adherence to current guidelines and support the transfer of new evidence into 
everyday clinical practice (Grube et al., 2012). 
There are now numerous stroke interventions that have been shown to improve patient 
outcomes in research trials; admission to specialized stroke units, use of intravenous 
thrombolysis, mechanical thrombectomy, antiplatelet drugs, anticoagulants, and management 
of fever, hyperglycaemia, and swallowing dysfunction for selected patient groups (Sandercock 
et a., 2003; Kwan and Sandercock, 2004; Saxena and Koudstaal, 2004; Middleton et al., 2011; 
Goyal et al., 2016). However, application into routine practice is challenging and regular 
monitoring is important (Cadilhac et al., 2016). Ideally, implementation of clinical evidence 
can be demonstrated using a range of stroke KPIs, which offer proxy measures for ideal care 
being delivered. In turn this would lead to evidence of better patient outcomes (Quality of 
Care and Outcomes Research in CVD and Stroke Working Groups, 2000).  
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 In a previous systematic review of the association between stroke quality (performance) 
indicators and patient-centered outcomes, out of 14 studies that met the eligibility criteria; nine 
had mostly positive associations, whereas five reported little or no association with a lower 
risk for mortality, disability, medical complications, stroke recurrence, or patient 
dissatisfaction (Parker et al., 2012). A limitation of that review was the exclusion of stroke 
unit care as a performance indicator. With the ongoing developments in clinical guidelines and 
quality indicators for monitoring the application of these guidelines (Reeves et al., 2010; 
Cadilhac et al., 2016), I believe that there is a need for up-to date comprehensive information 
on KPIs for stroke care. 
I aimed to conduct a systematic literature review to identify the KPIs that have been described 
in stroke care and to summarise their association with patient outcomes. I intend that 
information gathered from this review will provide decision makers and health care 
professionals with information on reliable and meaningful KPIs that can be implemented to 
improve outcomes post stroke.  
3.2 Methods 
This review was performed according to the PRISMA guidelines (Moher et al., 2015). This 
review was registered in Prospero Database (CRD42016050798). 
3.2.1 Search strategy  
Searching sources were Ovid Medline, Embase and PubMed databases, and relevant 
references from screening the bibliographies of the initial articles included in the search. 
I used Medical Subject Headings (MeSH) and all subheading terms including “stroke”, 
“cerebrovascular accident”, “cerebrovascular disease”, “cerebrovascular disorders”, “brain 
hemorrhage”, “intracranial hemorrhages”, “brain infarction”, “subarachnoid hemorrhage”, 
“health care quality”, “quality of health care” “quality indicators, health care”, “quality 
assurance, health care”, “quality control”, “quality indicator”, “performance indicator”, 
“register”, “registries”, “clinical audit”, “treatment outcome” , “case fatality rate”, “mortality”, 
“survival”, “disability”, “functional status”,” hospitalization”, “cost”, “quality of life”, 
“complication”, “hospital discharge” and “stroke recurrence”. My search was restricted to full-
text manuscripts published in English from January 1
st
, 2000 to May 24
th
, 2017. 
The search strategies for different databases are detailed in Appendix 3.1. 
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3.2.2 Inclusion criteria 
I included national or regional registers that recorded the independent association (after 
adjusting for at least age and a measure of stroke severity) between the KPIs and stroke patient 
outcomes, I anticipated that there could be a wide range of eligible studies, so I limited my 
review to only those studies that recruited patients from three or more hospitals and thus 
having an increased external valididy of the results. Due to various inclusion criteria across the 
eligible studies, I did not limit my literature search to any patient characteristics such as stroke 
types or age groups. Additionally, based on the aim of my review, there was no restriction to 
any stroke KPIs or patient outcomes. 
3.2.3 Exclusion criteria 
 I excluded reports that were reviews or did not provide odds ratio (OR), hazard ratio (HR) or 
rate ratio (RR) data. 
3.2.4 Screening and quality assessment 
I reviewed each title and excluded obviously irrelevant studies. My primary supervisor and I 
performed a full review of articles identified as potentially relevant to determine if they met 
the inclusion criteria. In cases of disagreement, final determination was by discussion and 
consensus. In the synthesis of the papers, we assessed whether the publications recorded the 
independent association (after adjusting for at least age and stroke severity) between the KPIs 
and patient outcomes. However, the quality assessment was not undertaken. 
3.2.5 Data extraction 
I used a standardized form to record information on country, main inclusion or exclusion 
criteria for the recruitment of participants, sample size, stroke severity measure, KPIs and 
outcome(s) reported, and reported results (and 95% CI). 
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3.2.6 Data analysis 
Initially, the identified KPIs and their association with the patient outcomes were categorized 
on whether the authors reported a significant association between the KPI and patient 
outcome. There was then a further quantitative analysis (meta-analysis) of the relationship 
(adjusted for at least age and stroke severity) between the KPIs identified and patient 
outcomes. Some checking of the consistency of KPIs and outcomes was required with 
grouping of similar KPIs. For the meta-analysis, I sought information on case fatality and poor 
outcome (death and disability or requiring support) after stroke.   
The meta-analysis was done using the Review Manager (version 5.3) software. Log ORs were 
combined using an inverse variance analysis (random effects model). First, I assumed that 
HRs and RRs approximate to ORs and performed the primary meta-analysis including all 
studies reporting on association of KPIs with case fatality and poor outcome. Second, I 
performed sensitivity meta-analysis by excluding studies that used HR or RR as measures of 
association.  
3.3 Results 
The review profile is shown in Figure 3.1. I identified 3606 references from which 30 studies 
were eligible for the qualitative review. Among these, only 22 were eligible for the meta-
analysis. 
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Figure 3. 1: Review profile showing selection of studies reporting on stroke KPIs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: HR, hazard ratio; KPI, key performance indicator; OR, odds ratio. 
3.3.1 Included studies 
Table 3.1 shows the studies considered for my systematic literature review. Most of the 
included studies (n=15) were conducted in Europe: One European study (Bhalla et al., 2004) 
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(n=2), United Kingdom (n=3) (one in England and two in Scotland), Italy (n=1), Spain (n=1), 
and Greece (n=1). The non-European studies were conducted in the USA, Canada, Chile, 
Australia, New Zealand, China, Thailand and Taiwan.  
Two reports from Denmark (Ingeman et al., 2008; Svendsen et al., 2009) and two from 
Scotland (Turner et al., 2015a; Turner et al., 2015b) were based on the same datasets but since 
they provided associations with different outcomes, they were all included in this systematic 
review. 
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Table 3. 1:  Studies eligible for the systematic literature review 
Study 
reference 
Country Stroke 
Type 
Stroke Severity 
Measure 
Sample 
size 
Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Glader et al., 
2001 
Sweden
 
SAH 
excluded 
Level of consciousness 8194 (All 
hospitals in 
Sweden) 
Stroke unit (Independent before stroke) 2-year case fatality   
2-year dependency   
0.81 
0.79 
0.72-0.92 
0.66-0.94 
      
McNaughton 
et al., 2003 
New 
Zealand 
All stroke 
types 
Age, initial FIM, pre-
stroke FIM, and being 
European 
181 (3 
hospitals) 
Swallowing assessment 1-year Poor outcome 
(death or moved from 
home) for swallowing 
recorded “no” 
3.2 0.97-10.7 
Bhalla et al., 
2004
 
Europe SAH 
excluded 
Level of consciousness, 
incontinence, dysphagia 
dysphasia and paralysis 
1847 (10 
countries) 
Brain imaging 3-month case fatality 0.7 0.4-1.3 
      3-month disability (BI≤18)  1.45 0.39–7.4 
     Organized stroke care
a
 3-month case fatality 0.5 0.3-0.8 
      3-month disability (BI≤18)  1.3 0.6–1.76 
Cadilhac et 
al., 2004 
Australia
 
SAH 
excluded 
GCS, ability to lift both 
arms, ability to walk, and 
urinary incontinence  
468 (8 
hospitals) 
Thorough (n-l≤1) b adherence to 15 
processes of stroke care 
c 
Independent at 28 weeks 1.78  0.93–3.38 
Being at home at 28 weeks 1.69  0.86–3.32 
Alive at 28 weeks 2.10 0.92–4.82 
Andersen 
and Olsen, 
2007 
Denmark IS SSS 
Scale (SSS) 
22179(All 
Danish 
hospitals) 
Anticoagulants for IS with AF 4-year survival  1.91 1.44-2.52 
Candelise et 
al., 2007 
Italy
 
All stroke types 
Level of consciousness 
11572 (424 
stroke 
units and 
260 
hospitals) 
Stroke Unit 2-year case fatality 0.79  0.68–0.91 
  2-year death or disability 
(mRS>2)
 
0.81  0.72–0.91 
  2-year not living at home 0.85  0.74–0.97 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke 
Type 
Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Ingeman et 
al., 2008
 
 
SAH 
excluded 
SSS 29573 (40 
hospitals) 
Specialized stroke unit by 2
nd
 day  90 –day case fatality 0.76  0.69–0.83 
     Antiplatelet therapy by 2
nd
 day   0.71  0.62–0.81 
     Anticoagulants for IS with AF by 14
th
 day  0.41  0.31–0.52 
     CT/MRI scan by first day  1.35 1.24–1.46 
     Assessment by a PT by 2
nd
 day  0.81  0.73–0.88 
     Assessment by an OT by 2
nd
 day   0.83  0.75–0.91 
     Nutritional risk assessment by 2
nd
 d.   0.69 0.61–0.76 
     Number of criteria fulfilled    
     1 vs 0  0.94  0.65-1.49 
     2 vs 0  0.78  0.54–1.02 
     3 vs 0  0.60  0.42–0.78 
     4 vs 0  0.61  0.42–0.79 
     5 vs 0  0.45  0.31–0.60 
     6 vs 0  0.48  0.31–0.65 
Saposnik et 
al., 2008 
Canada
 
IS CNS 3631 (11 hospitals) OCI
d
 1 vs 0 1-year case fatality 0.69  0.44–1.09 
   OCI  2 vs 0  0.39  0.25–0.62 
   OCI 3 vs 0  0.40 0.25–0.64 
    Antithrombotic therapy  0.33 0.22-0.50 
Ding et al., 
2009 
China
 
IS NIHSS 1951 (23 hospitals 
in 11 major cities 
of China) 
Antiplatelet therapy for IS 1-year case fatality 0.42 0.21–0.86 
    Recurrent cerebrovascular 
event 
0.58 0.36–0.92 
     Functional improvement 1.25 1.02–1.52 
Milionis et 
al., 2009 
Greece
 
First-ever 
acute IS 
SSS 794 (Different 
Athenian hospitals) 
Statin at discharge 10 year-Case fatality 0.43 0.29-0.61 
   10-year stroke recurrence 0.65 
 
0.39-0.97 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke 
Type 
Stroke Severity Measure Sample 
size 
Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Svendsen et al., 
2009
 
 
Denmark
 
SAH 
excluded 
SSS 2636 (7 
stroke 
units) 
Stroke unit (2
nd
 day) Prolonged LoS  0.71  0.65–0.77 
  Antiplatelet for IS (2
nd
 day)  0.80  0.73–0.87 
  Anticoagulant for IS with AF (14
th
 day)  0.78  0.62–0.98 
  CT/MRI scan (2
nd
 day)  0.82 0.74–0.91 
  PT assessment (2
nd
 day)  0.87  0.81–0.93 
  OT assessment (2
nd
 day)  0.85  0.80–0.91 
  Nutritional risk assessment (2
nd
 day)  0.83 0.77–0.90 
  Swallowing assessment (2
nd
 day)  0.78 0.69–0.87 
  Constipation risk assessment (2
nd
 day)  0.70  0.63–0.78 
  Mobilization (2
nd
 day)  0.67 0.61–0.73 
  Intermittent catheterisation (2
nd
 day)  0.77 0.64–0.92 
  DVT prophylaxis (2
nd
 day)  0.82 0.71–0.95 
  Percentage of criteria fulfilled    
  25%–49% vs 0%–24%  0.77  0.69–0.86 
  50%–74% vs 0%–24%  0.67  0.60–0.75 
  75%–100% vs 0%–24%  0.53 0.48–0.59 
Åsberg et al., 
2010 
Sweden
 
First ever 
IS cases 
ADLs Function 14 529 (All 
hospitals in 
Sweden) 
Antiplatelet therapy for IS 3-month case fatality 0.83 0.68-1.01 
  ACE inhibitors therapy  1.00 0.87–1.14 
  Statins Therapy  0.78 0.67–0.91 
  Anticoagulants therapy for IS with AF  0.58 0.44–0.76 
Bravata et al., 
2010 
USA IS  NIHSS 1363 (5 
hospitals) 
 
Neurology assessment In-hospital mortality, 
discharge to hospice, or 
discharge to a skilled 
nursing facility 
1.13  0.59-2.17 
   Swallowing evaluation 0.64  0.43-0.94 
    DVT prophylaxis 0.60  0.37-0.96 
    Early mobilization 0.69  0.42-1.14 
    Blood pressure management  1.00  0.67-1.50 
    Fever management 0.71 0.35-1.41 
     Hypoxia management  0.26  0.09-0.73 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke 
Type 
Stroke Severity 
Measure 
Sample 
size 
Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Hsieh et al., 
2010 
Taiwan All stroke 
types 
NIHSS 30599 (39 
hospitals) 
IV tPA for 2 hours 6-momth functional 
dependency (mRS≥2)  
0.52  0.35-0.76 
  Antithrombotics at discharge 6-momth risk of 
cardiovascular events and 
death   
0.41  0.35-0.47 
  Anticoagulation for IS with AF at 
discharge 
0.59  0.44-0.80 
     Lipid-lowering agents at discharge 0.94  0.78-1.13 
Lakshminarayan 
et al., 2010 
USA
 
All stroke 
types 
Weakness and altered 
level of consciousness 
18017(222 
hospitals 
from 6 
States) 
Dysphagia screening Higher risk of pneumonia 
for no screening 
2.15 1.74-2.66 
Smith et al., 
2010 
Canada IS CNS 
 
6223 (12 
Centres) 
OCI
d
  2–3 vs 0–1 30-day case fatality 0.23 0.19-0.28 
Ingeman et al., 
2011 
Denmark
 
All stroke 
types 
SSS 11757 (10 
stroke 
units in 2 
counties) 
Early admission to a stroke unit Any medical 
complication
e
 during 
admission
 
(LoS=13 days) 
 
0.79  0.68–0.92 
  Antiplatelet therapy for IS 0.95  0.79–1.15 
  Anticoagulant therapy for IS with AF 0.59  0.45–0.76 
  CT/MRI scan  1.52  1.35–1.72 
   Assessment by a PT   1.10 0.94-1.28 
    Assessment by an OT  1.10  0.94–1.27 
     Assessment of Nutritional risk   0.87  0.70–1.07 
     Swallowing assessment  0.97  0.84–1.11 
     Early mobilization  0.43  0.35–0.53 
     Percentage of criteria fulfilled    
     25%–49% vs 0%–24%  0.77  0.67–0.88 
     50%–74% vs 0%–24%  0.57  0.46–0.70 
     75%–100% vs 0%–24%  0.50 0.36–0.68 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke Type Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Abilleira et al., 
2012 
Spain
 
SAH 
excluded 
NIHSS 1767 (47 
hospitals) 
Brain imaging < 24 hours 1-year   case fatality risk 
for noncompliance 
1.4  0.71–2.76 
   Screening of dysphagia 1.23  0.88–1.71 
     Antiplatelets < 48 h for IS  1.3  0.84–2.02 
     Early mobilization  1.54  1.05–2.24 
     Assessment of rehabilitation needs  1.48  1.06–2.07 
     DVT prevention  0.98  0.60–1.60 
     Management of hyperthermia  0.67  0.25–1.79 
     Management of hypertension  1.87  1.22–2.86 
     Management of dyslipidemia   1.29  0.86–1.93 
     Anticoagulants for IS with AF  1.70  0.95–3.05 
     Antithrombotics at discharge (IS)  2.79  1.41–5.54 
Dowlatshahi et 
al., 2012 
Canada Intracerebral 
Haemorrhage 
Stroke 
CNS 2466 (11 
hospitals) 
Statin use in hospital 6 months case fatality  0.2  0.1–0.3 
   Poor outcome (mRS=4–6) 
at discharge 
0.6  0.4–0.9 
Hubbard et al., 
2012 
Australia
 
All stroke 
types 
FIM 2119 (108 
Rehabilitations 
units) 
ADLs rehabilitation Discharged home (Median 
LoS= 26 days) 
1.01 0.33–3.13 
 DVT prevention 0.58 0.41–0.81 
  Home assessment 6.15 3.70–10.22 
  Balance rehabilitation 0.54 0.35–0.83 
    Secondary prevention on discharge 
f 
1.99 1.12–3.53 
    Education to patients 
g 
 2.37 1.30–4.29 
     Discussing post-discharge needs with 
patients 
 1.27 0.66–2.43 
 
 
64 
 
Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke 
Type 
Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Bray et al., 
2013 
UK 
(England) 
Ischaemic 
stroke 
Level of consciousness 
and neurological deficit 
36197 (106 
hospitals) 
Seen by a stroke consultant or associate 
specialist within 24 h hours  
30-day case fatality 0.88 0.80-0.97 
     Brain scan within 24 hours  0.96  0.86-1.07 
     Bundle 1: seen by nurse and one 
therapist within 24 hours and all relevant 
therapists within 72 hours 
 0.90  0.82-0.99 
     Bundle 2: nutrition screening and formal 
swallow assessment within 72 hours 
where appropriate 
 0.76 0.67-0.87 
     Bundle 3: patient’s first ward of 
admission was stroke unit and they 
arrived there within four hours of 
hospital admission 
 0.99  0.90-1.08 
     Bundle 4: patient given antiplatelet 
therapy where appropriate and had 
adequate fluid and nutrition for first 72h 
 0.46  0.42-0.50 
 
 
     Quality score 5 or 6 v 0-4  0.74 0.66-0.83 
Hoffmeister 
et al., 2013 
Chile
 
IS Aphasia, hemiplegia, 
reduced level of 
consciousness, and 
speech disturbance 
677 (7 
hospitals) 
Neurological evaluation on admission 30-day case fatality 2.02  0.77-5.30 
  In-hospital pneumonia 1.07  0.79-1.44 
 Dysphagia screening within 48hours 30-day case fatality 0.52 0.26-1.04 
  In-hospital pneumonia 1.58  0.60- 4.15 
 Complete (n-l≤0) adherence to 15 
processes of stroke care
 
 
Independent at 28 weeks 2.61  0.96–7.10 
   Being at home at 28 weeks 3.09   0.96–9.87 
   Alive at 28 weeks 3.22 0.66-15.86 
Nilanont et 
al., 2014 
Thailand
 
IS NIHSS 1222 (76 
hospitals) 
Stroke unit admission Poor outcome (mRS  5-6 at 
discharge) (LoS=4 days) 
0.54  0.33-0.87 
   Thrombolysis  0.09  0.03-0.23 
    Aspirin within 48 hours  1.25  0.73-2.15 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke Type Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Pan et al., 
2014 
China
 
ICH stroke NIHSS 3218 (132 hospitals) Stain use during hospitalization 1-year Case fatality 0.49 0.27–0.86 
    1-year Good functional outcome   2.04 1.37–3.06 
Schmitz et al, 
2014 
Denmark All IS cases  SSS 
 
4292 (All Danish 
hospitals) 
Thrombolysis 1.4 year-mortality 
1.4 year-recurrent stroke 
0.66 
1.05 
0.49–0.88 
0.68–1.64 
      1.4 years major bleeding 0.59 0.24–1.47 
Song et al., 
2014 
China
 
First ever IS NIHSS 7455 (132 hospitals) Stain use during hospitalization 3-month Case fatality 0.51 0.38–0.67 
     3-months dependency 0.95 0.81–1.11 
Mortensen et 
al., 2015 
Denmark
 
First ever 
IS cases 
SSS 5070 (Aarhus County) Antidepressants during 
hospitalization 
30-day case fatality 0.28  0.18–0.43 
Turner et al., 
2015a 
UK 
(Scotland) 
All stroke 
types 
SSV 41692 (36 hospitals) Admission to stroke unit 1-year survival 1.43 1.34-1.54 
   6-month discharged home  1.19 1.11-1.28 
Turner et al., 
2015b 
UK 
(Scotland)
 
All stroke 
types 
  SSV 36055 (36 hospitals) Stroke unit on day 0 or 1 6-month case fatality 0.79  0.74–0.85 
  Swallow screen on day 0  0.95 0.86–1.04 
    Brain scan on day 0  0.95  0.88–1.03 
     Aspirin on day 0 or 1  0.54  0.49–0.58 
     Number of criteria fulfilled 6-month case fatality   
     0 vs 4  2.26  1.60–3.21 
     1 vs 4  1.67  1.45–1.93 
     2 vs 4  1.44  1.31–1.59 
     3 vs 4  1.17  1.08–1.27 
     Number of criteria fulfilled Discharge to home/usual 
residence at 6 months 
  
     0 vs 4  0.70  0.50–0.98 
     1 vs 4  0.74  0.65–0.84 
     2 vs 4  0.84  0.76–0.91 
     3 vs 4  0.91  0.85-0.98 
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Table 3. 1:  Studies eligible for the systematic literature review    Continued 
Study 
reference 
Country Stroke Type Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/RR 
95% CI 
Cadilhac et 
al., 2017 
Australia
 
All stroke 
types 
Ability to walk on 
Admission 
16665 (42 Hospitals) 1 process received vs 0 180-days Case fatality 0.63  0.41-0.97 
  2 processes received vs 0  0.46  0.31-0.68 
     3 processes received vs 0  0.30  0.18-0.47 
     1 process received vs 0 90-180-days QoL 12.53*  −2.22-27.28 
     2 processes received vs 0 16.67*  0.30-33.05 
     3 processes received vs 0  18.70*  1.86-35.55 
Abbreviations: ACE, angiotensin-converting enzyme; ADLs, Activities of Daily Living; AF, atrial fibrillation; BI, Barthel Index; CNS, Canadian neurological scale; CT/MRI, computerized 
tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep vein thrombosis; FIM, functional independence measure; GCS, Glasgow coma scale;  
HR, hazard ratio; IS, ischemic stroke; LoS, length of hospital stay; mRS, modified Rankin Scale; NIHSS, national institute of health stroke scale; PT, physiotherapy; OR, odds ratio; OT, 
occupational therapy; RR, rate ratio; SAH, subarachnoid hemorrhage; SSS, Scandinavian stroke scale; SSV, six simple variable. 
* Visual analogue scale score (the health-related quality of life was measured with EQ-5D-3L16 visual analogue scale with deaths coded as zero). 
 
a Organized stroke care included wards which encompassed multidisciplinary team-working, a physician with an interest in stroke, as well as taking into account the proportion of time spent (>50% of their length of stay) 
in such an environment. The wards that encompassed organized stroke care included neurology, elderly care, stroke specific unit and intensive care unit. 
bn indicates number of applicable processes of care (PoC); i, number of PoC adhered to. 
c The 15 processes of care consisted of CT scan < 24 h since admission, swallow < 24 h since admission, allied health < 24 h since admission, incontinence addressed, discharged on antiplatelet 
d Organized care index (OCI) is a summary score based on the presence of occupational therapy or physiotherapy, stroke team assessment, and admission to a stroke unit. A score of zero indicates that stroke patients 
received none of these services, and higher scores indicate access to more services. The “organized care” index was classified as having received 0, 1, 2, or 3 services. 
agent, fever > 38.5 managed, documented premorbid function, documented discharge needs, regular neurology observations for the first 24 h of admission, physiotherapist within 24 h, occupational therapist within 24 h, 
speech pathologist within 24 h, enteric feeding if nil by mouth  > 48 h, aspiration avoidance, and DVT prophylaxis if not ambulant. 
e The complications that were considered in the analysis included pneumonia, urinary tract infection, pressure ulcer, falls, venous thromboembolism, and constipation. 
f Secondary prevention included deep vein thrombosis prophylaxis, discharged on lipid-lowering medication, discharged on blood-pressure–lowering medication, and discharged on antithrombotics. 
g Education to patients consisted of lifestyle advice, information on sexuality poststroke, information about peer support, information on self-management programs, carer training, and providing contact to patient. 
67 
 
The majority (23/30) of the included studies used prospective recruitment while the rest 
(Milionis et al., 2009; Bravata et al., 2010; Abilleira et al., 2012; Hubbard et al., 2012; 
Hoffmeister et al., 2013; Turner et al., 2015a; Turner et al., 2015b) consisted of retrospective 
audits. Thirteen (Andersen and Olsen, 2007; Saposnik et al., 2008; Ding et al., 2009; Milionis 
et al., 2009; Åsberg et al., 2010; Bravata et al., 2010; Smith et al., 2010; Bray et al., 2013; 
Hoffmeister et al., 2013; Nilanont et al., 2014; Schmitz et al., 2014; Song et al., 2014; 
Mortensen et al., 2015) included only patients with IS, and two (Dowlatshahi et al., 2012; Pan 
et al., 2014) included only patients with intracerebral haemorrhage. The remainder included 
both ischemic and haemorrhagic stroke. Among those studies that included both types of 
stroke, six (Glader et al., 2001; Bhalla et al., 2004; Cadilhac et al., 2004; Ingeman et al., 2008; 
Svendsen et al., 2009; Abilleira et al., 2012) excluded patients with subarachnoid 
haemorrhage.  
For the association between KPIs and patient outcomes, the majority (n=22) of the included 
studies used OR, six studies (Andersen and Olsen, 2007; Ding et al., 2009; Milionis et al., 
2009; Åsberg et al., 2010; Schmitz et al., 2014; Cadilhac et al., 2017) used HR while the 
remaining two (Ingeman et al., 2008; Svendsen et al., 2009) used rate RR. The included 
studies also used different measures for stroke severity as a case mix variable for adjustment to 
estimate the independent association between a KPI and a patient outcome. Twenty of the 
included studies used validated tools including National Institute of Health Stroke Scale (Ding 
et al., 2009; Bravata et al., 2010; Hsieh et al., 2010; Abilleira et al., 2012; Nilanont et al., 
2014; Pan et al., 2014; Song et al., 2014), Scandinavian Stroke Scale (Andersen and Olsen, 
2007; Ingeman et al., 2008; Milionis et al., 2009; Svendsen et al., 2009; Ingeman et al., 2011; 
Schmitz et al., 2014; Mortensen et al., 2015), Canadian Neurological Scale (Saposnik et al., 
2008; Smith et al., 2010; Dowlatshahi et al., 2012), Six Simple Variables (Turner et al., 2015a; 
Turner et al., 2015b), and Glasgow Coma Scale (Cadilhac et al., 2004), while the remainder 
used stroke severity proxies such as level of consciousness, incontinence, dysphagia, 
dysphasia, paralysis, and disability.   
 
 
 
68 
 
3.3.2 Reporting of published KPIs 
As there were some variations in data definitions and analysis methods, several assumptions 
were made to allow easy comparison between the studies: 
Swallow/nutritional assessment – This single KPI comprised an assessment of swallowing, 
dysphagia, and/or nutritional risk. If separate data for both swallow and nutritional risk 
assessment (Svendsen et al., 2009; Ingeman et al., 2011) were reported, I preferentially 
included data for swallow assessment. 
Antiplatelet drugs for IS – Aspirin administration reported in two studies (Nilanont et al., 
2014; Turner et al., 2015b) was combined with a KPI for antiplatelet drugs for IS reported in 
seven studies (Ingeman et al., 2008; Ding et al., 2009; Svendsen et al., 2009; Åsberg et al., 
2010; Ingeman et al., 2011; Abilleira et al., 2012; Bray et al., 2013).  
Early nurse/rehabilitation assessment – This combined indicator of early assessment by a 
nurse (Bray et al., 2013) and early assessment of rehabilitation needs (Abilleira et al., 2012).  
Early physiotherapy/mobilization – This combined four reports of early mobilization 
(Svendsen et al., 2009; Bravata et al., 2010; Ingeman et al., 2011; Abilleira et al., 2012) with 
one (Ingeman et al., 2008) about early physiotherapy assessment. 
 
3.3.3 Selection of outcome measures 
As there were minor variations in the approach to outcome analysis adjustments were made to 
the reported OR, HR, RR and CI to allow comparisons between the studies. Table 3.2 provides 
a summary of the adjustments made.  
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Table 3. 2: Adjustment of reported odds ratios/hazard ratios/rate ratios and confidence 
intervals (CIs) to allow comparisons between the studies 
Study Reported data Adjusted data 
Andersen and 
Olsen, 2007 
Association between anticoagulants for IS with 
atrial fibrillation (AF) and survival rate (HR: 
1.91, 95% CI: 1.44-2.52). 
Association between anticoagulants for IS with 
AF and case fatality rate by calculating the 
inverse (1/x) of the reported data (HR: 0.52, 95% 
CI: 0.40-0.69). 
Turner et al., 
2015b 
Association between the number of quality stroke 
care criteria fulfilled and being discharged home 
or to usual care: 
Association between the number of quality stroke 
care criteria fulfilled and not being discharged 
home or to usual care: 
Turner et al., 
2015a 
Association between stroke unit admission and 
survival rate (OR: 1.43, 95% CI: 2.71-3.56) and 
being discharged home (OR: 1.19, 95% CI: 1.11-
1.28). 
Association between stroke unit admission and 
case fatality (OR: 0.70, 95% CI:0.65-0.75), and 
not being discharged home (OR: 0.84, 95% CI: 
0.78-0.90) 
Abilleira et al., 
2012 
Association between noncompliance to 11 KPIs 
and case fatality risk at one-year post stroke 
Association between compliance to 11 KPIs and 
case fatality risk at one-year post stroke 
Lakshminarayan 
et al., 2010 
Association between lack of dysphagia screening 
and higher risk of pneumonia (OR: 2.15, 95% CI: 
1.74-2.66)  
Association between dysphagia screening and 
higher risk of pneumonia (OR: 0.47, 95% CI: 
0.38-0.57) 
Cadilhac et al., 
2004 
Association between thorough (n-l≤1)c adherence 
to 15 processes of stroke care and being at home 
at 28 weeks (OR: 1.69, 95% CI: 0.86–3.32) and 
being alive at 28 weeks (OR: 2.10, 95% CI: 0.92–
4.82). 
Association between thorough (n-l≤1)c adherence 
to 15 processes of stroke care and not being at 
home at 28 weeks (OR: 0.59, 95% CI: 0.30-1.16) 
and case fatality  at 28 weeks (OR: 0.48, 95% CI: 
0.21-1.09). 
 Association between Complete (n-l≤0) adherence 
to 15 processes of stroke care and being at home at 
28 weeks (OR: 3.09, 95% CI: 0.96–9.87) and 
being alive at 28 weeks (OR: 3.22, 95% CI: 0.66-
15.86). 
Association between Complete (n-l≤0) adherence 
to 15 processes of stroke care and not being at 
home at 28 weeks (OR: 0.32, 95% CI: 0.10-1.04) 
and case fatality at 28 weeks (OR: 0.31, 95% CI: 
0.06-1.52). 
Hubbard et al., 
2012 
Association between adherence to seven KPIs and 
being discharged home. 
Association between adherence to a KPI and not 
being discharged home. 
McNaughton et 
al., 2003 
Relationship between “no” swallowing recorded 
and poor discharge outcome (OR: 3.2, 95% CI: 
0.97 -10.7). 
Relationship between swallowing recorded and 
poor discharge outcome (OR: 0.31, 95% CI: 0.09-
1.03). 
Ding et al., 2009 Association of antiplatelets for IS with 
improvement in daily life activities (HR: 1.25, 
95% CI: 1.02–1.52).  
Association of antiplatelets for IS with 
deteriorations in daily life activities (HR: 0.80, 
95% CI: 0.66-0.98).  
Pan et al., 2014 Association of statin use with good functional 
outcome (OR: 2.04, 95% CI: 1.37–3.06).  
 
Association of statin use with poor functional 
outcome (OR: 0.49, 95% CI: 0.33-0.73).  
 
Data reported in terms of poor outcome (McNaughton et al., 2003; Dowlatshahi et al., 2012; 
Nilanont et al., 2014), disability (Glader et al., 2001; Bhalla et al., 2004; Hsieh et al., 2010; 
Song et al., 2014), death or disability (Ingeman et al., 2008; Bravata Bravata et al., 2010), or 
not returning home (Candelise et al., 2007) post stroke were all combined as a “poor outcome” 
post stroke. Finally, the results on the association between KPIs and stroke case fatality were 
categorized at the end of scheduled follow up although the timing of follow up was included in 
sensitivity analyses. 
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3.3.4 Key performance indicators 
There were 25 reported KPIs in total. The KPIs that were reported by at least a quarter of the 
eligible studies were swallow/nutritional assessment, stroke unit admission, and antiplatelets 
for IS.   
Stroke unit admission was variably defined across the related studies (Glader et al., 2001; 
Bhalla et al., 2004; Candelise et al., 2007; Ingeman et al., 2008; Svendsen et al., 2009; 
Ingeman et al., 2011; Bray et al., 2013; Nilanont et al., 2014; Turner et al., 2015a; Turner et 
al., 2015b). Two Danish studies (Ingeman et al., 2008; Svendsen et al., 2009) defined a “stroke 
unit” as a hospital department/unit that exclusively or primarily is dedicated to patients with 
stroke and which is characterized by multidisciplinary teams, a staff with a specific interest in 
stroke, involvement of relatives, and continuous education of the staff. In the Italian study 
(Candelise et al., 2007), stroke unit was defined as a hospital ward with dedicated beds (at 
least 80% stroke admission) and with a dedicated stroke staff (at least one physician and one 
nurse) who work exclusively in the care of stroke patients.  
Table 3.3 provides a list of reported KPIs and their frequencies out of the 30 studies.  
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Table 3. 3: Reported individual KPIs across the eligible studies 
Reported individual KPI Number of reporting studies/30 
Swallow/nutritional assessment 11 
Stroke unit admission 10 
Antiplatelets for IS 9 
CT/MRI brain imaging 7 
Anticoagulants for IS with AF 7 
Lipid management 7 
DVT Prophylaxis 6 
Early physiotherapy/mobilization 5 
Blood pressure lowering therapy 3 
Occupational therapy assessment 3 
Thrombolysis 3 
Neurological Assessment 2 
Early nurse/rehabilitation assessment 2 
Hyperthermia management
 
2 
Hypoxia management 1 
Early medical assessment 1 
Antidepressant therapy 1 
ADLs rehabilitation 1 
Home assessment 1 
Balance rehabilitation 1 
Secondary prevention on discharge 1 
Education to patients 1 
Discussing post-discharge needs with patients 1 
Intermittent catheterization 1 
Constipation risk assessment 1 
 
Table 3.4 indicates the reported KPIs and their association with patient outcomes.    
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Table 3. 4: Reported KPIs and their association with patient outcomes    
1. Reported KPIs and their association with case fatality 
KPI Study Treatment 
 Time 
End FU 
 period 
OR/HR/ 
RR 
95% CI 
CT/MRI brain imaging Bhalla et al., 2004  3 months 0.70 0.40-1.30 
 Ingeman et al., 2008 1st day of LoS 3 months 1.35 1.24–1.46 
 Abilleira et al., 2012 <24h 1 year 0.71 0.36-1.41 
 Bray et al., 2013 ≤24h 1 month 0.96  0.86-1.07 
 Turner et al., 2015b day 0 6 months 0.95  0.88–1.03 
Neurological Assessment Hoffmeister et al., 2013 On admission 1 month 2.02  0.77-5.30 
Thrombolysis Schmitz et al., 2014  1.4 year 0.66 0.49–0.88 
Stroke unit admission   Glader et al., 2001  2 years 0.81 0.72-0.92 
 Bhalla et al., 2004   3 months 0.50 0.30-0.80 
 Candelise et al., 2007  2 years 0.79  0.68–0.91 
 Ingeman et al., 2008 2nd day of LoS 3 months 0.76  0.69–0.83 
 Bray et al., 2013 ≤4h  1 month 0.99  0.90-1.08 
 Turner et al., 2015a  1 year 0.70 0.65-0.75 
 Turner et al., 2015b day 0 or 1 6 months 0.79  0.74–0.85 
Swallow/nutritional assessment Ingeman et al., 2008 2nd day of LoS 3 months 0.69  0.61–0.76 
 Abilleira et al., 2012  1 year 0.81  0.58-1.14 
 Bray et al., 2013 ≤72h 1 month 0.76 0.67- 0.87 
 Hoffmeister et al., 2013 ≤48h 1 month 0.52 0.26-1.04 
 Turner et al., 2015b day 0  6 months 0.95  0.86–1.04 
Antiplatelets for IS Ingeman et al., 2008 2nd day of LoS 3 months 0.71  0.62–0.81 
 Ding et al., 2009 LoS 1 year 0.42 0.21–0.86 
 Åsberg et al., 2010 - 3 months 0.83 0.68-1.01 
 Abilleira et al., 2012 < 48 hours 1 year 0.77 0.50-1.19 
 Bray et al., 2013 ≤72h 1 month 0.46  0.42-0.50 
 Turner et al., 2015b day 0 or 1 6 months 0.54  0.49–0.58 
Anticoagulants for IS with AF Andersen and Olsen,2007 Acute LoS 4 years 0.52 0.40-0.69 
Ingeman et al., 2008 By 14th day 3 months 0.41  0.31–0.52 
Åsberg et al., 2010 - 3 months 0.58 0.44–0.76 
 Abilleira et al., 2012  1 year 0.59 0.33-1.05 
Blood pressure lowering therapy Åsberg et al., 2010 - 3 months 1.00 0.87–1.14 
 Abilleira et al., 2012  1 year 0.53 0.35-0.82 
Hyperthermia management Abilleira et al., 2012  1 year 1.50 0.56-4.00 
Lipid management Milionis et al., 2009 At discharge 10 years 0.43 0.29-0.61 
 Åsberg et al., 2010 - 3 months 0.78 0.67–0.91 
 Abilleira et al., 2012  1 year 0.78 0.52-1.16 
 Dowlatshahi et al., 2012 Acute LoS 6 months 0.2  0.1–0.3 
 Pan et al., 2014 Acute LoS 1 year 0.49 0.27–0.86 
 Song et al., 2014 LoS 3months 0.51 0.38–0.67 
DVT Prophylaxis Saposnik et al., 2008 Acute LoS 1 year 0.33  0.22–0.50 
 Abilleira et al., 2012  1 year 1.02 0.63-1.67 
Early medical assessment Bray et al., 2013 ≤24h 1 month 0.88 0.80- 0.97 
Early nurse/rehabilitation assessment Abilleira et al., 2012  1 year 0.68 0.48-0.94 
 Bray et al., 2013 ≤24h 1 month 0.90  0.82-0.99 
Early physiotherapy/ mobilization Ingeman et al., 2008 2nd day of LoS 3 months 0.81  0.73–0.88 
Abilleira et al., 2012  1 year 0.65 0.45-0.95 
Occupational therapy assessment Ingeman et al., 2008 2nd day of LoS 3 months 0.83 0.75–0.91 
Antidepressant therapy Mortensen et al., 2015 LoS 1 month 0.28 0.18–0.43 
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Table 3.4: Reported KPIs and their association with patient outcomes    Continued 
2.  Reported KPIs and their association with poor outcome 
KPI Study Treatment  
time 
End FU 
 period 
OR/H
R/RR  
95% CI 
CT/MRI brain imaging Bhalla et al., 2004  3 months 1.45 0.39–7.4 
Thrombolysis Hsieh et al, 2010 3h of onset 6 months 0.52 0.35-0.76 
 Nilanont et al., 2014  LoS=4 days 0.09  0.03-0.23 
Neurological Assessment Bravata et al, 2010  LoS 1.13  0.59-2.17 
Stroke unit admission   Glader et al., 2001  2 years 0.79 0.66-0.94 
 Bhalla et al., 2004  3 months 1.3 0.6–1.76 
 Candelise et al., 2007  2 years 0.85  0.74–0.97 
 Nilanont et al., 2014  LoS=4 days 0.54  0.33-0.87 
 Turner et al., 2015a  6 months 0.84 0.78-0.90 
Swallow/nutritional assessment McNaughton et al., 2003  1 year 0.31 0.09-1.03 
 Bravata et al, 2010  LoS 0.64  0.43-0.94 
 Nilanont et al., 2014  LoS=4 days 0.54  0.33-0.87 
Antiplatelets for IS Ding et al., 2009 LoS 1 year 0.80 0.66-0.98 
 Nilanont et al., 2014 48h LoS=4 days 1.25 0.73-2.15 
Blood pressure lowering therapy Bravata et al, 2010  LoS 1.00  0.67-1.50 
Hyperthermia management Bravata et al, 2010 All episodes LoS 0.71 0.35-1.41 
Hypoxia management Bravata et al, 2010 All episodes LoS 0.26  0.09-0.73 
DVT Prophylaxis Bravata et al, 2010  LoS 0.60  0.37-0.96 
 Hubbard et al., 2012  26 days 1.72 1.23-2.44 
Early physiotherapy/mobilization Bravata et al, 2010  LoS 0.69  0.42-1.14 
ADLs rehabilitation Hubbard et al., 2012  26 days 0.99 0.32-3.03 
Home assessment Hubbard et al., 2012  26 days 0.16 0.10-0.27 
Balance rehabilitation Hubbard et al., 2012  26 days 1.85 1.20-2.86 
Secondary prevention on discharge Hubbard et al., 2012  26 days 0.50 0.28-0.89 
Education to patients Hubbard et al., 2012  26 days 0.42 0.23-0.77 
Discussing post-discharge needs with 
patients 
Hubbard et al., 2012  26 days 0.79 0.41-1.52 
Lipid management  Dowlatshahi et al., 2012 Acute LoS At discharge 0.6  0.4–0.9 
 Pan et al., 2014 Acute LoS 1 year 0.49 0.33-0.73 
 Song et al., 2014 Acute LoS 3 months 0.95 0.81–1.11 
3.  Reported KPIs and their association with prolonged LoS 
Stroke unit admission   Svendsen et al., 2009 2nd day  0.71  0.65–0.77 
Antiplatelets for IS Svendsen et al., 2009 2nd day  0.80  0.73–0.87 
Anticoagulants for IS with AF Svendsen et al., 2009 14th day  0.78  0.62–0.98 
CT/MRI brain imaging Svendsen et al., 2009 2nd day  0.82 0.74–0.91 
Swallow/nutritional assessment Svendsen et al., 2009 2nd day  0.78 0.69–0.87 
Constipation risk assessment Svendsen et al., 2009 2nd day  0.70 0.63-0.78 
Early physiotherapy/mobilization  Svendsen et al., 2009 2nd day  0.67 0.61–0.73 
Occupational therapy assessment  Svendsen et al., 2009 2nd day  0.85  0.80–0.91 
Intermittent catheterization Svendsen et al., 2009 2nd day  0.77 0.64–0.92 
DVT Prophylaxis Svendsen et al., 2009 2nd day  0.82 0.71–0.95 
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Table 3.4: Reported KPIs and their association with patient outcomes    Continued 
4.  Reported KPIs and their association with medical complications 
KPI Study Treatment 
time 
End FU 
period 
OR/H
R/RR 
95% CI 
CT/MRI brain imaging Ingeman et al., 2011  LoS=13days 1.52 1.35–1.72 
Neurological Assessment Hoffmeister et al., 2013 On admission 30 days 1.07  0.79-1.44 
Stroke unit admission   Ingeman et al., 2011  LoS=13days 0.79 0.68–0.92 
Swallow/nutritional assessment Lakshminarayan et al., 2010  LoS=5days 0.47 0.38-0.57 
 Ingeman et al., 2011  LoS=13days 0.97 0.84–1.11 
 Hoffmeister et al., 2013 ≤48h 30 days 1.58  0.60- 4.15 
Antiplatelets for IS Ingeman et al., 2011  LoS=13days 0.95 0.79–1.15 
Anticoagulants for IS with AF Ingeman et al., 2011  LoS=13days 0.59  0.45–0.76 
Early physiotherapy/mobilization Ingeman et al., 2011  LoS=13days 0.43  0.35–0.53 
Occupational therapy assessment Ingeman et al., 2011  LoS=13days 1.10  0.94–1.27 
Thrombolysis Schmitz et al., 2014  1.4 year 0.59 0.24–1.47 
5.  Reported KPIs and their association with stroke recurrence 
Antiplatelets for IS Ding et al., 2009 LoS 12 months 0.58 0.36–0.92 
Anticoagulants for IS with AF Hsieh et al., 2010 At discharge 6 months 0.59 0.44-0.80 
Lipid management Milionis et al., 2009 At discharge 10 years 0.65 0.39- 0.97 
 Hsieh et al., 2010 At discharge 6 months 0.94 0.78-1.13 
DVT Prophylaxis Hsieh et al., 2010 At discharge 6 months 0.41 0.35-0.47 
Thrombolysis Schmitz et al., 2014  1.4 year 1.05 0.68–1.64 
Abbreviations: ADLs, activities of daily living; AF, atrial fibrillation; CT/MRI, computerized tomography/magnetic resonance imaging; CI, 
confidence interval; DVT, deep vein thrombosis; FU, follow up; HR, hazard ratio; IS, ischemic stroke; KPI, key performance indicator; LoS, 
length of hospital stay; OR, odds ratio; RR, rate ratio. 
 
3.3.5 Association between individual KPIs and case fatality at the end of 
scheduled follow up 
The median time of scheduled follow up for the studies reporting on the association between 
individual KPIs and case fatality was one year; range from one month to 10 years. Significant 
reductions in case fatality were observed across multiple studies for stroke unit admission 
(Glader et al., 2001; Bhalla et al, 2004; Candelise et al., 2007; Ingeman et al., 2008; Turner et 
al., 2015a; Turner et al., 2015b), swallow/nutritional assessment (Ingeman et al., 2008; Bray  
et al., 2013), antiplatelets for IS (Ingeman et al., 2008; Ding et al, 2009; Bray  et al., 2013; 
Turner et al., 2015b), anticoagulants for IS with AF (Andersen and Olsen, 2007; Ingeman et 
al., 2008; Åsberg et al., 2010), lipid management (Milionis et al., 2009; Åsberg et al., 2010; 
Dowlatshahi et al., 2012; Pan et al., 2014; Song et al., 2014), early nurse/rehabilitation 
assessment (Abilleira et al., 2012; Bray  et al., 2013), early physiotherapy/mobilization 
(Ingeman et al., 2008; Abilleira et al., 2012). In addition, significant associations within single 
studies were observed for deep vein thrombosis (DVT) prophylaxis (Saposnik et al., 2008) 
and blood pressure lowering therapy (Abilleira et al., 2012).   
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In contrast, several studies reported wide CIs and no statistically significant association 
between the reported KPIs and stroke case fatality; stroke unit admission (Bray et al., 2013), 
swallow/nutritional assessment (Abilleira et al., 2012; Hoffmeister et al., 2013; Turner et al., 
2015b), antiplatelets for IS (Åsberg et al., 2010; Abilleira et al., 2012), anticoagulants for IS 
with AF, lipid management (Abilleira et al., 2012), DVT prophylaxis (Abilleira et al., 2012) 
and blood pressure lowering therapy (Åsberg et al., 2010). In one study (Ingeman et al., 2008) 
the CT/MRI brain imaging was associated with increased risk of early case fatality (RR: 1.35, 
95% CI: 1.24-1.46), while in other studies (Bhalla et al., 2004; Abilleira et al., 2012; Bray et 
al., 2013; Turner et al., 2015b) no evidence for an association of CT/MRI brain imaging and 
stroke case fatality was found. 
Figure 3.2 summarises the primary meta-analysis results regarding the associations between 
individual KPIs and stroke case fatality at the end of follow up. The KPIs that were associated 
with lower risk for case fatality include stroke unit admission (OR: 0.79, 95% CI: 0.72-0.87), 
swallow/nutritional assessment (OR: 0.78, 95% CI: 0.66-0.92), antiplatelets for IS (OR: 0.61, 
95% CI: 0.50-0.74), anticoagulants for IS with AF (OR: 0.51, 95% CI: 0.43-0.61), lipid 
management (OR: 0.52, 95% CI: 0.38-0.71), and early physiotherapy/mobilization (OR: 0.78, 
95% CI: 0.67-0.91). However, the significant associations of stroke unit admission, 
swallow/nutritional assessment, antiplatelets for IS and lipid management were complicated 
by substantial heterogeneity (I
2
>50%). When analyzed at a fixed time point, 
swallow/nutritional assessment (OR: 0.72, 95% CI: 0.66-0.79), antiplatelets for IS (OR: 0.64, 
95% CI: 0.44-0.93) and lipid management (OR: 0.64, 95% CI: 0.42-0.97) were associated 
with a lower risk for early case fatality (up to three months post stroke), but the heterogeneity 
was reduced for swallow/nutritional assessment (I
2
=1%) only. Stroke unit admission (OR: 
0.77, 95% CI: 0.71-0.82), antiplatelets for IS (OR: 0.57, 95% CI: 0.45-0.72) and lipid 
management (OR: 0.45, 95% CI: 0.27-0.74) were associated with lower risk for late case 
fatality (beyond three months post stroke), but the heterogeneity was reduced for antiplatelets 
for IS (I
2
=34%) only.  
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Figure 3. 2: Association between individual KPIs and case fatality  
 
Abbreviations: AF, atrial fibrillation; CT/MRI, computerized tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep vein thrombosis; I
2
, 
heterogeneity; IS, ischemic stroke; IV, inverse variance; KPI, key performance indicator; N, number of. 
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The meta-analysis showed no evidence for the association between the stroke case fatality and 
DVT prophylaxis, blood pressure lowering therapy, early nurse/rehabilitation assessment, and 
CT/MRI brain imaging. The sensitivity analysis excluding those that used HR or RR produced 
results that were similar to those  in Figure 3.2 (data not shown): stroke unit admission (OR: 
0.79, 95% CI: 0.71-0.89), swallow/nutritional assessment (OR: 0.82, 95% CI: 0.69-0.98), 
antiplatelets for IS (OR: 0.53, 95% CI: 0.44-0.63), and lipid management (OR: 0.47, 95% CI: 
0.30-0.74) remained associated with lower risk for case fatality, and  there was no evidence for 
the association between the stroke case fatality and DVT prophylaxis, early 
nurse/rehabilitation assessment, and CT/MRI brain imaging. Significant associations within 
single studies were observed for thrombolysis (Schmitz et al., 2014), early medical assessment 
(Bray et al., 2013), OT assessment (Ingeman et al., 2008), and antidepressant therapy 
(Mortensen et al., 2015), but there was no evidence for the association between stroke case 
fatality and hyperthermia management (Abilleira et al., 2012), and neurological assessment 
(Hoffmeister et al., 2013). 
3.3.6 Association between individual KPIs and poor outcome 
For studies reporting on the association between individual KPIs and poor outcome the 
available follow up periods were between four days and two years, with a mean of 282 days. 
KPIs that were reported to be associated with the lower risk for poor outcome included 
thrombolysis (Hsieh et al., 2010; Nilanont et al., 2014), stroke unit admission (Glader et al., 
2001; Candelise et al., 2007; Nilanont et al., 2014; Turner et al., 2015a), 
swallowing/nutritional assessment (Bravata et al., 2010; Nilanont et al., 2014), antiplatelets for 
IS (Ding et al., 2009), DVT prophylaxis (Bravata et al., 2010), and lipid management 
(Dowlatshahi et al., 2012; Pan et al., 2014). However, some studies found no evidence of an 
association with poor outcome and stroke unit admission (Bhalla et al., 2004); 
swallowing/nutritional assessment (McNaughton et al., 2003), antiplatelets for IS (Nilanont et 
al., 2014), DVT prophylaxis (Hubbard et al., 2012) and lipid management (Song et al., 2014). 
As summarized in Figure 3.3, the meta-analysis showed that the KPIs associated with the 
lower risk for poor outcome were stroke unit admission (OR: 0.83, 95% CI: 0.77-0.89) and 
swallowing/nutritional assessment (OR: 0.58, 95% CI: 0.43-0.78) while there was no evidence 
for a significant association with poor outcome for thrombolysis, antiplatelets for ischaemic 
stroke, DVT prophylaxis, and lipid management. 
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Figure 3. 3: Association between individual KPIs and poor outcome 
 
Abbreviations: ADLs, activities of daily living; CT/MRI, computerized tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep vein thrombosis; I
2
, 
heterogeneity; IS, ischemic stroke; IV, inverse variance; KPI, key performance indicator; N, number of. 
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Several individual studies reported significant associations between lower risk for poor 
outcome and hypoxia management (Bravata et al., 2010); home assessment, secondary 
prevention on discharge, and education to patients (Hubbard et al., 2012).  No association with 
poor outcome was found for CT/MRI brain imaging (Bhalla et al., 2004); neurological 
assessment, blood pressure lowering therapy, hyperthermia management and early 
physiotherapy/mobilization (Bravata et al., 2010); ADLs rehabilitation, balance rehabilitation 
and discussing post-discharge needs with patients (Hubbard et al., 2012).  
All the studies included for the primary meta-analysis about the association of KPIs with poor 
outcome used ORs, except one Chinese study (Ding et al., 2009). After excluding that study, 
antiplatelets for IS remained with a single study (Nilanont et al., 2014) which showed no 
association with poor outcome (OR: 1.25, 95% CI: 0.73-2.14). 
3.3.7 Association between individual KPIs and relative LoS 
A single Danish study (Svendsen et al., 2009), reported that a shorter relative LoS was 
associated with stroke unit admission, antiplatelets and anticoagulants for IS with AF, 
CT/MRI brain imaging, early physiotherapy/mobilization, occupational therapy assessment, 
swallowing/nutritional assessment, and DVT prophylaxis, with rate ratio ranging from 0.67 
(0.61–0.73) for early physiotherapy/mobilization to 0.85 (0.80–0.91) for occupational therapy 
assessment. 
3.3.8 Association between individual KPIs and the risk for medical 
complications and stroke recurrence  
Stroke unit admission, anticoagulants for IS with AF, and early physiotherapy/mobilization 
(Ingeman et al., 2011), as well as swallow/nutritional assessment (Lakshminarayan et al., 
2010) were found to be associated with lower risk for medical complications (OR: 0.79; 0.68–
0.92; 0.59, 0.45–0.76 and 0.43, 0.35–0.53; 0.47, 0.38-0.57 respectively). By contrast, CT/MRI 
brain imaging was associated with a greater risk for medical complications (OR: 1.52, 1.35–
1.72 (Ingeman et al., 2011). Other studies with wide CIs did not show evidence for the 
association between the occurrence of medical complications and neurological assessment 
(Hoffmeister et al., 2013); swallow/nutritional assessment (Ingeman et al., 2011; Hoffmeister 
et al., 2013); antiplatelets for IS, occupational therapy assessment (Ingeman et al., 2011); and 
thrombolysis (Schmitz et al., 2014).   
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KPIs that were reported to be associated with lower recurrence rate for stroke included 
antiplatelets for IS Ding et al., 2009), anticoagulants for IS with AF and DVT prophylaxis 
(Hsieh et al., 2010), and lipid management (Milionis et al., 2009). However, in one study 
(Ingeman et al., 2011) evidence for the association between lipid management and stroke 
recurrence was not found (Hsieh et al., 2010), and there was no evidence of an association 
with thrombolysis (Schmitz et al., 2014). 
3.3.9 Association between adherence to groups of KPIs and the risk for case 
fatality 
Seven studies (Cadilhac et al., 2004; Ingeman et al., 2008; Saposnik et al., 2008; Smith et al., 
2010; Bray et al., 2013; Turner et al., 2015b; Cadilhac et al., 2017) had consistent findings 
whereby adherence to a combination of several KPIs (“bundle”) was associated with a greater 
decrease in stroke mortality. A lower risk for poor outcome was also reported when full stroke 
care bundle was achieved (Cadilhac et al., 2004; Turner et al., 2015b). An Australian study 
(Cadilhac et al., 2017) also showed that achieving full care bundle was associated with better 
quality of life at three to six months post stroke. Increased adherence to stroke care KPIs 
(Svendsen et al., 2009) was associated with shorter LoS (data are not shown in Table 3.5). 
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Table 3. 5: Association between the number of KPIs achieved and patient outcomes 
 Case Fatality Poor Outcome Quality of Life 
Study FU Period Number of 
processes 
HR  95%CI FU Period Number of 
processes 
OR/ 
HR/ 
RR 
95%CI FU Period Number of 
processes 
OR/ 
HR/ 
RR 
95%CI 
Cadilhac et al., 2004 6 months All or n-1 0.48  0.21-1.09 6 months All or n-1 0.59 0.30-1.16     
  All 0.31  0.06-1.52  All 0.32 0.10-1.04     
             
Ingeman et al., 2008 3 months 1 vs 0 0.94  0.65-1.49 
 
        
  2 vs 0 0.78 0.54–1.02 
 
        
  3 vs 0 0.60 0.42–0.78 
 
        
  4 vs 0 0.61 0.42–0.79 
 
        
  5 vs 0 0.45 0.31–0.60 
 
        
  6 vs 0 0.48 0.31–0.65         
             
Saposnik et al., 2008 12 months OCI 1 vs 0 0.69   0.44–1.09         
  OCI 2 vs 0 0.39   0.25–0.62         
  OCI 3 vs 0 0.40  0.25–0.64         
             
Smith et al., 2010 1 month 2-3 vs 0-1 0.23 0.19-0.28         
             
Bray et al., 2013 1 month 5-6 vs 0-4 0.74 
 
0.66- 0.83         
            
Turner et al., 2015b 6 months 0 vs 4 2.26 
 
1.60–3.21 6 months 0 vs 4 1.43 1.02-2.00     
  1 vs 4 1.67 1.45–1.93  1 vs 4 1.35 1.19-1.54     
  2 vs 4 1.44 
 
1.31–1.59  2 vs 4 1.19 1.10-1.32     
  3 vs 4 1.17 1.08-1.27  3 vs 4 1.10 1.02-1.18     
             
Cadilhac et al., 2017 6 months 1 vs 0 0.63  0.41-0.97     3-6 months 1 vs 0 12.53*  −2.22-27.28 
  2 vs 0 0.46  0.31-0.68      2 vs 0 16.67*  0.30-33.05 
  3 vs 0 0.30  0.18-0.47      3 vs 0 18.70*  1.86-35.55 
Abbreviations: CI, confidence interval; FU, Follow up; HR, hazard ratio; n, number of applicable processes of care; OCI, Organized care index; OR, odds ratio; RR, rate ratio. 
* Visual analogue scale score (the health-related quality of life was measured with EQ-5D-3L16 visual analogue scale with deaths coded as zero). 
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Overall (see Table 3.6), only stroke unit admission, swallow/nutritional assessment, 
antiplatelets for IS, anticoagulants for IS with AF, lipid management and early 
physiotherapy/mobilization were found to be significantly associated with improved outcomes 
after a meta-analysis of two or more studies. Thrombolysis results were associated with 
reduced poor outcome in two studies, but the combined analysis was not significant due to 
substantial heterogeneity. Data were very limited for the outcomes of length of stay, stroke 
recurrence or medical complications. 
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Table 3. 6: Summary of results related to individual KPIs and outcomes 
KPI Case fatality Poor outcome Relative length of stay Medical complications Stroke recurrence 
Swallow/nutritional assessment 5 studies, 0.78a (0.66-0.92) b 3 studies, 0.58 (0.43-0.78) 1 study, 0.78 (0.69-0.87) 3 studies: 2 studies, NS; 
   1 study, 0.47 (0.38-0.57)  
 
Stroke unit admission  7 studies, 0.79 (0.72-0.87) 5 studies, 0.83 (0.77-0.89) 1 study, 0.71 (0.65-0.77) 1 study, 0.79 (0.68-0.92)  
Antiplatelets for IS 6 studies, 0.61 (0.50-0.74) 2 studies, NS 1 study. 0.80 (0.73-0.87) 1 study, NS 1 study, 0.58 (0.36-0.92) 
CT/MRI brain imaging 5 studies, NS 1 study, NS 1 study, 0.82 (0.74-0.91) 1 study, 1.52 (1.35-1.72)  
Anticoagulants for IS with AF 4 studies, 0.51 (0.43-0.61)  1 study, 0.78 (0.62-0.98) 1 study, 0.59 (0.45-0.76) 1 study, 0.59 (0.44-0.80) 
Lipid management 6 studies, 0.52 (0.38-0.71) 3 studies, NS   2 studies: 1 study, NS; 1 
study, 0.65 (0.39-0.97) 
DVT Prophylaxis 2 studies, NS 2 studies, NS 1 study, 0.82 (0.71-.095)  1 study, 0.41 (0.35-0.47) 
Early physiotherapy/mobilization 2 studies, 0.78 (0.67-0.91) 1 study, NS 1 study, 0.67 (0.61-0.73) 1 study, 0.43 (0.35-0.53)  
Blood pressure lowering therapy 2 studies, NS 1 study, NS    
Occupational therapy assessment 1 study, 0.83 (0.75-0.92)  1 study, 0.85 (0.80-0.91) 1 study, NS  
Thrombolysis 1 study, 0.66 (0.49-0.89) 2 studies, NS  1 study, NS 1 study, NS 
Neurological Assessment 1 study, NS 1 study, NS  1 study, NS  
Early nurse/rehabilitation assessment 2 studies, NS     
Hyperthermia management 1 study, NS 1 study, NS    
Hypoxia management  1 study, 0.26 (0.09-0.75)    
Early medical assessment 1 study, 0.88 (0.80-0.97)     
Antidepressant therapy 1 study, 0.28 (0.18-0.44)     
ADLs rehabilitation  1 study, NS    
Home assessment  1 study, 0.16 (0.10-0.26)     
Balance rehabilitation  1 study, NS     
Secondary prevention on discharge  1 study, 0.50 (0.28-0.89)    
Education to patients  1 study, 0.42 (0.23-0.77)    
Discussing post-discharge needs with 
patients 
 1 study, NS    
Intermittent catheterization   1 study, 0.77 (0.64-0.92)   
Constipation risk assessment   1 study, 0.70 (0.63-0.78)   
Abbreviations: ADLs, activities of daily living; AF, atrial fibrillation; CT/MRI, computerized tomography/magnetic resonance imaging; DVT, deep vein thrombosis; IS, ischemic stroke; KPI, key performance indicator; 
NS, no statistically significant association. 
a Overall odds ratio; b 95% confidence interval.    
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3.4 Discussion 
The publications I have reviewed provide a large and diverse body of evidence on whether 
quality of care, as measured by adherence to a KPI, is associated with improved clinical 
outcomes in patients hospitalized with stroke. My primary meta-analysis indicated that several 
KPIs including stroke unit admission, swallowing/nutritional risk assessment, antiplatelets for 
IS, anticoagulants for IS with AF, lipid management and early physiotherapy/mobilization 
were associated with a reduction in case fatality or poor outcome. However, although my 
meta-analysis showed significant associations between lower risk for case fatality and several 
individual KPs at the end of scheduled follow up, there was substantial heterogeneity 
(I
2
>50%) for stroke unit admission, swallowing/nutritional risk assessment, antiplatelets for IS 
and lipid management. Therefore, my meta-analysis results need to be interpreted with 
caution. 
The strong association of stroke unit care with improved outcomes could be anticipated from a 
substantial number of RCTs (Stroke Unit Trialists’ Collaboration, 2013). My review confirms 
this across a range of studies in routine care. Given the evidence for specialized 
multidisciplinary stroke unit care in stroke (Stroke Unit Trialists’ Collaboration, 2013), one 
might also expect to see benefits associated with early nurse or rehabilitation assessment and 
early medical assessment (Bray et al., 2013), as well as occupational therapy assessment 
(Ingeman et al., 2008). These indicators lack direct evidence from randomized trials but may 
possibly be markers for admission to a stroke unit and multidisciplinary stroke care. However, 
there were no comparable data from many studies about early medical assessment, early nurse 
or rehabilitation assessment or early occupational therapy assessment for my review.  
My finding of a reduced risk of case fatality after early physiotherapy/mobilization was in 
accordance with the literature about stroke unit care (Stroke Unit Trialists’ Collaboration, 
2013), and some small RCTs (Langhorne and Pollock, 2002) but not consistent with recent 
RCTs of very early mobilisation (The AVERT Trial Collaboration group, 2015). However, the 
recent AVERT trial tested mobilisation at an earlier stage than in routine care so the optimal 
timing of mobilization remains unclear, and very early intensive mobilization within 24 hours 
may carry some hazard (The AVERT Trial Collaboration group, 2015). 
My meta-analysis showed that swallow or nutritional assessment was associated with lower 
risk for both mortality and disability post stroke. This finding was consistent with a 
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randomized controlled trial (RCT) (Middleton et al., 2011) which found that reinforcement of 
multidisciplinary management of swallowing dysfunction was significantly associated with 
lower risk for death or dependency. Thus, swallowing or nutritional assessment may be of 
paramount importance.  The current meta-analysis also showed that early antiplatelet use for 
IS was associated with reduction in case fatality, and this was consistent with the results from 
a previous systematic review (Sandercock et al., 2014) of eight RCTs. It showed that early 
antiplatelet therapy was associated with mortality reduction at a final follow-up between one 
and six months. However, my review showed greater apparent benefit than the 8% reduction 
in case fatality that was reported in the review of RCTs (Sandercock et al., 2014). However, a 
recent individual patient data meta-analysis of aspirin trials (Rothwell et al., 2016) confirms an 
important short-term benefit of aspirin therapy in preventing recurrent cerebral ischemia and 
that benefits may be greater than previously estimated.  My meta-analysis finding of a reduced 
risk of stroke case fatality associated with lipid management was consistent with the results 
from a meta-analysis (O'Regan et al., 2008) of 42 RCTs.  
One major disagreement with the RCTs is that my meta-analysis also showed that early 
anticoagulant use for IS with AF was associated with a reduction in early and late case fatality. 
However, this finding was not supported by a review (Sandercock et al., 2015) of 24 RCTs.  
This disagreement may be explained by the participants’ inclusion criteria. In fact, while the 
RCTs included in the review (Sandercock et al., 2015) recruited patients with presumed or 
confirmed ischaemic stroke, the studies included in my review considered only patients with 
IS and AF. Additionally, as the studies included in my review were neither randomized nor 
blinded, the apparent effects of antiplatelets and anticoagulants for IS may have been 
overestimated due to selection bias and incomplete adjustment for confounders. Alternatively, 
KPIs may also reflect other important and unmeasured aspects of care which would not be 
tested in a well-designed RCT. Additionally, the duration of follow-up for the studies included 
in my meta-analysis varied between three and 48 months (mean: 16.5 ±21.4 months) while the 
duration of follow-up in the trials was generally shorter. This short-term follow-up may lead to 
missing a significant proportion of deaths that occur after one month, and disability is best 
assessed between three to six months when most of the recovery has taken place (Sandercock 
et al., 2015).  
My review has also identified some areas with inconsistent evidence of the association of KPIs 
with outcome. DVT prophylaxis was found to be associated with significant benefits in studies 
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in Canada (Saposnik et al., 2008) and the USA (Bravata et al., 2010) but not in Spain 
(Abilleira et al., 2012).  However, a meta-analysis of RCTs has failed to show improvements 
in survival or independence (Sandercock et al., 2015).  
Regarding thrombolysis, in two studies included for my review (Hsieh et al., 2010; Nilanont et 
al., 2014) thrombolysis was associated with a lower risk for poor functional outcome, and this 
was consistent with the systematic review of the RCTs (Wardlaw et al., 2014). However, 
because of high heterogeneity (I
2
=88%) between the two studies reviewed, the summary effect 
was not statistically significant.                                        
My review showed that CT/MRI brain imaging and neurological assessment were not 
associated with any reported patient outcomes. This may be due to several reasons. First, the 
assessment itself, if not combined with adequate care, is unlikely to show any difference in 
outcome. For instance, once IS is diagnosed with brain imaging, further management by 
intravenous tissue plasminogen activator was found to be effective. It was however recently 
reported that only 3% of low-income, 19% of lower-middle-income, 33% of upper-middle-
income, and 50% of high-income-countries use it (Berkowitz et al., 2014). Second, the 
increased risk of early case fatality (Ingeman et al., 2008) and medical complications 
(Ingeman et al., 2011) that were reported after early CT/MRI brain imaging in two Danish 
studies, was most likely due to reverse causality; patients who deteriorated during the first 
hours after hospitalization were more likely to receive an early CT/MRI brain imaging, and 
also had a greater risk of death or medical complications (Ingeman et al., 2011). Third, some 
of the analyses of data may have been hampered by small sample sizes, and lack of statistical 
power to show the differential benefit.    
Adherence to an individual measure in isolation may not have a clinically detectable impact on 
outcomes, making determination of an effect more difficult (Katzan, 2011). However, 
adherence to several KPIs was always associated with improved outcomes.  
Strengths and weaknesses 
My systematic review has several strengths including searching a wide range of databases 
using standardised methodology. Furthermore, the review report was based on the PRISMA 
guidelines. The studies that were included in my review involved large sample sizes in 
general, allowing sufficient statistical power and enhancing the external validity of the results. 
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One study (Bhalla et al., 2004) was multinational, and 12 studies (Glader et al., 2001; 
Andersen and Olsen, 2007; Candelise et al., 2007; Ingeman et al., 2008; Åsberg et al., 2010; 
Hsieh et al., 2010; Hubbard et al., 2012; Nilanont et al., 2014; Pan et al., 2014; Schmitz et al., 
2014; Song et al., 2014; Cadilhac et al., 2017) involved nationwide datasets. The remaining 
studies were conducted regionally with the recruitment of participants from between three 
(McNaughton et al., 2003) to 222 hospitals (Lakshminarayan et al., 2010). Additionally, I only 
conducted analyses using data from studies that corrected for patient casemix (age and stroke 
severity). My approach to meta-analysis has used a conservative random-effects approach to 
acknowledge the diversity of studies identified. Finally, I performed a sensitivity analysis to 
evaluate the robustness of my findings. 
I must acknowledge some weaknesses. I did not use any scoring system to assess risk of bias 
in included studies, but simply included large register studies reporting independent 
association of KPIs with patient outcomes after adjusting at least two variables including age 
and stroke severity. Second, the review was based on data from observational studies with 
different follow-up time periods and designs.  Third, although I have only included data that 
used a multivariable analysis to correct for patient casemix, there remains the possibility that 
the patient outcomes were influenced by unmeasured or residual confounding factors such as 
indication bias or factors related to the nonrandomized study design rather than the reported 
KPIs themselves. Fourthly, my review could be subject to publication bias because my search 
strategy was limited to electronic databases and references known to the authors, and 
manuscripts published in English only. Fifth, there is a potential concern about combining 
results from studies from different settings and using different research methodologies. For 
instance, there were different measures for stroke severity for case mix adjustment, different 
models of stroke unit, and different models of implementing or measuring the KPIs. Finally, I 
was limited to a few studies reporting data on important outcomes such as the LoS and QoL, 
and none of the studies considered the cost of care which is clearly important in a disabling 
condition such as stroke.   
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3.5 Conclusion 
My review showed that the most frequently reported KPIs for stroke care were 
swallow/nutritional assessment, stroke unit admission, antiplatelets for IS, CT/MRI brain 
imaging, anticoagulants for IS with AF, lipid management, DVT prophylaxis, and early 
physiotherapy/mobilization. Stroke unit admission and early interventions including 
swallowing/nutritional risk assessment, antiplatelets for IS, anticoagulants for IS with AF, 
lipid management and physiotherapy/mobilization were all associated with better patient 
outcomes. Achieving a combination of several KPIs was always associated with a better 
outcome. Both policy makers and health care professionals should be encouraged to 
implement the KPIs for stroke management that are reliable and meaningful for regularly 
monitoring the quality of stroke care. Future research could focus on stroke care quality 
indicators that are never or rarely reported, particularly in the post-acute period. Such quality 
indicators could include for instance access to early supported discharge and ADLs 
rehabilitation.  
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Chapter 4: Stroke services in African and other low and middle-income 
countries in an international study  
4.1 Introduction 
In my systematic literature review on the epidemiology and impact of stroke in Africa I found 
that stroke is common and important in Africa. By contrast, in my second review, I found that 
the provision of stroke care in Africa was below the recommended standards with variations 
across countries and settings. There is therefore a need for appropriate measures to improve 
stroke care in African countries, and hence reduce mortality and disability after stroke. The 
third thesis chapter explored the role of key performance indicators of quality stroke care and 
their association with patient outcomes. However, the publications I reviewed were mainly 
from high-income countries (HICs). This raises a question of whether the key performance 
indicators in HICs are applicable to LMICs. I am convinced that initiatives to improve stroke 
care in Africa should focus on those stroke care elements that are relevant to the local context 
in terms of feasibility and effectiveness. I therefore aimed to explore the examples of key 
stroke care elements outside high-income healthcare settings. First, I aimed to identify those 
stroke care elements that have been established in low and middle-income world settings, 
generally and African settings in particular. Second, I aimed to assess the association of the 
existing stroke care services with patient outcomes in those countries with limited resources.  
4.2 Methods 
I used the INTERSTROKE study data to identify the availability and delivery of stroke care 
services and their association with patient outcomes in LMICs generally and African countries 
in particular. 
4.2.1 INTERSTROKE study 
The INTERSTROKE study is an international, multicentre, case-control study, designed to 
establish the association of traditional and emerging risk factors with stroke (and primary 
stroke subtypes) in countries of high, middle, and low income. I explored data from the second 
phase of the INTERSTROKE study which was conducted between Jan 11, 2007, and Aug 8, 
2015. This second phase of the INTERSTROKE study involved 13447 stroke cases and 13472 
controls. The 13447 stroke patients were enrolled from 142 hospitals in 32 countries in Asia, 
Africa, Europe, the Middle East, North America, South America, and Australia. The African 
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countries were five in total including South Africa, Mozambique, Uganda, Sudan and Nigeria. 
Recruitment, inclusion and exclusion criteria for the study participants as well as the data 
collection process have been described elsewhere (O’Donnell et al., 2016). 
INTERSTROKE data collection was at two levels: 
 i) Individual stroke patient data included the following; demographic features (age, sex, level 
of education, marital status, main occupation before stroke, mother’s and father’s level of 
education), risk factors, pre-stroke disability (using the modified Rankin Score), comorbidity 
(based on the Charleston Comorbidity Index), stroke characteristics (including haemorrhage or 
infarct classified with the Oxfordshire Community Stroke Project (OCSP) classification), 
modified Rankin Score at baseline, level of consciousness at baseline) and acute management 
received (brain imaging, antiplatelet therapy, thrombolysis, lipid lowering therapy and blood 
pressure lowering therapy). 
ii) Service-level data; Using a short questionnaire, information was collected on health-care 
and stroke service facilities  at each participating hospital: a) local and national healthcare 
system characteristics b) hospital characteristics  and resources (e.g. tertiary or secondary level 
hospital, departments and beds available), c) stroke service characteristics (presence of stroke 
unit, stroke unit characteristics and resources), d) additional features (other aspects of patient 
care such as post-discharge rehabilitation). 
After combining all the data, there was complete information for 12343 (92%) of 13447 
INTERSTROKE patients, from 108 hospitals in 28 countries; 2577 from 38 hospitals in ten 
HICs and 9766 from 70 hospitals in 18 LMICs. 
The list of the involved countries, grouped according to their 2015 World Bank classification 
by income, with the number of the centres and participants are provided in table 4.1. 
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Table 4. 1: Countries involved in the 
INTERSTROKE study 
African low-income and middle-income countries 
Country Total number of 
hospitals                                                                                                   
N  
South Africa 3 100 
Mozambique 1 281 
Uganda 2 265 
Sudan 1 308 
Nigeria 1 29 
Sub-total 1 8 983 
Other low-income and middle-income countries 
Russia 1 204 
China 12 3456 
India 11 2162 
Pakistan 1 291 
Argentina 6 129 
Brazil 15 384 
Chile 1 101 
Colombia 3 181 
Ecuador 2 600 
Peru 1 143 
Turkey 5 297 
Philippines 3 571 
Malaysia 1 264 
Sub-total 2 62 8783 
High-income countries 
Canada 3 259 
Australia 4 120 
Germany 3 293 
Denmark 1 36 
Sweden 2 166 
UK 19 1002 
Ireland 1 25 
Poland 2 409 
Croatia 1 61 
UAE 2 206 
Sub-total 3 38 2577 
Total 108 12343 
Abbreviations: UAE, United Arab Emirates; UK, United 
Kingdom 
 
 I was interested in exploring the results 
from the INTERSTROKE study because it 
was the novel study that describes the 
pattern of stroke care on a large scale 
covering many low-income and middle-
income countries.   
Seventy-one percent of the centers and 
80% of the participants for the 
INTERSTROKE study were in LMICs. 
Permission to use the INTERSTROKE 
data  
Permission to use the INTERSTROKE 
data was provided by Professor Martin J 
O’Donnell on behalf of the 
INTERSTROKE investigators. 
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4.2.2 INTERSTROKE data included in my analysis 
I analyzed the data about the participants with stroke because my objective was to identify 
the services that were available or offered to patients with stroke. I analyzed data for 
12343 INTERSTROKE participants with stroke for whom there were complete data. The 
data included in my analysis consisted of demographic and clinical characteristics of the 
participants, and stroke care services available for or offered to patients with stroke.  
Patient demographic variables included in my analyses were age, sex, and level of 
education and the clinical ones were Charlson Comorbidity Index (CCI), baseline mRS 
score, baseline level of consciousness, stroke type, the OCSP classification of stroke, and 
30-day patient outcomes.  
Regarding the stroke care services, I analyzed data about healthcare service funding and 
availability of special services for stroke care. I also analyzed data about the capacity of 
the available stroke services plus the education of patient families about rehabilitation and 
availability of post-discharge rehabilitation services.  
Finally, I explored the data about the provision of stroke care interventions at hospital such 
as brain imaging, thrombolysis, carotid surgery or stenting for revascularization, and 
medications given. 
4.2.3 Statistical analysis 
I analyzed the data using the Statistical Package for the Social Sciences (SPSS) software, 
version 24. I aimed to compare African countries to all LMICs in general for all the 
analyses. I computed both descriptive and inferential statistics. First, I computed the 
descriptive statistics including the frequencies and percentages for categorical variables 
and means/ranges for continuous variables to describe the characteristics of the 
participants and the availability or delivery of stroke care services. Regarding the stroke 
care services, I computed the frequency and percentage of the participants who had the 
services available for them to use, and the participants who received each of the 
interventions included in my analysis. The availability of stroke care services was 
determined as proportions of participants that the local investigator estimated had the 
services available for them. This was cross-validated using the number of beds available 
relative to the number of patients admitted. The implementation of each of the stroke care 
interventions was measured as the number of participants who received an intervention in 
relation to the total number of the participants. Both the available stroke care services and 
the interventions received by the participants were all grouped as “stroke care variables”.   
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Second, I performed univariate and multivariate logistic regression analyses to generate 
odds ratios (ORs) with 95% CI and chi-squared (χ2) test p-values for determining the 
association between patient outcomes and individual selected stroke care services, 
comparing African countries to all LMICs and all study countries. The patient outcomes 
that were considered in my analysis included 30-day case fatality and 30-day death or 
severe disability (inability to walk independently) (mRS=4-6) (Langhorne et al., 2018). 
The stroke care variables that were considered in my analysis for association with patient 
outcomes included brain imaging with CT scan on the day of admission, availability of a 
stroke unit for at least (≥) 50% of stroke patients, availability of a stroke specialist for at 
least (≥) 50% of stroke patients, lipid therapy, antihypertensive therapy, antiplatelet 
therapy for IS, availability of continuing rehabilitation in hospital, and the availability of 
post-discharge rehabilitation. The patient characteristics that were considered for the case 
mix adjustment for the multivariate logistic regression analysis included age, baseline 
level of consciousness, OCSP classification of stroke and baseline stroke severity. These 
variables were selected because a logistic regression analysis showed that only them were 
significantly (p<0.0001) associated with patient outcomes. A regression analysis for 
collinearity diagnosis showed that there was no significant collinearity (variance inflation 
factors (VIF (j)) <2.2) between the covariates.  
While performing  the logistic regression analysis for each variable, I followed the “rule of 
thumb” according to which there should be no fewer than 10 outcomes for each binary 
category (e.g., alive ⁄ dead) in both intervention and control groups (Stoltzfus, 2011). As I 
had eight independent variables for my regression analysis, I used the Bonferroni 
correction method to control the familywise error rate (false predictors). For this, I 
determined the critical p-value (alpha) by dividing p=0.05 by 8 and I got Bonferroni 
critical value p= 0.006 as the level of significance for all the regression analyses. 
Third, I aimed to assess the association between patient outcomes and the level of 
adherence to a stroke care bundle consisting of five variables including brain CT scan on 
the day of admission, availability of stroke unit for at least (≥) 50% of stroke patients, 
availability of stroke specialist for at least (≥) 50% of stroke patients, antiplatelet therapy 
in hospital, and the availability of post-discharge rehabilitation. “Antiplatelet therapy” was 
defined as giving antiplatelet drugs for IS or not giving them in case of hemorrhagic 
stroke.  This sub-analysis was only possible to do among participants who were assumed 
to be eligible for all the stroke care bundle components. Consequently, lipid therapy and 
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antihypertensive therapy in hospital were not included in the bundle because I could not 
determine who was eligible for those interventions.  
Availability of continuing rehabilitation in hospital variable was also not included in the 
stroke care bundle because of insufficient data (it was generating a logistic regression 
model with a category of participants who did not achieve any component (score 0) for 
which there was no any single death case).  
Stroke care bundle score “0”, “1”, “2”, “3”, “4”, “5” corresponded respectively to having 
achieved none, one, two, three, four, five stroke care bundle components. Participants who 
achieved the full bundle were used as the reference group. The level of significance for 
this analysis was the same (p=0.006) as for the analyses for the association between 
patient outcomes and individual stroke care variables. 
 
4.3 Results 
Table 4.2 shows the demographic and clinical characteristics of the 12343 
INTERSTROKE study participants included in my analysis. However, as they were 
missing data with variations across the variables investigated, the sample size varied 
across the analyses. 
African participants were younger (mean age was 58.8 years) than the participants from 
LMICs in general (mean age was 61.4 years) and all the study countries (mean age was 
62.3 years). The majority (66%) of African participants compared to 62% for all LMICs 
and 53% for all countries did not have more than eight years of education. Regarding the 
CCI, I found that 87% of the African participants compared to only 66% for all LMICs 
and 67% for all countries had CCI score of 1 and above. The study results also indicated 
that a large majority (87.3%) of African participants compared to 68.5% of all LMICs 
participants and 62% of all study participants had moderate to severe disability (mRS 3-6) 
at baseline. African participants were more likely to have a reduced level of consciousness 
at baseline. The proportion of hemorrhagic type of stroke was higher in African countries 
(30.3%) and all LMICs in general (29.5%) than the percentage for all the countries 
(25.0%).  
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Table 4. 2: Demographic and clinical characteristics of the participants 
 Overall, 
N=12343 
LMICs,  
n=9766 
African countries, 
n=983 
Age, years    
                                 Mean 62.3  61.4  58.8  
                                 Range 17-99 17-99 18-97 
Sex, male 7233 (58.6%) 5690 (58.3%) 498 (50.7%) 
Education    
                     None 1918 (15.5%) 1855 (19.0%) 253 (25.7%) 
                     1-8 years 4598 (37.3%) 4212 (43.1%) 398 (40.5%) 
                     9-12 years  3346 (27.1%) 2198 (22.5%) 194 (19.7%) 
                     Trade school 1036 (8.4%)   675 (6.9%)  44 (4.5%) 
                     College/University 1444 (11.7%)   825 (8.4%)  94 (9.6%) 
Charlson Comorbidity Index (CCI)    
                                                                0 4046 (32.8%) 3316 (34.0%) 117 (11.9%) 
                                                                1 8048 (65.2%) 6253 (64.0%) 809 (82.3%) 
                                                                2 206 (1.7%)    157 (1.6%) 20 (2.0%) 
                                                                3 40 (0.3%)       39 (0.4%) 37 (3.8%) 
Baseline mRS score     
                           mRS = 0-2 4679 (37.9%) 3074 (31.5%) 125 (12.7%) 
                           mRS = 3 3102 (25.1%) 2630 (26.9%) 326 (33.2%) 
                           mRS = 4 2840 (23.0%) 2467 (25.3%) 338 (34.4%) 
                           mRS = 5 1719 (13.9%) 1593 (16.3%) 194 (19.7%) 
Baseline level of consciousness     
                                       Alert  8387 (68.0%) 6005 (61.5%) 529 (53.8%) 
                                       Reduced  3945 (32.0%) 3756 (38.5%) 454 (46.2%) 
Stroke type    
             Infarct 9251 (75.0%) 6881 (70.5%) 684 (69.7%) 
             Hemorrhage 3088 (25.0%) 2882 (29.5%) 297 (30.3%) 
OCSP stroke classification    
             Hemorrhage 3199 (25.9%)  2941 (30.1%) 308 (31.3%) 
             Total anterior circulation infarct  599 (4.9%) 488 (5.0%) 87 (8.9%) 
             Partial anterior circulation infarct 4268 (34.6%) 3246 (33.2%) 398 (40.5%) 
             Posterior circulation infarct 1266 (10.3%) 860 (8.8%) 54 (5.5%) 
             Lacunar infarction 2429 (19.7%) 1723 (17.6%) 89 (9.1%) 
             Other/Undetermined 577 (4.7%) 407 (5.2%) 47 (4.8%) 
Patient outcomes, yes, n (%)      
             Death at 30 days                                   1190 (9.7%) 1136 (11.7%) 203 (21.0%) 
             Death or severe disability (mRS 4-6) at  
             30 days                                                             
2427 (19.8%) 2180 (22.4%) 333 (34.5%) 
Abbreviations: LMICs, low and middle-income countries; mRS, modified Rankin scale; OCSP, Oxfordshire 
Community Stroke Project. 
For the patient outcomes, the results showed that the rates for both 30-day case fatality 
(21.0%) and inability to walk independently (34.5%) in African countries were higher than 
the rates found in all LMICs (11.7% for case fatality and 22.4% for inability to walk 
independently) and all the study countries (9.7% for case fatality and 19.8% for inability 
to walk independently).  
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Table 4.3 shows the levels of availability and delivery of stroke care services in African 
countries compared with LMICs 
Table 4. 3: Stroke care services in African countries compared with LMICs 
 Overall LMICs African countries 
Healthcare service funding, n (%)                                                                                                                                                                                               
                       Government funding 3781 (30.6%) 2068 (21.2%) 439 (44.7%) 
                       Health insurance funding 1307 (10.6%) 214 (2.2%) 0 (0%) 
                       Private funding 2542 (20.6%) 2542 (26.0%) 29 (0.3%) 
                       Mixed funding 5847 (47.4%) 574 (58.8%) 515 (52.4%) 
Availability of specialties for stroke care, n (%)                                                                                                                         
                       Neurology 8638 (70.0%) 7462 (76.4%) 658 (66.9%) 
                       General (internal) medicine 8872 (71.9%) 7554 (77.3%) 983 (100%) 
                       Geriatric medicine 2255 (18.3%) 1036 (10.6%) 0 (0%) 
                       Rehabilitation medicine 4976 (40.6%)  4150 (42.5%) 368 (37.4%) 
                       Stroke medicine 4632 (37.5%)  2975 (30.5%) 0 (0%) 
                       Family medicine 1701 (13.8%)  1587 (16.3%) 0 (0%) 
Availability of stroke specialist, yes, n (%)      
                      SS available 9962 (81.2%) 7565 (77.5%) 615 (62.6%) 
                      SS available to ≥50% of stroke patients 8576 (69.9%) 6317 (64.7%) 387 (39.4%) 
Availability and capacity of stroke units, yes, n (%)    
                      SU available 6055 (49.1%) 3685 (37.7%) 373 (37.9%) 
                      SU available to ≥50% of stroke patients 4867 (39.7%) 2631 (26.9%) 44 (4.5%) 
                      Number of beds in stroke unit     
                                                          Mean 6.8 3.8 1.7 
                                                          Range 0-59 0-34 0-6 
                      Estimated proportion (%) of patients 
                      admitted to SU per month    
   
                                                          % Mean 34.2% 21.8% 6.5% 
                                                           Range 0-100% 0-100% 0-70% 
Staff workload for stroke patients in a 10-bed 
stroke unit, yes, n (%)                                                                                                                                                           
   
                        Doctors at least 0.1 WTE 5752 (96.3%)  3604 (98.1%) 308 (82.6%) 
                        Nurses at least 1.0 WTE 1651 (27.7%)  1131 (30.8%) 308 (82.6) 
                        PT at least 1.0 WTE 5227 (87.5%)  3400 (92.5%) 308 (82.6) 
                        OT at least 1.0 WTE 2136 (35.8%)  1349 (36.7%) 0 (0%) 
                        SLP at least 0.04 WTE 4175 (69.9%)   2650 (72.1%) 21 (5.6%) 
MDT meetings at least once per week 
                                              yes, n (%)    4764 (40.0%)    2667 (28.5%) 100 (14.2%) 
Availability of continuing rehabilitation in 
hospital,                               yes, n (%)   
 
10733 (87.0%) 
   
   8170 (83.7%) 
 
675 (68.7%) 
Availability of post-discharge rehabilitation,  
                                               yes, n (%)   
 
5741 (46.5%) 
  
    3384 (34.7%) 
 
100 (10.2%) 
Availability of education to family members about 
rehabilitation,                       yes, n (%)   
 
9096 (73.7%) 
      
6927 (70.9%) 
 
286 (29.1%) 
Delivery of stroke care interventions in hospital, 
yes, n (%)  
   
                        Brain CT Scan by day 1 11482 (93.2%) 9022 (92.6%)  655 (66.8%) 
                        Antihypertensive therapy  8671 (70.3%) 6853 (70.2%) 640 (65.2%) 
                        Lipid therapy  8674 (70.3%) 7856 (70.2%)  641 (65.2%) 
                        Aspirin for IS  6951 (75.1%) 5083 (73.9%) 440 (64.3%) 
                        Antiplatelet for IS  7693(83.2%) 5555 (80.7%) 451 (65.9%) 
                        Oral anticoagulants for IS  475 (5.1%) 265 (3.9%) 34 (5.0%) 
                        Thrombolysis for IS  704 (7.6%) 241(3.5%) 4 (0.6%) 
                        Carotid surgery or stent for IS   97/ (1.1%)   18 (0.3%) 0 (0.0%) 
Abbreviations: CT Scan, Computerized Tomography Scanning; IS, ischemic stroke; LMICs, low and middle-income 
countries; OT, occupational therapist; PT, physiotherapist, SLP, speech and language pathologist; SS, stroke specialist; 
SU, stroke unit; WTE, Whole Time Equivalent. 
 
Government-funded healthcare systems were reported to be more available for African 
participants (44.7%) than all LMICs participants (21.2%).  Health insurance funding was 
reported to be non-existent for the African participants (0%) and rare for LMICs in general 
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(2.2%) compared to 10.6% for all study countries. Mixed funding was the most common 
funding system in all LMICs (58.8%), African countries (52.4%), and all countries 
(47.4%). The most available specialties to African participants were internal or general 
medicine (100%) and neurology (66.9%), and this was the same for all LMICs (77.3% for 
internal or general medicine and 76.4% for neurology).  However, in all African study 
centers, there were neither geriatric, stroke nor family medicine although they were 
reported in other LMICs.  
Stroke units were equally rare in African countries (37.9%) and in all LMICs in general 
(37.7%) compared to the availability rate (49.1%) for all the study countries. The study 
also showed that the stroke units that could manage at least 50% of stroke patients that 
present to hospital were available for only 4.5% of the African participants compared to 
26.9% and 39.7% of LMICs and all the study participants in general respectively. 
Regarding the capacity and admission rate, the average of beds per stroke unit in Africa 
(1.7) was lower than the ones found in all LMICs in general (3.8) and in all the study 
countries (6.8), and the stroke unit admission rate in Africa (6.5%) was also lower than the 
rates reported in all LMICs in general (21.8%) and in all the study countries (34.2%).  
There were also stroke unit staffing variations across the countries especially for the 
occupational therapists (OTs) and speech and language pathologists (SLPs). For instance, 
it was found that the percentage of OTs who could spend at least 10% of their time in a 
10-bed stroke unit was 0 in African countries compared to 36.7 for all LMICs in general. 
The percentage of speech and language pathologists who could spend at least 4% of their 
time in a 10-bed stroke unit was 5.6 in African countries compared to 72.1 for all LMICs 
in general. 
Concerning rehabilitation, the results indicated that both in-hospital and post-discharge 
stroke rehabilitation services were available to only 68.7% and 10.2% respectively in 
African countries compared to the rates of 83.7% and 34.7% for all LMICs in general, 
87.0% and 46.5% for all the study countries. 
Table 4.3 also illustrates that the provision of any of the stroke care interventions that were 
investigated was lower in African countries than in all LMICs in general.  The proportion 
of African participants who received any of the interventions including brain CT scan on 
the day of admission, antihypertensive therapy in hospital, lipid therapy in hospital and 
antiplatelet for IS in hospital was lower than 67%. Carotid surgery was not performed for 
any African participant, and oral anticoagulants for IS (5%) as well as thrombolysis 
98 
 
(0.6%) were rarely received during the hospital stay. This finding was common to all 
LMICs: 0.3% for carotid surgery, 3.9% for oral anticoagulants and 3.5% for thrombolysis. 
In summary, neurology and general (internal) medicine specialties, continuing 
rehabilitation in hospital services were available, and brain CT scan on the day of 
admission, antihypertensive and lipid therapy as well antiplatelet for IS services were 
delivered to more than a half of the participants from African countries. In all LMICs 
combined, in addition to those services commonly found in African countries, stroke 
specialist to at least 50% of stroke patients and education to family members about 
rehabilitation services were available to more than a half of the participants. 
Table 4.4 presents the odds ratios for 30-day case fatality and death or severe disability 
(mRS=4-6) for the stroke care variables comparing African countries with LMICs, and all 
countries in general.  
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Table 4. 4: Association between stroke care variables and 30-day patient outcomes 
    
         Crude ORs (95%CI)  Adjusted* ORs (95%CI) 
    
Stroke care variable         All countries LMICs African countries  All countries LMICs African countries 
        
 30-day case fatality 
 
Brain CT scan by day 1 0.77(0.62-0.96), 
p=0.018 
0.83(0.66-1.03), 
p=0.090 
1.26(0.90-1.76), 
p=0.186 
 0.82(0.64-1.05), 
p=0.121 
0.85(0.66-1.10), 
p=0.211 
1.08(0.73-1.60), 
p=0.705 
Availability of stroke unit ≥ 50% 0.66(0.58-0.75), 
p<0.0001 
1.08(0.94-1.24), 
p=0.260 
Insufficient data  0.67(0.58-0.78), 
p<0.0001 
0.71(0.60-0.83), 
p<0.0001 
Insufficient data 
Availability of stroke specialist ≥ 
50% 
0.41(0.36-0.46), 
p<0.0001 
0.48(0.43-0.55), 
p<0.0001 
1.21(0.89-1.66), 
p=0.226 
 0.72(0.62-0.83), 
p<0.0001 
0.74(0.64-0.85). 
p<0.0001 
1.41(0.96-2.05), 
p=0.077 
Lipid therapy in hospital 1.19(1.04-1.37), 
p=0.011 
1.18(1.02-1.35), 
p=0.021 
0.87(0.63-1.21), 
p=0.411 
 0.87(0.74-1.02), 
p=0.080 
0.87(0.74-1.03), 
p=0.095 
0.73(0.50-1.06), 
p=0.099 
Antihypertensive therapy in hospital 1.19(1.04-1.37), 
p=0.011 
1.18(1.03-1.35), 
p=0.021 
0.87(0.63-1.21), 
p=0.418 
 0.87(0.74-1.02), 
p=0.081 
0.87(0.74-1.03), 
p=0.096 
0.73(0.50-1.07), 
p=0.102 
Antiplatelet therapy for IS 0.41(0.34-0.48), 
p<0.0001 
0.46(0.38-0.55), 
p<0.0001 
0.93(0.62-1.39), 
p=0.724 
 0.65(0.53-0.80), 
p<0.0001 
0.69(0.56-0.85), 
p=0.001 
1.08(0.68-1.73), 
p=0.748 
Availability of continuing 
rehabilitation in hospital 
0.99(0.83-1.19), 
p=0.940 
1.26(1.05-1.50), 
p=0.012 
0.59(0.43-0.81), 
p=0.001 
 0.66(0.53-0.82), 
p<0.0001 
0.70(0.57-0.87), 
p=0.001 
0.59(0.40-0.88), 
p=0.009 
Availability of post-discharge 
rehabilitation 
0.30(0.26-0.35), 
p<0.0001 
0.41(0.35-0.48), 
p<0.0001 
Insufficient data  0.41(0.35-0.48), 
p<0.0001 
0.41(0.34-0.48), 
p<0.0001 
Insufficient data 
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Table 4.4: Association between stroke care variables and 30-day patient outcomes           Continued 
    
        Crude ORs (95%CI)  Adjusted* ORs (95%CI) 
    
Stroke care variable         All countries LMICs African countries  All countries LMICs African countries 
        
30-day death or severe disability 
 
Brain CT scan by day 1 0.72 (0.61-0.85), 
p<0.0001 
0.72(0.61-0.85), 
p<0.0001 
1.12(0.85-1.49), p=0.423  0.75(0.61-0.92), 
p=0.005 
0.71(0.58-0.88), 
p=0.001 
1.04(0.74-1.47), 
p=0.833 
Availability of stroke unit ≥ 50% 0.80(0.73-0.88), 
p<0.0001 
1.17(1.05-1.30), 
p=0.003 
1.47(0.80-2.71), p=0.215  0.68 (0.61-0.77), 
p<0.0001 
0.62(0.55-0.71), 
p<0.0001 
Insufficient data 
Availability of stroke specialist ≥ 50% 0.60 (0.54-0.65), 
p<0.0001 
0.65(0.59-0.72), 
p<0.0001 
1.03(0.79-1.35), p=0.829  1.21(1.07-1.36), 
p=0.002 
1.17(1.04-1.32), 
p=0.010 
1.13(0.80-1.58), 
p=0.490 
Lipid therapy in hospital 1.20(1.08-1.32), 
p<0.0001 
1.16(1.04-1.29), 
p=0.006 
1.11(0.84-1.46), p=0.484  0.92(0.81-1.04), 
p=0.194 
0.89(0.78-1.02), 
p=0.099 
1.07(0.76-1.50), 
p=0.712 
Antihypertensive therapy in hospital 1.20(1.08-1.32), 
p<0.0001 
1.16(1.04-1.29), 
p=0.006 
1.11(0.84-1.47), p=0.474  0.92(0.81-1.04), 
p=0.197 
0.90(0.78-1.02), 
p=0.100 
1.07(0.76-1.51), 
p=0.701 
Antiplatelet therapy for IS 0.55(0.48-0.62), 
p<0.0001 
0.56(0.49-0.65), 
p<0.0001 
1.22(0.86-1.73), p=0.258  0.84(0.71-0.99), 
p=0.048 
0.81(0.68-0.97), 
p=0.022 
1.58(1.04-2.40), 
p=0.033 
Availability of continuing rehabilitation 
in hospital 
1.29(1.12-1.48), 
p<0.0001 
1.55(1.34-1.78), 
p<0.0001 
0.87(0.65-1.15), p=0.318  0.96(0.81-1.15), 
p=0.663 
0.97(0.82-1.16), 
p=0.737 
0.90(0.63-1.30), 
p=0.576 
Availability of post-discharge 
rehabilitation 
0.64(0.59-0.71), 
p<0.0001 
0.83(0.75-0.92), 
p<0.0001 
0.68(0.43-1.07), p=0.095  0.90(0.80-1.00), 
p=0.059 
0.87(0.77-0.98), 
p=0.024 
Insufficient data 
Abbreviations: CI, confidence interval; CT Scan, Computerized Tomography Scanning; LMICs, low and middle-income countries, OR, odds ratio; p, p-value for the χ2 test 
*Adjusted for age, baseline stroke severity, baseline level of consciousness, and Oxfordshire Community Stroke Project (OCSP) classification of stroke.  
101 
 
The analysis before case mix adjustment suggested that in Africa only the availability of 
continuing rehabilitation in hospital was associated with lower risk for 30-day case fatality 
(crude OR: 0.59, 0.43-0.81; p=0.001). In all study countries and LMICs in general, stroke 
care variables that were found to be associated with lower risk for 30-day case fatality 
(p<0.006) included availability of a stroke specialist for the majority of stroke patients, 
antiplatelet therapy for IS and availability of post-discharge rehabilitation. Availability of a 
stroke unit for the majority of stroke patients (crude OR: 0.66, 0.58-0.75; p<0.0001) was 
associated with lower risk for 30-day case fatality only in all the study countries combined. 
After adjustment, I found that the availability of a stroke unit and stroke specialist for the 
majority of stroke patients, ongoing in-hospital and post-discharge rehabilitation, and 
delivery of antiplatelet therapy for IS during the hospital stay were all independent 
predictors of lower risk for 30-day case fatality (p<0.006) in all countries and in LMICs, 
but not in African countries.  
Regarding the relationship with 30-day death or severe disability (mRS=4-6), the 
univariate analysis showed that brain CT scan on the day of admission, availability of a 
stroke specialist for the majority of stroke patients, antiplatelet therapy for IS and 
availability of post-discharge rehabilitation were all associated with lower risk for 30-day 
death or severe disability (p<0.006), not only in all countries together, but also in LMICs 
in particular, and not in the African group considered apart. In all countries combined, the 
availability of a stroke unit for the majority of stroke patients also was found to be 
associated with lower risk (crude OR: 0.80, 0.73-0.88; p<0.0001) for death or severe 
disability. After adjustment however, I only found that brain CT scan on the day of 
admission and availability of a stroke unit for the majority of stroke patients were 
associated with lower risk for 30-day death or severe disability not only in all countries 
(adjusted OR: 0.75, 0.61-0.92; p=0.005 and 0.68, 0.61-0.77; p<0.0001 respectively), but 
also in LMICs considered apart (adjusted OR: 0.71; 0.58-0.88, p=0.001 and 0.62, 0.55-
0.71; p<0.0001 respectively). By contrast, the availability of a stroke specialist appeared to 
be independently associated with higher risk for 30-day death or severe disability in all 
countries combined (adjusted OR: 1.21, 1.07-1.36; p=0.002). Table 4.5 illustrates the 
frequency of participants per number of stroke care components achieved, and the 
proportions for patient outcomes for each stroke care bundle score. 
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      Table 4. 5: Proportions of stroke care bundle scores and patient outcomes 
Stroke care  
bundle score 
All countries LMICs African countries 
n (%) 30-day 
CF rate 
30-day 
mRS=4-6 rate 
n (%) 30-day 
CF rate 
30-day 
mRS=4-6 rate 
n (%) 30-day 
CF rate 
30-day 
mRS=4-6 rate 
0 115 (0.9%)  18(15.7%) 29(25.2%) 115(1.2%) 18(15.7%) 29(25.2%) 106(10.8%) 15(14.2%) 26(24.5%) 
1 576 (4.7%) 93(16.4%) 158(27.8%) 568(5.8%) 93(16.6%) 158(28.2%) 243(24.8%) 54(22.5%) 85(35.4%) 
2 2491(20.4%) 355(14.4%) 582(23.6%) 2293(23.5%) 352(15.5%) 568(25.1%) 308(31.4%) 70(23.3%) 118(39.3%) 
3 3851 (31.5%) 484(12.6%) 827(21.5%) 3819(39.2%) 483(12.7%) 825(21.7%) 250(25.5%) 58(23.8%) 81(33.2%) 
4 2168 (17.7%) 130(6.0%) 431(19.9%) 1787(18.3%) 118(6.6%) 397(22.2%) 63(6.4%) 3(4.8%) 14(22.2%) 
5 3037(24.8%) 102(3.4%) 384(12.7%) 1157(11.9%) 66(5.7%) 194(16.8%) 10(1.0%) 2 (20.0%) 8(80.0%) 
Abbreviations: CF, case fatality; mRS, modified Rankin Scale score  
 
The analysis regarding the association between the number of stroke care variables met and patient outcomes consisted of 12238 participants in total.  Only 
32.9% of the African participants compared to 69.4% in LMICs in general and 74% for all countries had achieved from three to five stroke care bundle 
components. Additionally, among 115 participants in total who did not achieve any component, almost all of them (92.2%) were from African countries, and 
among 3037 participants who achieved all five stroke care bundle components, only 10 of them were from Africa. 
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The highest mortality rates were observed among the participants who achieved a smaller 
number of stroke care bundle components: 30-day case fatality rate was 15.7% for the 
participants who did not achieve any component and it was 16.4% for the participants who 
achieved one component only for all the countries together. For LMICs alone, the 30-day 
case fatality rate was also 15.7% for the participants who did not achieve any component 
and it was 16.6% for the participants who achieved one component only 
In African countries, the highest case fatality rates were found among the participants who 
achieved three (30-day case fatality was 23.8%) or two components (30-day case fatality 
was 23.3%).  
The findings about 30-day death or severe disability were consistent with those for the 30-
day case fatality.  The highest 30-day death or severe disability rates were found among the 
participants with the lowest stroke care bundle scores in all countries together (25.2%) for 
the participants who did not achieve any component and 27.8% for those who achieved 
one component only) and in LMICs (25.2% for the participants who did not achieve any 
component and 28.2% for those who achieved one component only). By contrast, in 
African countries the highest 30-day death or severe disability rates were found among the 
participants who achieved all components (eight out of ten participants) and those who 
achieved two components (39.3%).  
Table 4.6 shows crude and adjusted 30-day case fatality and 30-day death or severe 
disability rates by number of stroke care components achieved among patients who were 
eligible for all the stroke care bundle components. 
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Table 4. 6: Association between stroke care bundle scores and 30-day patient outcomes 
Stroke care  
bundle score 
Crude ORs (95%CI)  Adjusted* ORs (95%CI) 
All countries LMICs African countries  All countries LMICs African countries 
30-day case fatality 
5 (Ref.) 1 1 1  1 1 1 
4 1.83(1.40-2.38); P<0.0001 1.17(0.86-1.60), p=0.325 0.20(0.03-1.39); P=0.103  1.05(0.79-1.41); P=0.722 1.00(0.72-1.39), p=0.986 0.46(0.06-3.62); P=0.461 
3 4.12(3.31-5.13); P<0.0001 2.40(1.84-3.13), P<0.0001 1.25(0.26-6.04); P=0.784  2.50(1.96-3.18); P<0.0001 2.44(1.83-3.25), P<0.0001 1.54(0.27-8.74); P=0.624 
2 4.81(3.84-6.04); P<0.0001 3.04(2.31-3.99); P<0.0001 1.22(0.25-5.87); P=0.806  2.60(2.02-3.35); P<0.0001 2.64(1.96-3.55), P<0.0001 1.35(0.24-7.56); P=0.731 
1 5.60(4.16-7.53); P<0.0001 3.29(2.36-4.60); P<0.0001 1.16(0.24-5.63); P=0.853  3.02(2.16-4.24); P<0.0001 2.96(2.04-4.29), P<0.0001 1.49(0.26-8.35); P=0.653 
0 5.30(3.09-9.10); P<0.0001 3.07(1.75-5.37); P<0.0001 0.66(0.13-3.41); P=0.619  4.10(2.22-7.57); P<0.0001 3.95(2.10-7.43), P<0.0001 1.16(0.19-6.97); P=0.870 
30-day death or severe disability 
5 (Ref.) 1 1 1  1 1 1 
4 1.71(1.47-1.98); P<0.0001 1.42(1.17-1.72), P<0.0001 0.07(0.01-0.38); P=0.002  1.17(0.98-1.40); P=0.087 1.46(1.17-1.82), P<0.0001 0.13(0.02-0.70); P=0.018 
3 1.88(1.65-2.15); P<0.0001 1.37(1.15-1.63), P<0.0001 0.12(0.03-0.60); P=0.009  1.24(1.05-1.45); P=0.010 1.50(1.23-1.84), P<0.0001 0.16(0.03-0.83); P=0.029 
2 2.12(1.84-2.45); P<0.0001 1.66(1.39-1.99), P<0.0001 0.16(0.03-0.78); P=0.023  1.27(1.07-1.51); P=0.007 1.58(1.28-1.96), P<0.0001 0.20(0.04-1.06); P=0.058 
1 2.64(2.14-3.27); P<0.0001 1.95(1.53-2.48), P<0.0001 0.14(0.03-0.66); P=0.013  1.66(1.28-2.17); P<0.0001 2.03(1.52-2.70), P<0.0001 0.19(0.04-0.99); P=0.048 
0 2.31(1.50-3.57); P<0.0001 1.67(1.07-2.62), P<0.0001 0.08(0.02-0.41), p=0.002  1.68(1.02-2.78); P=0.043 2.01(1.20-3.35), P<0.0001 0.13(0.02-0.72); P=0.019 
Abbreviations: CI, confidence interval; LMICs, low and middle-income countries; OR, odds ratio  
*Adjusted for age, baseline stroke severity, baseline level of consciousness, and Oxfordshire Community Stroke Project (OCSP) classification of stroke.  
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I found an indication of an inverse dose-response relationship between the number of 
stroke care components achieved and mortality as well as mortality or severe disability. In 
other words, lower level of care was associated with higher stroke mortality or severe 
disability. The highest 30-day case fatality, death or severe disability rates were found 
among patients for whom none or only one of stroke care bundle components was 
achieved, not only in all study countries in general, but also in LMICs alone. Only 
relatively small differences were seen between the univariate and multivariable-adjusted 
ORs. 
Overall, for the participants who did not meet any component, the adjusted OR was 4.10, 
2.22-7.57; P<0.0001 for 30-day case fatality and was 1.68, 1.02-2.78; P=0.043 (although 
not statistically significant) for 30-day death or severe disability, compared to those who 
met all the stroke care components. This pattern was the same for LMICs alone: the 
adjusted OR was 3.95, 2.10-7.43; P<0.0001 for 30-day case fatality and was 2.01, 1.20-
3.35; P<0.0001 for 30-day death or severe disability for the participants who did not meet 
any component compared to those who met all the stroke care components. For the African 
countries alone, I did not find evidence of an association between the number of stroke 
care components met and 30-day patient outcomes.  
To further examine the impact of each of the individual stroke care components within the 
logistic regression model, I performed a sensitivity analysis excluding the five stroke care 
bundle components one by one and I found that removing any of the components did not 
change the pattern of the results. Appendix 4.1 provides the sensitivity analysis results.   
In summary, in LMICs, availability of a stroke unit (adjusted OR: 0.71, 0.60-0.83; 
p<0.0001) and stroke specialist (adjusted OR: 0.74, 0.64-0.85; p<0.0001) for the majority 
of stroke patients, antiplatelet therapy for IS (adjusted OR: 0.69, 0.56-0.85; p=0.001), 
availability of continuing in-hospital (adjusted OR: 0.70, 0.57-0.87; p=0.001) and post-
discharge (adjusted OR: 0.41, 0.34-0.48; p<0.0001) rehabilitation all appeared to be 
associated with lower risk for 30-day case fatality. In the same LMICs, brain CT scan on 
the day of admission (adjusted OR: 0.71, 0.58-0.88; p=0.001) and availability of a stroke 
unit for the majority of stroke patients (adjusted OR: 0.62, 0.55-0.71; p<0.0001) both 
appeared to be associated with lower risk for 30-day death or severe disability (mRS=4-6). 
There was an inverse dose-response relationship between the number of stroke care 
components achieved and mortality as well as mortality or severe disability. For instance, 
the adjusted OR for 30-day case fatality was 3.95, 2.10-7.43; P<0.0001 and for 30-day 
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death or severe disability it was 2.01, 1.20-3.35; P<0.0001 for the participants who did not 
meet any component compared to those who met all the stroke care components.  
However, for the African countries alone, I had not enough evidence to show an 
association between any of the stroke care variables investigated and patient outcomes. 
4.4 Discussion 
My analysis indicated that several KPIs including the availability of stroke unit and stroke 
specialist for the majority of stroke patients, in-hospital and post-discharge rehabilitation, 
as well as antiplatelet therapy for IS, and brain CT scan on the day of admission in LMICs 
were independently associated with lower risk for 30-day mortality or poor outcome (death 
or severe disability). These findings were generally consistent with the ones from various 
clinical trials and our recent review and meta-analysis (Urimubenshi et al., 2017) of 
national or regional registers mostly from HICs.  
Given the evidence for the association between stroke unit admission and specialized 
multidisciplinary stroke unit care with better patient outcomes (Langhorne and Pollock, 
2002; Stroke Unit Trialists’ Collaboration, 2013; Urimubenshi et al., 2017), one might also 
expect to see benefits associated with the availability of stroke unit and stroke specialist for 
the majority of stroke patients, as well as in-hospital and post-discharge rehabilitation. 
However, while several small clinical trials (Chieu and Man, 2004; McClellan and Ada, 
2004; Sackley et al., 2006; Chaiyawat and Kulkantrakorn, 2012; Chumbler et al., 2012), 
showed that post-discharge rehabilitation was associated with better functional outcome, I 
did not find enough evidence for the association between the availability of post-discharge 
rehabilitation and lower risk for death or severe disability. This disagreement can be 
attributed to several reasons. For instance, the availability of post-discharge rehabilitation 
services does not necessarily imply that they were received by every patient for instance 
due to geographical or financial inaccessibility.  Second, the duration of follow-up for my 
analysis was shorter (30 days) than the follow-up duration (3 months at least) for the 
clinical trials. This short-term follow-up may lead to missing a significant proportion of 
outcome changes after one month, and disability is best assessed between three to six 
months when most of the recovery has taken place (Sandercock et al., 2015).  However, if I 
had considered p=0.05 as the significance value, I would also conclude that the availability 
of post-discharge rehabilitation was associated with lower risk for poor outcome in LMICs 
(adjusted OR: 0.87, 95% CI: 0.77-0.98; p=0.024). 
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The finding that the availability of a stroke specialist was associated with higher risk for 
30-day death or severe disability in all countries combined (adjusted OR: 1.21, 1.07-1.36; 
p=0.002) may be explained by an indication bias. In fact, stroke specialists in all countries 
in general may have been often involved in the management of more severe stroke patients, 
and stroke severity is a strong independent predictor for poor outcome (Govan et al., 2009).   
The findings also showed that antiplatelet use for IS in LMICs was associated with 
reduction in case fatality and this was consistent with the results from previous systematic 
reviews of observation studies (Urimubenshi et al., 2017) and RCTs that were mainly from 
HICs. However, my INTERSTROKE data analysis showed greater apparent benefit than 
the 8% reduction in case fatality that was reported in the review of RCTs (Sandercock et 
al., 2014). Perhaps, as the INTERSTROKE study was observational, the apparent effects of 
antiplatelets for IS may have been overestimated due to selection bias and incomplete 
adjustment for confounders. Alternatively, KPIs may also reflect other important and 
unmeasured aspects of care which would not be tested in a well-designed RCT 
(Urimubenshi et al., 2017).   
Early brain CT scan was independently associated with a reduced risk for death or severe 
disability in LMICs. Although there are no comparable data from clinical trials or similar 
studies, the benefits from early brain CT scan may be linked to subsequent early 
interventions such as antiplatelet therapy for instance that was found to be associated with 
better patient outcomes. I also found that in LMICs there was a dose dependent 
relationship of number of KPIs with a better outcome, and this finding was consistent with 
results from HICs (Urimubenshi et al., 2017).  
However, for the African countries alone, I had not enough evidence to show an 
association between any of the stroke care variables investigated and patient outcomes 
possibly due to two main reasons. First, some of the analyses may have been hampered by 
small sample sizes, and lack of statistical power to show the differential benefit.  Second, 
perhaps the stroke services were poorer in African countries than in LMICs in general and 
were consequently unable to demonstrate a difference in terms of patient outcomes.  
Despite the available evidence, my INTERSTROKE data analysis indicated that in LMICs, 
stroke units with adequate capacity (26.9%) and post-stroke rehabilitation (34.7%) were 
available to less than a half of the participants from LMICs.  In the same LMICs, stroke 
specialist for the majority of stroke patients and ongoing in-hospital rehabilitation were 
available to only 64.7% and 83.7% of the participants respectively. Additionally, only 
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80.7% of the participants with IS were given antiplatelet therapy.  Furthermore, I found 
that several other KPIs (not included in my regression analysis) such as carotid surgery 
(0.3%), oral anticoagulants (3.9%) as well as thrombolysis (3.5%) for IS were rarely 
received by the participants from LMICs during their hospital stay.  
The situation was particularly limited in the African countries; only 4.5% had access to an 
adequate stroke unit and 39.4% to a stroke specialist as well as 68.7% and 10.2% 
respectively for in-hospital and post-discharge rehabilitation availability, and 0% for 
carotid surgery, 5% for oral anticoagulants, 65.9% for antiplatelet and 0.6% for 
thrombolysis for IS. These findings on service availability or delivery may partly explain 
the ones that participants enrolled from African countries had poorer clinical outcomes 
than those enrolled from all LMICs in general (case fatality 21% vs 12%; death or severe 
disability 35% vs 22%). However, the differences in patient outcomes can also be partly 
explained by the differences in stroke severity: African participants had higher proportions 
of severe baseline mRS score (mRS=4-6), reduced level of consciousness at baseline and 
hemorrhagic stroke type than LMIC participants in general. That was the reason for 
adjustment during the analysis for the association between stroke care variables and patient 
outcomes. Strategies to improve the availability and delivery of stroke care services in all 
LMICs are suggested.  
Strengths and weaknesses 
Several studies on stroke KPIs and their association with patient outcomes have been 
published previously but, to the best of my knowledge, this is the first analysis on the same 
topic focusing on LMICs. I analysed data from the INTERSTROKE study that was the 
novel study that described the pattern of stroke care on a large scale covering many low-
income and middle-income countries. On this note, the INTERSTROKE study included 
9766 participants from 70 hospitals in 18 low and middle-income countries. Second, I 
followed the “rule of thumb” and only performed the logistic regression analyses with 
sufficient sample sizes.  
Third, I performed a sensitivity analysis to confirm my results regarding the association 
between the number of stroke care variables met and patient outcomes.   
However, my analysis may well be subject to some weaknesses. First, the current results 
may not indicate the real picture about stroke KPIs in LMICs. In fact, only five of 32 
countries included in the study were African and of 70 hospitals from LMICs assessed for 
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the INTERSTROKE study, only three were from low-income countries (Mozambique and 
Uganda). Additionally, many of the participants may have been recruited from urban 
settings with better resources and services. Second, only those patients with stroke in 
whom CT or MRI brain imaging could be completed within 1 week of presentation were 
included in the study while the study did not cover the brain imaging costs. This implies 
that patients who could not afford brain imaging costs and as early as possible, this being 
the common scenario in Africa, were automatically excluded from the study. 
Consequently, the current results cannot be generalized within or across all LMICs. Third, 
during service-level data collection, a reporting bias by drawing a too positive picture 
cannot be excluded especially when study investigators or health-care providers describe 
their own institutions (Brainin, 2018). Fourth, various KPIs were assessed for availability 
at hospital level and I cannot be certain which specific patients received any of those KPIs. 
It was for this reason that I chose availability of a stroke unit or stroke specialist for at least 
50% of stroke patients to ensure a higher probability of receiving the KPI. Fifth, the 
INTERSTROKE study assessed the patient outcomes at only one month of follow-up. This 
short-term follow-up may lead to missing a significant proportion of deaths that occur after 
one month, and disability is best assessed between three to six months when most of the 
recovery has taken place (Sandercock et al., 2015). Sixth, the data I analysed were from an 
observational study and having performed a multivariate analysis to correct for patient case 
mix does not exclude the possibility that the patient outcomes were influenced by 
unmeasured or residual confounding factors. However, to control the possibility of chance 
findings, I used the Bonferroni correction method and considered 0.006 as the p-value of 
significance. 
 
4.5 Conclusion 
My INTERSTROKE data analysis showed that many stroke patients in LMICs, 
particularly in Africa, do not have access to commonly well-established stroke KPIs. My 
findings also suggest that the commonly reported KPIs including early brain CT scan, 
stroke unit, stroke specialist, antiplatelet therapy for IS, in-hospital and post-discharge 
rehabilitation, may have similar utility in LMICs as has been noted in HICs. Initiatives to 
promote the implementation of common stroke KPIs in all LMIC settings for improving 
the quality of care and stroke outcomes are suggested.  
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Chapter 5: Implementing stroke unit care in Rwanda: a two-hospital before 
and after implementation trial 
5.1 Introduction  
The first chapter of the thesis demonstrated that stroke is common and important in Africa. 
In contrast, the second and fourth chapters revealed that the provision of stroke care in 
Africa appears to be below the recommended standards using the measures summarised in 
chapter three. There were also considerable variations across countries and settings. In 
Rwanda, stroke is estimated to be the third cause of mortality, accounting for 6.4% of all 
deaths (WHO, 2015). As the Rwandan economy grows, the burden of stroke is expected to 
increase even more. The Ministry of Health of Rwanda reported that NCDs and their risk 
factors are a significant public health problem and called for more relevant research to 
generate evidence for the policy makers to respond efficiently to the scourge (Ministry of 
Health, 2014a). In 2012, the Ministry of Health of Rwanda published the clinical treatment 
guidelines for various conditions including stroke, although not comprehensive. Later in 
2016, the same ministry published emergency medicine clinical guidelines. However, 
translating research evidence into clinical practice is very difficult. Healthcare 
professionals sometimes fail to provide the level of care to which they aspire and, 
consequently, patients don’t benefit optimally from advances in healthcare resulting in 
poorer quality of life and loss of productivity both personally and at the societal level 
(Grimshaw et al., 2012). 
Organised in-patient (stroke unit) care has become established as the central component of 
a modern stroke service to reduce the risk of death and disability for patients admitted to 
hospital after stroke (Langhorne and Rudd, 2009). A stroke unit is a complex intervention 
that entails a combination of medical and rehabilitation interventions that are delivered by 
a multidisciplinary team of stroke specialists who work in a focussed and coordinated way 
to provide care for patients with stroke in hospital (Stroke Unit Trialists’ Collaboration, 
2013).  
A systematic review to identify the effectiveness of a stroke unit compared with a general 
medical ward on system- and patient-level outcomes for the management of stroke showed 
that, compared to persons admitted to a general medical ward, those admitted to a stroke 
unit had a 19% odds reduction in death, a 20% odds reduction in death or 
institutionalization, and a 21% odds reduction in institutionalization. In addition, the trials 
showed that there was a 13% odds reduction in death or dependency, and a possible 
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reduction in the LoS in persons admitted to a stroke unit (Health Quality Ontario, 2014). 
However, since stroke unit implementation requires a range of health professional 
resources, co-location of beds and clinical leadership, most service developments have 
taken place in HICs in which most of the health service is publicly funded.  
A review by Langhorne et al. (2012) to explore the applicability of stroke-unit care to low 
income settings revealed lower death rates in patients admitted to a stroke unit than in 
alternative services, and the difference was statistically significant for many of the studies. 
The authors noted that the interpretation of this information is difficult because many 
settings in low-income countries are likely to be characterized as much by diversity 
(inequity) of resources as by universally low resources. Most of the studies identified were 
done in large cities and therefore might not show the situation in rural areas. This raises the 
question of whether stroke unit care is feasible and applicable to low income and middle-
income country settings (Langhorne et al., 2012) like Rwanda. I aimed to explore the 
feasibility and effectiveness of implementing stroke unit care in selected hospitals in 
Rwanda with the aim of developing a transferable model for wider implementation.  
5.2 Methods 
My study was part of an international initiative “Organized Stroke Care Across Income 
Levels (OSCAIL)”. This study aimed to investigate whether stroke services and patient 
outcomes can be improved through providing tailored support in LMIC settings and was 
being conducted in four LMICs including South Africa, India, Uganda and Rwanda.  
5.2.1 Study design 
A before and after implementation trial design was used for the purpose of my study. A 
similar study (Middleton et al., 2011) showed the possibility of improving aspects of acute 
stroke care using an implementation trial design. However, while the study by Middleton et 
al. (2011) used a controlled trial, I was unable to conduct my study on the process of 
implementing a stroke unit care in Rwanda using a controlled trial design because of 
practical and logistical reasons. First, although controlled before and after studies can 
protect against secular trends and sudden changes in guideline implementation 
performance, it is often difficult to identify a comparable control group (Grimshaw et al., 
2000). However, even in apparently well-matched control and intervention groups, 
performance at baseline is often observed to differ (Grimshaw et al., 2000). Second, there 
was a danger of contamination if the clinical staff at the study hospitals were allocated in 
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either control or intervention groups. Furthermore, randomizing the staff into control and 
intervention groups was not practical because of the existing staff shortage and the 
randomization could conflict with the staff rotation plans in place. I could not use cluster 
randomization to compare hospitals implementing the intervention to those not 
implementing the intervention because this was very difficult and expensive to undertake 
(Goodacre, 2015). Moreover, I was unable to use interrupted time series analysis because 
this also would have taken more time and funds (Goodacre, 2015) while I had limited 
resources. I therefore used an uncontrolled before and after implementation trial approach. 
The trial was designed according to the Standards for Reporting Implementation Studies 
(StaRI) (Pinnock et al., 2017). 
 
5.2.2 Study context     
Rwanda is a small, hilly, landlocked sub-Saharan country with 26,338 Km
2
 only and a 
densely packed population of about 12,374,397 (National Institute of Statistics, 2019a). 
About 85% of the Rwandan population lives in rural areas. 76% of the population is aged 
34 years or younger, with people aged 65 years and above making up 3% of the population 
(National Institute of Statistics, 2017). Rwanda borders the Democratic Republic of Congo 
to the west, Tanzania to the east, Uganda to the north, and Burundi to the south. Figure 5.1 
shows the location of Rwanda on the African map. 
Figure 5. 1: Location of Rwanda on the African map 
 
             
Rwanda 
 113 
 
Socio-economic context 
Rwanda is a low-income country and its economy is agriculture-based (World Bank, 
2017). Rwanda’s development goals seek to transform the country from an agriculture-
based to a knowledge and service-oriented economy. In 2018, Gross Domestic Product 
(GDP) at market prices was estimated to be Rwandan francs 8,189 billion, up from 
Rwandan francs 7,600 billion in 2017. Services sector contributed 48 percent of GDP, 
agriculture sector contributed 29 percent of the GDP, and industry sector contributed 16 
percent of GDP while 7 percent was attributed to adjustment for taxes less subsidies on 
products. In 2018, GDP per head in USD was estimated at 787 up from 774 in the previous 
year of 2017 (National Institute of Statistics, 2018). The strong economic growth was 
accompanied by substantial improvements in living standards, with a two-thirds drop in 
child mortality and near-universal primary school enrolment (World Bank, 2017). A strong 
focus on homegrown policies and initiatives has contributed to significant improvement in 
access to services and human development indicators. For instance, the life expectancy at 
birth has reached to 67 years in 2018 (National Institute of Statistics, 2019b). The poverty 
rate dropped from 44% in 2011 to 39% in 2014, while inequality measured by the Gini 
coefficient fell from 0.49 to 0.45 (World Bank, 2017). 
Health context 
For over a century, Rwanda experienced governance problems which culminated in the 
Genocide against Tutsi in 1994. The Post-Genocide Government inherited a country with a 
situation characterized by poor resources and systems in all areas, health sector included.  
Fortunately, after the genocide, Rwanda has seen great improvements in several key health 
indicators. For instance, estimates by several United Nations agencies and the World Bank 
categorised Rwanda among 11 countries that are ‘on track’ to achieve target 5A of the 
Millennium Development Goals, which involves a decline of the maternal mortality rate by 
at least 75 % between 1990 and 2013 (WHO, 2016). Rwanda has also made relatively good 
progress in improving access to health care services; the average time to walk to a nearby 
health facility was 57 minutes (Ministry of Health, 2018).  Additionally, the national health 
insurance programme, “Mutuelle de Santé”, has increased the utilisation of health care 
services, and decreased the percentage of households facing catastrophic health 
expenditure by more than 1.5 percent between 2005 and 2010 (Ministry of Health, 2015a).  
Despite substantial efforts by the Government of Rwanda (GOR) to provide quality health 
care services, various problems remain regarding the achievement of universal access to 
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affordable quality health care services. The main challenge to the health care system is the 
shortage of qualified healthcare staff. In 2016, qualified healthcare staff per population 
ratio was 1/10,055 for doctor (general practitioners and specialists as well), 1/1,094 for 
nurse, 1/4,064 for midwife (women aged from 15-49), 1/16,871 for pharmacist, and 
1/10,500 for laboratory technician (Ministry of Health, 2018). A related challenge is the 
skewed distribution of health care providers (Ministry of Health, 2014b). Most specialised 
care providers are in urban areas, particularly Kigali City, leaving the rural districts, where 
the majority of Rwandans live, with limited access to specialised care. Another important 
challenge is the lack of diagnostic medical equipment and maintenance technicians. There 
is also a very high import dependency and a heavy dependency on foreign donor support 
(National Institute of Statistics, 2017).  
Non-communicable diseases (NCDs) in Rwanda 
As in many other low-income countries, non-communicable diseases (NCDs) are an 
emerging problem in Rwanda. NCDs include cancers, cardiovascular diseases, chronic 
respiratory diseases, diabetes, and kidney diseases. The main risk factors for NCDs include 
tobacco use, unhealthy diet, harmful alcohol consumption, injury, physical inactivity and 
obesity (Ministry of Health, 2015a). According to Rwanda’s Health Management 
Information Systems (HMIS) data in 2013, NCDs accounted for at least 51.9 percent of all 
district hospital outpatients’ consultation and 22.3 percent of district hospital inpatients 
(Ministry of Health, 2015a). The WHO Global Health observatory showed that Rwanda 
had an NCD death rate of 607 deaths per 100,000 people in 2015 (WHO, 2017). Health 
services and personnel are however not well trained and equipped to diagnose and treat 
NCDs at early stages, coupled with inadequate information to the population on prevention 
and management of NCDs (National Institute of Statistics, 2017). Additionally, most of the 
population is ensured by community-based health insurance “Mutuelle de Santé” and does 
not yet have access to private and some high level NCDs services (Ministry of Health, 
2015b). 
5.2.3 Study sites  
I conducted my study at two public referral hospitals in Rwanda including “Centre 
Hospitalier Universitaire de Kigali” (CHUK) and “Centre Hospitalier Universitaire de 
Butare” (CHUB). To select the two hospitals, two criteria were considered: 
1) No stroke unit or plans for implementing a stroke unit in the following year; 
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2) Sites that are similar to each other in terms of resources, bed size, funding structure and 
interventions. 
To identify the suitable study sites, I sent a survey questionnaire to four referral hospitals 
in Rwanda to assess the existing services and resources, and readiness to take part in my 
implementation study. The questionnaire consisted of several items including the stroke 
admission areas and specialties of staff who look after stroke patients. The last question 
was about whether the hospital was willing to participate in the study. Based on the 
answers provided, I selected two most suitable hospitals as my study settings. 
The locations of the study hospitals on the Rwandan map are indicated on figure 5.2. 
Figure 5. 2: Locations of the study sites on Rwandan map 
 
 
 
 
 
 
Centre Hospitalier Universitaire de Kigali (CHUK)  
CHUK is a referral hospital located in District of Nyarugenge at KN 4 Ave, Kigali City. It 
is also the biggest hospital of the country with a capacity of 519 beds with a turnover of 
1,000 patients per day.  
The hospital has around 800 staff including 100 doctors, 400 nurses and midwives, 200 
paramedicals, and 100 other (administrative and support) staff.  
CHUK has a mandate to provide quality healthcare to the population, training, clinical 
research and technical support to district hospitals. Its current clinical services include 
emergency, intensive care unit, high dependency unit, neurosurgery, anaesthesiology and 
critical care medicine, out-patient department, internal medicine, surgery, gynaecology and 
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obstetrics, paediatrics, ear-nose-throat (ENT), ophthalmology, dermatology, mental health, 
medical laboratory, imaging services including CT-scan, pharmacy, physiotherapy, 
prosthetics and orthotics, nutrition and dietetics, social work, community health 
supervision, and quality assurance and accreditation. 
Stroke patients at CHUK are first received at the emergency department and then, after the 
triage process, admitted in high dependency unit (HDU) or intensive care unit (ICU) or 
neurosurgery or internal medicine ward. However, the facility has no specific protocol for 
stroke patients’ hospitalisation. Once admitted, stroke patients are mainly looked after by 
internist doctors, nurses and physiotherapists, but none of them received specialist stroke 
care training, and none is dedicated to caring for stroke patients only.  
Centre Hospitalier Universitaire de Butare (CHUB) 
CHUB is referral hospital located at Mamba, Butare Cell, Huye District in the Southern 
Province of Rwanda. The hospital has a capacity of 500 beds, with 540 staff members 
among whom only 40 are specialists, but no cardiologist, no neurosurgeon (only three in 
the whole country), no nephrologist, no neurologist. CHUB serves the Southern Province’s 
populations and others from some districts of the Western Province. Its catchment area 
consists of 15 district hospitals and, according to the last 2012 national census, the total 
population to be served by CHUB is more than 3,772,230 people. 
The hospital has various clinical services including internal medicine, surgery, gynecology 
and obstetrics, accident and emergency, pediatrics, ear-nose-throat (ENT), ophthalmology, 
anesthesiology and critical care medicine, dialysis, dermatology, mental health, pathology 
services, imaging services including CT-scan, pharmacy, physiotherapy and functional 
rehabilitation, nutrition and dietetics, social work, community health supervision, and 
quality assurance and accreditation. 
Stroke patients at CHUB are first received at the emergency department and later, after the 
triage process, are admitted in intensive care unit (ICU), or a general ward. Like CHUK, 
CHUB has no specific protocol for stroke patients’ hospitalisation. Stroke patients are 
mainly looked after by internist doctors, nurses and physiotherapists, but none of them 
received specialist stroke care training, and none is dedicated to caring for stroke patients 
only.  
Although both study sites are university teaching hospitals, there are some relevant 
differences between them that should be noted. First, while CHUB is located in a 
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secondary city of Rwanda, CHUK is in the capital city of the country, Kigali, and has 
better resources. For instance, there were a neurologist, a neurosurgeon and a high 
dependency unit (HDU) at CHUK but not at CHUB. Second, in case the CT-scan is not 
functioning, patients at CHUK can get brain imaging from nearby hospitals in Kigali while 
the patients at CHUB would travel to Kigali for a distance of 135 km. Third, while CHUB 
serves only about a quarter of the national population, CHUK receives patients from all 
parts of the country. Therefore, the patient recruitment rate would likey be higher at CHUK 
than CHUB.  
5.2.4 Population, inclusion criteria and sample size  
Population and inclusion criteria 
The study population consisted of all stroke patients hospitalized at CHUK and CHUB.  
Only patients diagnosed for stroke with brain imaging or satisfying the WHO clinical 
criteria for stroke were recruited as study participants “rapidly developing clinical signs of 
focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or 
longer or leading to death, with no apparent cause other than of vascular origin” (WHO 
MONICA Project Investigators, 1988).  
Sample size 
Before the implementation of the intervention, I recruited a pre-intervention patient cohort 
to provide baseline data. After the intervention, I recruited a second cohort to evaluate 
changes in stroke services and patient outcomes. The INTERSTROKE study showed that 
the delivery of eight stroke care interventions in African hospitals varied between 0% for 
carotid surgery or stenting for IS and 66.8% early brain CT scan (Chapter 4), giving an 
average implementation rate of approximately 40% in Africa. I estimated that I needed 62 
patients per each site and phase to have 80% power at 5% two-sided significance level to 
show 25% improvement (Campbell et al., 1995) in adherence to stroke key performance 
indicators (KPIs). However, previous similar studies recorded a 3-month loss to follow-up 
which varied between 5% (Bhalla et al., 2004) and 12% (Åsberg et al., 2010). I therefore 
aimed to recruit 70 stroke patients at each hospital, and for each phase of the study. 
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5.2.5 Description of the clinical intervention  
My clinical intervention was the “stroke unit care”. This is more than a hospital geographic 
physical area. It consists of a discrete area of a hospital that takes care of stroke patients, a 
specialist multidisciplinary stroke team, coordination through regular meetings to plan 
patient care, and existence of protocols of care to cover common problems (ESO Executive 
Committee and Writing Committee, 2008). To determine the stroke KPIs to include in my 
clinical intervention, I considered the results from the pre-intervention audit and my 
systematic review of the literature on stroke KPIs (chapter 3) and analysis of 
INTERSTROKE study (chapter 4), the recommendations from the WSO stroke services 
framework (Lindsay et al., 2014) plus the Rwandan context and clinical guidelines 
(however these were too broad to highlight the necessary key elements of quality stroke 
care). Therefore, my intervention consisted of 11 key stroke unit care elements including 
acute stroke diagnosis (recognition of strokes and brain imaging), use of stroke severity 
assessment tools, admission to a geographic stroke unit, swallowing assessment, 
antithrombotic therapy (such as aspirin, enoxaparin/lovenox) for IS, management of 
intracerebral hemorrhage (ICH), early mobilization, blood sugar and pressure monitoring 
and treatment, secondary prevention, and multidisciplinary team meetings.  
5.2.6 Description of the implementation intervention  
The Cochrane Effective Practice and Organization of Care (EPOC) Review Group (2002) 
classified the implementation interventions or strategies that are often used to change 
practice in the categories of professional, financial, organizational and regulatory. Others 
have identified three main categories of the practice change interventions: persuasive; 
educational and informational; and action and monitoring (Johnson and May, 2015). 
Powell et al. (2015) identified 73 potential implementation techniques from which relevant 
components may be selected. A systematic overview (Johnson and May, 2015) of 
systematic reviews on the effectiveness of behavior change interventions revealed that 
using the interventions focusing on action or education including audit and feedback, 
reminders and educational outreach appeared to be associated with better improvements in 
professional practice and/or patient outcomes. The same review also showed that bundles 
of interventions packaged together seem more effective than single interventions.   
Based on the available evidence on the effectiveness of various implementation 
interventions (Johnson and May, 2015) and the local context, I targeted clinical staff 
involved in stroke care and hospital directors and used a combination of four main 
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interacting interventions. These included identification and preparation of site champions, 
provision of educational materials (soft and printed copies), face-to-face educational 
seminar including feedback on usual care audit results, training on stroke KPIs and local 
consensus discussions), and discussions with the study hospital directors. 
Identification and preparation of site champions 
Based on their important roles in daily stroke care, their willingness and readiness to 
facilitate the implementation of my clinical intervention, two site champions (one at each 
study hospital) were identified first. Thereafter, I informed them about the study aim and 
process, discussed and agreed with them on what was expected from them: 
 Completing the survey questionnaires to assess if their working hospitals were 
eligible to participate in the OSCAIL study; 
 Contacting the hospital administration about the maximum number of staff who 
could be released from work to attend the educational seminar; 
 Participating in planning the intervention by identifying the most suitable staff to 
invite to the educational seminar and those who can facilitate some topics); 
 Facilitating some intervention training modules; 
 After the training, monitoring whether the key stroke care elements were getting 
implemented and, if gaps were noticed, encouraging their colleagues to improve 
their services; 
 Conducting additional training sessions for local staff as needs arise. 
We provided the site champions with reasonable communication fees during intervention 
and post intervention data collection periods. 
Provision of educational materials 
A week prior to the face-to-face educational seminar, recommended and optional 
documents to read were sent to the educational seminar participants through the site 
champions’ emails with an intention to provide them with basic knowledge as a pre-
requisite to easily follow the presentations and discussions. After the seminar, the 
participants were informed that they could get soft and hard copies from the site 
champions. 
The recommended reading documents included the Rwandan internal medicine clinical 
treatment guidelines (Ministry of Health, 2012) and emergency medicine clinical 
guidelines (Ministry of Health, 2016), the world stroke organization global stroke services 
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guidelines and action plan (Lindsay et al., 2014), and the applicability of stroke unit care to 
LMICs (Langhorne et al., 2012). 
The optional reading documents were the road map for quality stroke care (Lindsay et al., 
2014), the impact of multidisciplinary stroke care in a secondary-level hospital in South 
Africa (de Villiers et al., 2009), the development of stroke care in Ghana (Gould et al., 
2011), the collaboration works to improve stroke outcomes in Ghana (Morris, 2011), the 
best practice guidelines for stroke in Cameroon (Cockburn et al., 2014), the United 
Kingdom clinical guideline for stroke (Royal College of Physicians, 2016), the clinical 
guideline for stroke in childhood (Royal College of Paediatrics and Child Health, 2017), 
the lessons from the Wessex-Ghana stroke partnership (Johnsona, 2017), strategies to 
improve stroke care services in LMICs (Pandian et al., 2017), and the key performance 
indicators of stroke care quality and their association with patient outcomes (Urimubenshi 
et al., 2017).  
Face-to-face educational seminar 
The face-to-face education seminar covered three interventions including feedback on 
usual care audit results, training on stroke KPIs and local consensus discussions. It was a 
two-day seminar that took place at CHUK on 17-18 April 2018. The seminar aimed to 
promote the implementation of the KPIs of quality stroke care. For this purpose, I aimed to 
invite the hospital staff members including medical doctors, nurses, and physiotherapists 
mainly that were known to be involved in stroke care in their daily practice. After 
consideration of the needs of the study, I aimed to cover 11 KPIs as described under 
clinical intervention. However, my training was broad for covering all the OSCAIL study 
objectives, and consisted of 20 modules that I developed in collaboration with the OSCAIL 
study team:  
Module 1: Holistic case management approach (Introduction to the International 
Classification of Functioning, Disability and Health (ICF) framework);  
Module 2: General approach to organised stroke care; 
Module 3: Importance of stroke units; 
Module 4: Preliminary OSCAIL baseline findings and opportunities for improvement; 
Module 5: Recognition of strokes, Radiology, Acute stroke diagnosis; 
Module 6: Thrombolysis; 
Module 7: Intra-arterial interventions and management of intra-cerebral haemorrhage 
(ICH); 
Module 8: Fever monitoring and treatment; 
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Module 9: Blood sugar monitoring and treatment;  
Module 10: Geographic stroke unit; 
Module 11: Multidisciplinary teams;  
Module 12: Stroke severity scales; 
Module 13: Swallowing; 
Module 14: Bowels, bladder and pressure care; 
Module 15: Early Mobility; 
Module 16: Prevention of secondary strokes; 
Module 17: Psychological aspects of stroke care; 
Module18: Discharge planning; 
Module 19: Self-management; 
Module 20: Stroke support group. 
All the training presentations were structured to include evidence summaries, guidelines’ 
recommendations, and the presentation of the pre-intervention usual care audit results 
followed by further discussion on exiting gaps and recommendations for improvement.  
I used several strategies to optimize the training attendance rate and the adoption of the 
training content by the training participants: 
a) The educational seminar was accredited by Rwanda Allied Health Professions 
Council (Accreditation number: 0023/RAHPC/17) for continuing professional 
development (CPD) for a maximum of 12 credits for participants (1 credit=1 hour-
attendance) and 24 credits for facilitators (2 credits=1 hour-facilitation); 
b) Lunch, transport fees to and from the training venue for all participants, and one-
night accommodation fees for participants from CHUB were provided;  
c) I involved the principal of the College of Medicine and Health Sciences (CMHS) at 
the University of Rwanda (UR) in two ways. First, the training participants were 
officially invited by the Principal of the CMHS at the UR through the director 
generals of the two study hospitals. In fact, the study sites, being the university 
teaching hospitals, have close collaboration with the CMHS at the UR, and the 
principal of CMHS was as a key person who could influence the adoption of my 
intervention by the hospital staff. Second, the Principal of CMHS-UR introduced 
the training facilitators and presented on an introductory topic about the 
comprehensive patient management;   
d) The seminar was officially opened and closed by the head of clinical services 
division at CHUK;  
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e) I involved two OSCAIL investigators as experts in stroke care and research 
including Peter Langhorne and Jackie Bosch.  
Peter Langhorne is Professor of Stroke Care at the University of Glasgow, United 
Kingdom. His research work has focused on the effectiveness of different treatment 
strategies for stroke patients, including service delivery (e.g. stroke units and early 
supported discharge) and stroke rehabilitation (e.g. early rehabilitation). He is also 
the coordinating editor of the Cochrane Stroke Group. 
Jackie Bosch is Associate Professor at McMaster University, School of 
Rehabilitation Science and Population Health Research Institute, Hamilton, 
Ontario, Canada. Her clinical interests are in adult neurological rehabilitation and 
functional recovery post-stroke particularly. She has conducted many large trials in 
cardiovascular disease prevention as well as studies on stroke rehabilitation. She is 
interested in understanding the causes of functional declines and interventions to 
address these problems. She is a full time faculty member in the School of 
Rehabilitation Science and an Investigator at the Population Health Research 
Institute, McMaster University. 
Discussions with the study hospital directors 
Two OSCAIL investigators (PL and JB) and I as the OSCAIL national champion for 
Rwanda met with the head of clinical services division (also deputy director) at CHUK on 
different occasions on 17
th
 and 18
th
 April 2018. A similar meeting was held with the 
Director General of CHUB on 19
th
 April 2018 in the director’s office. The aim of the 
meetings was to discuss on the way forward to translate the knowledge gained from the 
seminar and the participants’ recommendations into practice.  
5.2.7 Implementation intervention outcomes 
The primary outcome of the implementation intervention was an increase in the proportion 
of participants who received the selected stroke KPIs. The secondary outcome was an 
increase in the proportion of participants with better outcomes including in-hospital and 3-
month post stroke survival, 3-month independent survival (mRS=0-2), shorter LoS, and 3-
month post stroke good quality of life (quality of life score ≥ 75%).   
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5.2.8 Data collection  
We collected data before and after the implementation intervention. 
Pre-intervention audit of usual stroke care 
The pre-intervention audit consisted of collecting data about the participant demographic 
and clinical characteristics, the implementation of selected stroke KPIs, and the patient 
outcomes. To select the KPIs that I considered for the audit, I used the results from my 
systematic review of the literature on stroke KPIs (chapter 3) and analysis of 
INTERSTROKE study (chapter 4), and the recommendations from the WSO stroke 
services framework (Lindsay et al., 2014). Table 5.1 summarizes the definitions of the 
stroke KPIs considered in my data collection.  
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Table 5. 1: Definitions of the selected stroke KPIs for audit 
KPI Definition 
Brain imaging Participant having been examined with CT scan or MRI. I did not 
consider “early brain imaging” because the date and/or time of the 
examination were missing for many participants 
Use of standardized (stroke) 
assessment measure 
Participant having been assessed with any of the standardized (stroke) 
assessment tools including mRS, National Institutes for Health Stroke 
Scale (NIHSS), Glasgow Coma Scale (GCS), Functional Independence 
Measure (FIM) or any other tool at arrival or during admission  
Admission to a geographic 
stroke unit 
Participant having been admitted in a hospital area dedicated to stroke 
patients 
Swallowing assessment Participant having been assessed for swallowing function during 
hospital stay before being offered food, drink, or oral medications 
Antithrombotic therapy for 
IS 
Participant with IS having received any antithrombotic drugs (such as 
aspirin, enoxaparin/lovenox) 
Surgery for ICH Participant with ICH having received surgical intervention 
Blood sugar lowering 
therapy 
Participant with elevated blood sugar (Fasting: >6.0 mmol/L (108 
mg/dL); Non-fasting: >11.1 mmol/L (>200 mg/dL); 2 Hour Glucose 
Tolerance Test (GTT): >7.8 mmol/L (140 mg/dL)) having received any 
blood sugar lowering drugs 
Blood pressure lowering 
therapy 
Participant with systolic blood pressure equal to or greater than 130 
mmHg or diastolic blood pressure equal to or greater than 80 mmHg 
having received any hypertensive drugs  
Mobilization Participant having been mobilized during the hospital stay. 
Mobilization included different aspects such as passive movements and 
proper positioning in bed, rolling and moving in bed and up to chair, 
and walking retraining. The date for the first mobilization session was 
also captured if documented. 
Multidisciplinary team 
meeting 
At least one documented meeting of health-care professionals in 
hospital to coordinate the patient care 
 
The patient outcomes investigated included in-hospital case fatality, LoS, mRS and quality 
of life scores at three months post stroke.   
Data were collected by a trained staff at each hospital using the case report form (CRF) 
that I developed in collaboration with the OSCAIL study team. The first CRF draft was 
pilot tested with four medical files, and necessary modifications were made.  
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The final CRF version included three parts: admission CRF, Discharge CRF, and 3-month 
follow-up CRF. These CRFs, in addition to variables relevant to my thesis, comprised 
other several variables for the OSCAIL study. 
Admission CRF. This consisted of data about patient characteristics and clinical 
information (see appendix 5.1). 
Discharge CRF. This consisted of data about discharge or death, past medical history, 
medications, standardized patient outcome scores and details of care (see appendix 5.2). 
Three-month follow-up CRF. This consisted of data about patient status at 3-months post 
stroke, visit completion details, participant details, participant income status, and health 
related quality of life (see appendix 5.3). 
Admission and discharge data were collected from patient medical files while the 3-month 
post-stroke onset data were collected using telephone interviews.  
Before starting data collection, the data collectors were trained on participant recruitment, 
admission, discharge and 3-month follow-up CRFs, and the process for data collection. 
There was an initial one-hour online Skype training, a four-hour face-to face training, and 
regular reminders through email, WhatsApp and face-to-face contacts.  
For quality assurance purposes, I reviewed the first 10 audited medical files at each site in 
collaboration with the data collector with agreement occurring 98% of the time, and 
disagreement was managed by discussion and consensus. 
Additionally, data quality reports were generated and sent to data collectors weekly to 
review the missing and misreported data and do corrections.  
Post-intervention data collection 
After delivering the implementation interventions, we had a 2-week bedding down period 
to allow the stroke KPIs to become embedded into usual care before recruitment of the 
post-intervention cohort. The post-intervention data were collected using identical tools 
and methods to those used to collect the pre-intervention data. 
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5.2.9 Data analysis 
While the OSCAIL study considered several variables, I only analyzed the data for the 
variables that were relevant to my thesis. I used the Statistical Package for the Social 
Sciences (IBM Corp., USA) version 25, Minitab version 18 and Excel version 2010 
programs to analyse the data, comparing the before and after intervention phases.  
First, I summarised continuous and categorical data using conventional descriptive 
statistics including median with lower and upper quartiles (data were not normally 
distributed), frequency distribution and percentage. Regarding the implementation of 
stroke KPIs, as the guidelines and good clinical practice specify that the steps in the 
management of patients with stroke should be well documented, where there was no 
documentation to suggest that the stipulated standard of care (brain imaging, swallowing 
assessment, use of standardized outcome tool, elevated blood sugar or pressure lowering 
therapy, antithrombotic therapy for IS, surgical intervention for ICH, mobilization and 
multidisciplinary team meeting) had been met, the cases were analyzed as if the KPIs had 
not been implemented (Faluyi et al., 2008). Using the available data, I generated two 
variables including antithrombotic therapy and early mobilization. Antithrombotic therapy 
was defined as “giving any antithrombotic drugs (such as aspirin, enoxaparin/lovenox) for 
IS or not giving them in case of hemorrhagic stroke” while early mobilization was defined 
as “starting mobilization within the first two days of admission”. 
Before and after intervention continuous variables were compared using the Mann-
Whitney test (the variables’ values were not normally distributed) and categorical variables 
were compared using the unpaired χ2 test. As I could not specify with certainty the 
direction of any difference in stroke services and patient outcomes between the two study 
phases before collecting data, I calculated two-sided p-values and one of 0.05 or less was 
considered significant. The data were presented in the forms of normal tables.  
Second, I performed univariate and multivariate logistic regression analyses to generate 
unadjusted and adjusted odds ratios (ORs) with 95% CI and χ2 test p-values for 
determining the association between the after-intervention phase and receiving a KPI and 
the association between the after-intervention phase and better patient outcomes. 
The baseline variables that were considered for the case mix adjustment for the 
multivariate logistic regression analysis included the six simple variables (age, living alone 
before stroke, being independent in everyday activities before stroke, being able to talk, 
being able to lift both arms to horizontal and being able to walk independently), stroke type 
and stroke onset-hospital arrival interval. The stroke KPIs that were never or were rarely 
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implemented including admission to a geographic stroke unit, surgery for ICH and blood 
sugar lowering therapy were not included in the logistic regression analyses. 
5.2.10 Ethical considerations 
My study was approved by the Ethics Committee of the College of Medical, Veterinary 
and Life Sciences (MVLS) at University of Glasgow (Appendix 5.4), the Institutional 
Review Board of the College of Medicine and Health Sciences (IRB-CMHS) at the 
University of Rwanda (Appendix 5.5), CHUK (Appendix 5.6) and CHUB (Appendix 5.7).  
Before collecting the data, potential participants who met inclusion criteria and their 
guardians were informed about the study using the participant information sheet (Appendix 
5.8). They were assured about confidentiality and anonymity, as well as the right to 
withdraw from the study at any time and without giving a reason. Potential participants 
were given time to ask questions about the study and their participation. Twenty-four hours 
at least after informing the patients and guardians, written informed consent or assent 
(Appendix 5.9 and Appendix 5.10) was requested from all patients or their guardians 
where the participants were less than 18 years-old, or not able to provide consent due to 
communication or cognitive limitation. In this case however, when the participants’ 
condition improved, we requested their consent to continue in the study (Appendix 5.11). 
The participant information sheet, the written informed consent and assent forms were 
translated in Kinyarwanda (Appendix 5.12, 5.13, 5.14, 5.15), the language commonly used 
by the potential participants.  
The administration of the study hospitals will get a copy of the study results not later than 
February 2020. 
5.2.11 Funding  
My study was conducted in Rwanda as part of the international OSCAIL study as 
mentioned earlier and was funded by a grant from the Population Health Research Institute 
(PHRI) at McMaster University in Canada. There was no financial or other conflict of 
interest for the study. 
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5.3 Results 
5.3.1 Educational seminar achievements 
The educational seminar was well attended, multidisciplinary, and covered the common 
stroke KPIs. 
Excellent attendance rate 
Thirty-nine out of 40 invited participants attended to the training, giving an excellent 
attendance rate (97.5%). There were 20 and 19 participants from CHUK and CHUB 
respectively. Figure 5.3 shows the seminar participants and the facilitators. 
Figure 5. 3: Educational seminar participants and facilitators 
 
 
Multidisciplinary seminar 
The participants from CHUK included the head of clinical services division, the head of 
emergency department, the director of quality assurance, a neurosurgeon, four internal 
medicine physicians, six nurses, two physiotherapists, one psychiatrist, one clinical 
psychologist, one anaesthetist and one nutritionist.  
The participants from CHUB included six internal medicine physicians, 11 nurses and two 
physiotherapists.
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Comprehensive seminar 
We covered all the modules on 11 stroke KPIs including multidisciplinary teams, acute 
stroke diagnosis (recognition of strokes and brain imaging), use of stroke severity 
assessment tools, swallowing assessment, blood sugar and pressure monitoring and 
treatment, early mobilization, geographic stroke unit, antithrombotic (oral drugs and 
thrombolysis) therapy for IS, management of intra-cerebral haemorrhage (ICH) and the 
prevention of secondary strokes.  
The participants were asked to rate several aspects of the seminar using a 1 (strongly 
disagree) to 5 (strongly agree) scale. The mean scores indicated that the seminar was 
highly appreciated by the participants from both study hospitals as showed in table 5.2.  
Table 5. 2: Educational seminar evaluation results 
a
 A scale of 1-5 was used (1= strongly disagree; 2= disagree; 3= neutral; 4= agree; 5= strongly agree). 
b
 Educational documents were sent to participants a week before the seminar. 
Consensus on stroke service improvement 
At the end of the two-day educational seminar, the participants discussed on KPIs that they 
could improve and agreed on six recommendations: 
a. CHUK and CHUB should plan to establish geographic stroke units as soon as 
possible. Meanwhile, stroke patients within a general ward should be admitted in 
the same area/corner;  
b. All stroke patients should receive mobility assessment and treatment if there is no 
contraindication with 24-48 hours of admission; 
c. Stroke care team should meet at least once a week; 
Seminar aspect, Median score 
a
 (Q1-Q3) All CHUK CHUB 
Overall 5 (4-5) 5 (4-5) 4 (4-5) 
Expectations met 5 (4-5) 5 (4-5) 5 (4-5) 
Content appropriate/relevant 5 (4-5) 5 (4-5) 5 (4-5) 
Time allocation for modules 4 (4-5) 5 (4-5) 4 (3-4) 
Sessions flow 4 (4-4) 4 (4-4.5) 4 (4-4) 
Time for asking questions 5 (4-5) 5 (4-5) 5 (4-5) 
Own opinions respected 5 (4-5) 5 (4-5) 5 (4-5) 
Workshop was collaborative 5 (5-5) 5 (5-5) 5 (5-5) 
Readings 
b
 were relative to work 5 (4-5) 4.5 (4-5) 5 (4-5) 
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d. Every activity should be accurately documented, and using standardized forms if 
these are available; 
e. Stroke care members are encouraged to use standardized outcome measures while 
assessing stroke severity and disability; 
f. The training participants should transfer their knowledge to their workmates who 
did not attend the training 
Furthermore, the participants were individually asked to indicate the KPIs that could be 
improved immediately after the seminar. Table 5.3 shows the number (percentage) of 
participants who indicated that KPIs could be better implemented at their work hospitals. 
Table 5. 3: Number (percentage) of participants who indicated that KPIs could be 
better implemented at their work hospitals 
In general, more than 20% of the seminar participants indicated that early mobilization 
(58%), swallowing assessment (53%), multidisciplinary meetings (45%), blood sugar 
lowering therapy (24%) and secondary stroke prevention (24%) could be improved. Two 
seminar participants (one from each hospital) however responded that none of the KPIs 
could be improved. Regarding the geographic stroke unit, only one participant from CHUK 
thought that the geographic stroke unit could be established.  
5.3.2 Participants recruitment 
Overall, we recruited 106 participants for each of the two study phases. For CHUK, we 
recruited 71 and 70 participants during the pre and post-intervention phases respectively. 
The recruitment rate was therefore 100%. During the pre-intervention phase, 74 patients 
admitted for stroke at CHUK from 12
th
 July 2017 to 12
th
 January 2018 were contacted to 
participate in the study. Seventy-one patients or their proxies agreed to participate in the 
KPI, n (%) All  
n=38 
CHUB 
n=19 
CHUK  
n=19 
Early Mobilization 22 (57.9) 10 (52.6) 12 (63.2) 
Swallowing Assessment 20 (52.6) 8 (42.1) 12 (63.2) 
Multidisciplinary teams 17 (44.7) 9 (47.4) 8 (42.1) 
Blood sugar monitoring and treatment 9 (23.9) 5 (26.3) 4 (21.1) 
Prevention of secondary strokes 9 (23.9) 4 (21.1) 5 (26.3) 
Acute stroke diagnosis 6 (15.8) 5 (26.3) 1 (5.3) 
Geographic stroke unit 1 (2.6) 0 1 (5.3) 
None 2 (5.3) 1 (5.3) 1 (5.3) 
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study.  One of the 71 participants was found to have a different diagnosis (brain atrophy) at 
discharge but was considered for intention to treat analysis. During the post-intervention 
phase from 16
th
 May 2018 to 31
st
 August 2018, we contacted 71 patients admitted for 
stroke. One patient was unable to communicate and there was no a competent person to 
provide consent and only 70 patients were recruited.  
For CHUB, although the recruitment lasted longer compared to CHUK, we did not reach 
the desired sample size. During the pre-intervention phase, we contacted 37 patients 
admitted for stroke at CHUB from 15
th
 July 2017 to 30
th
 April 2018 to participate in the 
study. Thirty-five patients or their proxies agreed to participate in the study. Three of the 
35 patients had different diagnoses (right parietal glioblastoma, brain tumor, and suspected 
spaceoccupying lesion or meningitis or brain abscess) at discharge but were considered for 
intention to treat analysis. For the post-intervention phase, 36 patients were recruited from 
18
th
 May 2018 to 1
st
 January 2019.  
However, as there were missing data for both hospitals with variations across the variables 
investigated, the sample size varied across the analyses. Table 5.4 shows the demographic 
and clinical characteristics of participants according to phase of study.  
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Table 5. 4: Baseline characteristics of participants according to phase of study 
Variable   All  CHUB CHUK 
 Pre-intervention 
n=106 
Post-intervention 
n=106 
P-value Pre-intervention 
n=35 
Post-intervention 
n=36 
P-value Pre-intervention 
n=71 
Post-intervention 
n=70 
P-value 
Age, years, median (Q1-Q3) 61 (45-70.25) 62 (50-73.25) 0.265 63 (50-74) 65 (51.25-73.75) 0.683 60 (40-68) 61.5 (49.5-73.25) 0.283 
Male sex 55 (51.9) 53 (50.0) 0.783 13 (37.1) 21 (58.3) 0.074 42 (59.2) 32 (45.7) 0.110 
Living alone, Yes, n (%) 52 (49.1) 26 (24.5) <0.0001 17 (48.6) 18 (50.0) 0.904 35 (49.3) 8 (11.4) <0.0001 
Independent before stroke, Yes, n (%) 96 (90.6) 104 (98.1) 0.017 35 (100) 35 (97.2) 0.321 61 (85.9) 69 (98.6) 0.005 
Can talk, Yes, n (%) 58 (54.7) 16 (15.1) <0.0001 10 (28.6) 11 (30.6) 0.855 48 (67.6) 5 (7.1) <0.0001 
Can lift both arms, Yes, n (%) 17 (16.0) 7 (6.6) 0.030 3 (8.6) 3 (8.3) 0.971 14 (19.7) 4 (5.7) 0.013 
Can walk, Yes, n (%) 12 (11.3) 3 (2.8) 0.016 1 (2.9) 0 0.307 11 (15.5) 3 (4.3) 0.026 
Stroke type          
         Ischemic 57 (53.8) 37 (34.9) 0.021 16 (45.7) 12 (33.3) 0.518 41 (57.7) 25 (35.7) 0.016 
         Haemorrhagic 34 (32.1) 50 (47.2)  5 (14.3) 5 (13.9)  29 (40.8) 45 (64.3)  
         Unknown 15 (14.2) 19 (17.9)     1 (1.4) 0  
Onset-hospital arrival interval, days, median 
(Q1-Q3) 
4 (1-12) 2 (1-4.5) 0.012 7 (2.5-13) 3 (1-10) 0.107 3 (1-12) 1 (1-4) 0.040 
Early arrival to study hospital a, b, Yes, n (%) 32 (31.1) 49 (46.7) 0.021 7 (21.9) 9 (25.7) 0.713 25 (35.2) 40 (57.1) 0.009 
Referred from a different hospital, Yes, n (%) 53 (50.0) 72 (67.9) 0.013 30 (85.7) 34 (94.4) 0.386 23 (32.4) 38 (54.3) 0.008 
Onset-3-month interview interval, days, 
Median (Q1-Q3) 
 
96.50 (92-104.75) 
 
95 (92.25-102.75) 
 
0.918 
 
98 (91-123) 
 
93 (91-102) 
 
0.425 
 
96 (92-103) 
 
96 (93-104) 
 
0.535 
a Early arrival to study hospital was defined as arriving to the study hospital in not later than one day from the stroke onset date 
b  The denominator consisted of  participants with documented stroke onset and hospital arrival dates. 
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Table 5.4: Baseline characteristics of participants according to phase of study                                                           Continued 
Variable   All  CHUB CHUK 
 Pre-intervention 
n=106 
Post-intervention 
n=106 
P-value Pre-intervention 
n=35 
Post-intervention 
n=36 
P-value Pre-intervention 
n=71 
Post-intervention 
n=70 
P-value 
Formal education c           
        None 20 (30.3) 29 (32.6) 0.558 5 (26.3) 3 (11.5) 0.325 15 (31.9) 26 (41.3) 0.096 
        1-8 years 26 (39.4) 27 (30.3)  11 (57.9) 18 (69.2)  15 (31.9) 9 (14.3)  
        9-12 years 12 (18.2) 14 (15.7)  2 (10.5) 5 (19.2)  10 (21.3) 9 (14.3)  
        Vocation Training 3 (4.5) 8 (9.0)  0 0  3 (6.4) 8 (12.7)  
       College/University 5 (7.6) 11 (12.4)  1 (5.3) 0  4 (8.5) 11 (17.5)  
Ubudehe category C, d          
1 16 (24.2) 15 (17.2) 0.461 9 (47.4) 9 (37.5) 0.075 7 (14.9) 6 (9.5) 0.575 
2 10 (15.2) 18 (20.7)  1 (5.3) 8 (33.3)  9 (19.1) 10 (15.9)  
3 40 (60.6) 54 (62.1)  9 (47.4) 7 (29.2)  31 (66.0) 47 (74.6)  
4 0 0  0 0  0 0  
 
c The sample size included the participants who did not die in hospital and for whom the information was available during the follow-up interviews. 
d Category 1: Families who do not own a house and can hardly afford basic needs; Category 2: Those who have a dwelling of their own or are able to rent one but rarely get full time jobs; Category 3: Those 
who have a job and farmers who go beyond subsistence farming to produce a surplus which can be sold. The latter also includes those with small and medium enterprises who can provide employment to 
dozens of people; Category 4: Those who own large-scale businesses, individuals working with international organizations and industries as well as public servants.   
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Participants in both study phases were similar for the demographic characteristics 
including age, sex, education and socio-economic status distributions, but it appeared that 
the post-intervention participants had more severe strokes than the pre-intervention 
participants. In fact, the proportion of hemorrhagic stroke (p=0.021), and participants who 
could not talk (p<0.0001), lift both arms (p=0.030) or walk (p=0.016) at their admission 
was higher in post than pre-intervention phase. I found that the proportion of the 
participants who were referred by other health care facilities (p=0.013) and also those who 
presented to hospital early (p=0.021) was higher in post than pre-intervention phase. For 
the study sites individually, the significant differences mentioned were remarkable at 
CHUK, but not at CHUB. There was no single participant with the highest socio-economic 
status at any of the two hospitals. 
5.3.3 Implementation of stroke KPIs 
Table 5.5 shows the proportion of participants who received the selected stroke KPIs 
according to phase of study. In general, there was a significant increase in participants who 
were assessed with a standardized tool (absolute increase of 22%, p=0.001) and those who 
received swallowing assessment (absolute increase of 31%, p<0.0001), mobilization 
(absolute increase of 14%, p=0.035), and multidisciplinary team meeting to plan care 
(absolute increase of 28%, p<0.0001). 
 At CHUK, I found significant increase in patients who received assessment with a 
standardized tool (absolute increase of 26%, p<0.0001), swallowing assessment (absolute 
increase of 42%, p<0.0001), mobilization (absolute increase of 26%, p=0.002) and 
multidisciplinary team meeting to plan care (absolute increase of 43%, p<0.0001). At 
CHUB, there was a significant increase only in participants who received early 
mobilization (absolute increase of 24%; p=0.049). No participant was admitted in a 
geographic stroke unit during either study phase. 
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Table 5. 5: Number (Percentage) of participants who received KPIs according to phase of study  
KPI All  CHUB  CHUK 
 
Pre-
intervention 
Post-
intervention 
P-value  Pre-
intervention 
Post-
intervention 
P-value  Pre-
intervention 
Post-
intervention 
P-value 
Brain Imaging 91 (85.8) 90 (84.9) 0.846  23 (65.7) 21 (58.3) 0.522  68 (95.8) 69 (98.6) 0.317 
Use of standardized assessment tool a 33 (31.1) 56 (52.8) 0.001  30 (85.7) 35 (97.2) 0.081  3 (4.2) 21 (30.0) <0.0001 
Admission in a geographic stroke unit  0 0   0 0   0 0  
Swallowing assessment 6 (5.7) 39 (36.8) <0.0001  5 (14.3) 9 (25.0) 0.257  1 (1.4) 30 (42.9) <0.0001 
Antithrombotic therapy for IS 51 (89.5) 34 (91.9) 0.697  14 (87.5) 9 (75.0) 0.393  37 (90.2) 25 (100) 0.107 
Antithrombotic therapy b 82 (90.1%) 80 (92.0) 0.667  17 (81.0) 14 (82.4) 0.912  65 (92.9) 66 (94.3) 0.730 
Surgery for ICH 3 (8.8) 7 (14.0) 0.472  0 0   3 (10.3) 7 (15.6) 0.522 
Sugar lowering therapy 9 (64.3) 13 (56.5) 0.641  2 (66.7) 3 (60.0) 0.850  7 (63.6) 10 (55.6) 0.668 
Blood pressure lowering therapy 42 (71.2) 61 (78.2) 0.346  10 (62.5) 15 (68.2) 0.715  32 (74.4) 46 (82.1) 0.351 
Mobilization 57 (53.8) 72 (67.9) 0.035  25 (71.4) 22 (61.1) 0.358  32 (45.1) 50 (71.4) 0.002 
Early mobilization C 15 (29.4) 20 (33.3) 0.658  3 (12.8) 8 (36.4) 0.049  12 (46.2) 12 (31.6) 0.237 
MDT Meeting 5 (4.7) 35 (33.0) <0.0001  3 (8.6) 3 (8.3) 0.971  2 (2.8) 32 (45.7) <0.0001 
Abbreviations: IS, ischemic stroke; KPI, stroke key performance indicator; MDT, multidisciplinary team 
a Use of any of the following tools: modified Rankin Scale (mRS], National Institutes for Health Stroke Scale (NIHSS), Glasgow Coma Scale (GCS) and Functional Independence Measure (FIM) 
b Giving any antithrombotic drugs (such as aspirin, enoxaparin/lovenox) for IS or not giving them in case of hemorrhagic stroke   
C Starting mobilization within the first two days of admission  
 
Table 5.6 presents the odds ratios for receiving a KPI after implementation of the intervention. 
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Table 5. 6: Odds ratios for receiving a KPI after implementation of the intervention 
KPI All  CHUB  CHUK 
 
 OR c  95% CI p-value  OR c 95% CI p-value  OR c 95% CI p-value 
 
Unadjusted ORs 
 
Brain Imaging 0.93 0.43-1.99 0.846  0.73 0.28-1.91 0.522  3.04 0.31-30.00 0.340 
Use of standardized assessment tool a 2.48 1.41-4.34 0.002  5.83 0.65-52.74 0.116  9.71 2.74-34.39 <0.0001 
Swallowing assessment 9.70 3.89-24.19 <0.0001  2.00 0.60-6.71 0.262  52.50 6.90-399.69 <0.0001 
Antithrombotic Therapy 1.25 0.45-3.53 0.668  1.10 0.21-5.75 0.912  1.27 0.33-4.94 0.731 
Blood pressure lowering therapy 1.45 0.67-3.16 0.348  1.29 0.33-4.97 0.716  1.58 0.60-4.16 0.353 
Mobilization 1.82 1.04-3.18 0.036  0.63 0.23-1.70 0.360  3.05 1.52-6.12 0.002 
Early mobilization  1.20 0.54-2.69 0.658  4.19 0.95-18.53 0.059  0.54 0.19-1.51 0.239 
MDT Meeting b 9.96 3.72-26.66 <0.0001  0.97 0.18-5.16 0.971  29.05 6.60-127.94 <0.0001 
 
Adjusted for SSV 
 
Brain Imaging 1.02 0.43-2.45 0.964  0.67 0.25-1.82 0.436  1.66 0.09-31.61 0.737 
Use of standardized assessment tool a 2.18 1.14-4.17 0.019  2.92 0.24-34.78 0.397  12.66 1.76-91.30 0.012 
Swallowing assessment 5.41 2.01-14.58 0.001  3.19 0.78-13.11 0.107  47.33 3.08-728.37 0.006 
Antithrombotic Therapy 0.93 0.27-3.23 0.906  1.80 0.27-12.07 0.547  0.45 0.05-4.08 0.479 
Blood pressure lowering therapy 1.79 0.71-4.47 0.215  1.20 0.29-4.93 0.797  3.93 0.98-15.75 0.053 
Mobilization 1.92 1.01-3.64 0.047  0.69 0.22-2.15 0.527  4.88 1.72-13.84 0.003 
Early mobilization  1.82 0.70-4.74 0.219  5.34 0.82-34.57 0.079  0.49 0.11-2.19 0.353 
MDT Meeting b 9.28 2.80-30.76 <0.0001  1.17 0.19-7.29 0.869  36.58 3.60-372.10 0.002 
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Table 5.6: Odds ratios for receiving a KPI after implementation of the intervention                                       Continued 
KPI All  CHUB  CHUK 
 
 OR c  95% CI p-value  OR c 95% CI p-value  OR c 95% CI p-value 
 
Adjusted for SSV and stroke type 
 
Brain Imaging 2.06 0.54-7.90 0.292  1.90 0.24-15.35 0.547  1.87 0.11-32.95 0.668 
Use of standardized assessment tool a 2.03 1.04-3.96 0.038  3.03 0.25-37.02 0.386  12.63 1.75-91.11 0.012 
Swallowing assessment 6.17 2.23-17.07 <0.0001  3.75 0.86-16.36 0.079  54.80 3.52-854.37 0.004 
Antithrombotic Therapy 0.94 0.27-3.28 0.918  1.79 0.27-12.09 0.549  0.48 0.06-4.13 0.501 
Blood pressure lowering therapy 1.80 0.71-4.57 0.216  1.28 0.29-5.61 0.745  4.57 1.08-19.31 0.039 
Mobilization 2.05 1.07-3.92 0.031  0.77 0.24-2.46 0.660  5.41 1.85-15.80 0.002 
Early mobilization  1.47 0.54-4.00 0.449  5.28 0.76-36.77 0.093  0.34 0.07-1.68 0.187 
MDT Meeting b 9.66 2.92-32.01 <0.0001  1.25 0.19-8.14 0.815  36.57 3.59-372.25 0.002 
 
Adjusted for SSV, stroke type and stroke onset-hospital arrival interval 
 
Brain Imaging 1.69 0.41-7.05 0.469  1.67 0.13-22.24 0.699  0.51 0.01-22.78 0.730 
Use of standardized assessment tool a 2.98 1.36-6.51 0.006  3.72 0.25-54.45 0.338  19.38 2.15-174.42 0.008 
Swallowing assessment 5.73 2.08-15.74 0.001  4.50 0.81-25.03 0.086  33.01 3.62-301.19 0.002 
Antithrombotic Therapy 1.20 0.33-4.41 0.787  5.79 0.39-86.79 0.203  0.26 0.02-2.97 0.278 
Blood pressure lowering therapy 2.21 0.83-5.92 0.114  1.64 0.32-8.37 0.552  5.04 1.15-22.18 0.032 
Mobilization 2.30 1.16-4.56 0.017  0.88 0.24-3.19 0.843  5.29 1.80-15.67 0.002 
Early mobilization  1.73 0.58-5.18 0.327  14.38 0.92-225.93 0.058  0.34 0.07-1.68 0.186 
MDT Meeting b 9.04 2.74-29.86 <0.0001  1.66 0.22-12.81 0.626  18.62 3.19-108.87 0.001 
Abbreviations: CI, confidence interval; KPI, stroke key performance indicator; MDT, multidisciplinary team; OR, odds ratio; SSV, six simple variables: (age, living alone before stroke, 
being independent in everyday activities before stroke, being able to talk, being able to lift both arms to horizontal and being able to walk independently) 
a 
Use of any of the following tools: modified Rankin Scale (mRS), National Institutes for Health Stroke Scale (NIHSS), Glasgow Coma Scale (GCS) and Functional Independence Measure 
(FIM)  
b 
Starting mobilization within the first two days of admission  
C
 Reference is the pre-intervention phase
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As summarized in Figure 5.4, after case mix adjustment for six simple variables, stroke 
type and stroke onset-hospital arrival interval, I found a consistent trend of associations 
between the intervention and an increase in participants who received the KPIs 
investigated, although the associations were generally complicated by very wide CIs, and 
were significant for the use of standardized assessment tool, swallowing assessment, 
mobilization and multidisciplinary team meetings in general and at CHUK considered 
alone only. There was also a significant association between the intervention and the 
delivery of blood pressure lowering therapy (adjusted OR: 5.04; 1.15-22.18, p=0.032) at 
CHUK.  I did not find evidence for improved KPI delivery at CHUB.  
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Figure 5. 4: Adjusted odds ratios for receiving KPIs after implementation of the intervention  
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5.3.4 Patient outcomes 
Table 5.7 shows the number of participants with better outcomes according to phase of study 
 
Table 5. 7: Number (Percentage) of participants with better outcomes according to phase of study  
Variable, n (%) All  CHUB  CHUK 
 
Pre-
intervention 
Post-
intervention 
P-value  Pre-
intervention 
Post-
intervention 
P-value  Pre-
intervention 
Post-
intervention 
P-value 
Survival in hospital 82 (77.4) 90 (84.9) 0.160  28 (80.0) 29 (80.6) 0.953  54 (76.1) 61 (87.1) 0.090 
Survival at 3 months post stroke onset 68 (64.8) 76 (71.7) 0.279  20 (58.8) 22 (61.1) 0.845  48 (67.6) 54 (77.1) 0.206 
Independent survival (mRS=0-2) at 3 months 
post stroke onset 
 
20 (26.0) 
 
36 (40.4) 
 
0.049 
  
4 (16.7) 
 
6 (23.1) 
 
0.571 
  
16 (30.2) 
 
30 (47.6) 
 
0.056 
Shorter LoS (<10 days) 50 (47.6) 52 (50.0) 0.731  10 (29.4) 18 (50.0) 0.079  40 (56.3) 34 (50.0) 0.454 
Good quality of life a at 3 months post stroke 
onset 
11 (16.4) 29 (34.9) 0.011  1 (5.0) 4 (15.4) 0.262  10 (21.3) 25 (43.9) 0.015 
Abbreviations: LoS, length of hospital stay; mRS, modified Rankin Scale 
a  Good quality of life was defined as quality of life score ≥ 75% 
 
I found a trend of improved patient outcomes in general and at both hospitals individually, although the improvements were significant for the survival with 
independence (mRS=0-2) (absolute increase of 14%, p=0.049) and the survival with good quality of life (absolute increase of 19%, p=0.011) both sites 
combined. For individual sites, there was significant improvement for good quality of life at CHUK (absolute increase of 23%, p=0.015) only. I did not find 
evidence for improved patient outcomes at CHUB.  
Table 5.8 presents the odds ratios for receiving a KPI after implementation of the intervention. 
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Table 5. 8: Odds ratios for better outcomes after implementation of the intervention 
Variable All  CHUB  CHUK 
 
OR b  95% CI p-value  OR* 95% CI p-value  OR* 95% CI p-value 
Unadjusted ORs 
Survival in hospital 1.65 0.82-3.32 0.163  1.04 0.32-3.34 0.953  2.13 0.88-5.18 0.094 
Survival at 3 months post stroke onset 1.38 0.77-2.47 0.280  1.10 0.42-2.86 0.845  1.62  0.77-3.41 0.207 
Independent survival (mRS=0-2) at 3 months post stroke 1.94 1.00-3.74 0.050  1.50 0.37-6.14 0.573  2.10 0.98-4.53 0.058 
Shorter LoS (<10 days) 1.10 0.64-1.89 0.731  2.40 0.90-6.43 0.082  0.76 0.40-1.51 0.454 
Good quality of life a at 3 months post stroke onset 2.73 1.24-6.01 0.012  3.46 0.36-33.63 0.286  2.89 1.21-6.92 0.017 
ORs adjusted for SSV 
Survival in hospital 2.32 1.02-5.28 0.045  1.25 0.35-4.40 0.733  4.65 1.32-16.47 0.017 
Survival at 3 months post stroke onset 1.87 0.94-3.72 0.076  1.62 0.53-4.93 0.395  2.35 0.83-6.62 0.107 
Independent survival (mRS=0-2) at 3 months post stroke 1.55 0.71-3.37 0.273  3.18 0.51-19.99 0.218  1.19 0.38-3.70 0.761 
Shorter LoS (<10 days) 1.09 0.58-2.02 0.796  2.74 0.95-7.93 0.062  0.67 0.26-1.72 0.409 
Good quality of life a at 3 months post stroke onset 1.95 0.77-4.99 0.162  4.17 0.36-48.69 0.255  1.11 0.31-3.95 0.874 
ORs adjusted for SSV and stroke type 
Survival in hospital 2.59 1.12-5.98 0.026  1.61 0.40-6.43 0.501  4.64 1.31-16.48 0.018 
Survival at 3 months post stroke onset 1.99 0.98-4.04 0.056  1.97 0.59-6.63 0.273  2.34 0.82-6.62 0.111 
Independent survival (mRS=0-2) at 3 months post stroke 1.60 0.72-3.57 0.250  3.11 0.48-20.07 0.233  1.22 0.39-3.79 0.737 
Shorter LoS (<10 days) 0.99 0.52-1.86 0.967  2.85 0.96-8.45 0.059  0.64 0.24-1.68 0.364 
Good quality of life a at 3 months post stroke onset 1.84 0.70-4.84 0.217  3.61 0.28-45.99 0.323  1.09 0.30-3.93 0.896 
ORs adjusted for SSV, stroke type and stroke onset-hospital arrival interval 
Survival in hospital 2.97 1.25-7.05 0.014  2.17 0.48-9.72 0.312  4.76 1.33-17.03 0.016 
Survival at 3 months post stroke onset 2.30 1.10-4.78 0.026  2.79 0.74-10.50 0.130  2.48 0.87-7.09 0.091 
Independent survival (mRS=0-2) at 3 months post stroke 2.05 0.87-4.82 0.100  10.23 0.78-134.41 0.077  1.20 0.37-3.87 0.756 
Shorter LoS (<10 days) 0.93 0.48-1.80 0.825  3.08 0.89-10.67 0.076  0.64 0.24-1.72 0.378 
Good quality of life a at 3 months post stroke onset 1.73 0.65-4.62 0.275  2.66 0.19-37.57 0.469  1.05 0.28-3.91 0.940 
Abbreviations: CI, confidence interval; LoS, length of hospital stay; mRS, modified Rankin Scale; OR, odds ratio; SSV, six simple variables: (age, living alone before stroke, being independent 
in everyday activities before stroke, being able to talk, being able to lift both arms to horizontal and being able to walk independently) 
a  Good quality of life was defined as quality of life score ≥ 75%; 
b 
 Reference is the pre-intervention phase
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 As summarized in Figure 5.5, after case mix adjustment for six simple variables, stroke 
type and stroke onset-hospital arrival interval, all the results, except for the LoS, 
consistently suggested improved patient outcomes. However, the results were significant 
for the survival in hospital for CHUK (adjusted OR: 4.76; 1.33-17.03, p=0.016) and both 
sites combined (adjusted OR: 2.97; 1.25-7.05, p=0.014), and the survival at three months 
post stroke onset both sites combined (adjusted OR: 2.30; 1.10-4.78, p=0.026) only.   
 
Figure 5. 5: Adjusted odds ratios for better outcomes after implementation of the 
intervention 
 
 
Abbreviations: LoS, length of hospital stay; mRS, modified Rankin Scale 
a  Good quality of life was defined as quality of life score ≥ 75% 
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5.4 Facilitators and barriers to stroke unit care implementation  
5.4.1 Facilitators 
The hospital directors were aware of the need for stroke service improvement and pledged 
their support to the success of the study. For instance, the two directors said that it was 
important to improve stroke care in their hospitals and nationally because NCDs were 
rising and were recognized as important causes of death and disability in Rwanda. They 
also mentioned that my study was in line with the hospitals’ vision to provide evidence-
based quality services to their clients and commended their staff to translate the knowledge 
gained during the educational seminar into practice.  
5.4.2 Barriers 
Although there was a consensus to implement all stroke care elements that were presented 
during the training, there were several barriers to stroke unit care implementation in the 
study hospitals and in Rwanda in general. 
 First, there were challenges to deliver thrombolysis, intra-arterial interventions and ICH 
management services including lack or shortage of infrastructure and competent personnel, 
and patient transfer delays. My audit results also showed the delays in arriving to hospital, 
and they were barriers to deliver the KPIs as early as recommended. Second, the hospital 
directors and the seminar participants said that there were no resources to establish 
geographic stroke units. Meanwhile, they agreed on the possibility of organizing stroke 
patients’ beds in the same ward areas. Third, during the post-intervention patient 
recruitment period, the CT scan machine at CHUB was not functioning, and patients were 
referred to other hospitals for brain imaging.  
5.5 Discussion 
The key finding of this study was that, after adjusting for casemix and hospital arrival 
delay, the intervention was significantly associated with improved delivery of almost all 
the KPIs investigated including; the use of standardized assessment tool (adjusted OR: 
2.98; 1.36-6.51, p=0.006), swallowing assessment (adjusted OR: 5.73; 2.08-15.74, 
p=0.001), mobilization (adjusted OR: 2.30; 1.16-4.56, p=0.017) and multidisciplinary team 
meetings (adjusted OR: 9.04; 2.74-29.86, p<0.0001). Secondly, I found that, after adjusting 
for casemix and hospital arrival delay, the intervention was significantly associated with 
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improved survival in hospital (adjusted OR: 2.97; 1.25-7.05, p=0.014) and survival at three 
months post stroke (adjusted OR 2.30; 1.10-4.78, p=0.026). 
Overall, I found that my implementation intervention resulted in an absolute increase in the 
percentage of participants who received any of the KPIs investigated, except for brain 
imaging and availability of a geographic stroke unit. However, the improvements were 
statistically significant only for the use of standardized assessment tools, swallowing 
assessment, mobilization, and multidisciplinary team meetings. These results were in 
agreement with the views from the educational seminar participants who indicated that 
early mobilisation, swallowing assessment and multidisciplinary teams were the top three 
KPIs that could be improved. Regarding swallowing assessment, a similar Australian study 
(Middleton et al., 2011) showed an absolute increase of 39%, which was similar to what I 
found (absolute increase of 31%). Any difference might be due imprecision or a lower 
compliance to the intervention by the study hospitals staff.  
Despite the available evidence for the substantial benefits from a stroke unit admission 
(Health Quality Ontario, 2014), geographic stroke units were not yet established at either 
study hospital. During the consensus discussions, only one of 38 participants thought that a 
geographic stroke unit could be established at the work place. As access to a geographic 
stroke unit is associated with improved use of investigations and treatments, access to other 
rehabilitation services, and consequently improved patient outcomes (de Villiers et al., 
2009; Langhorne et al., 2018), lack of geographic stroke unit and multidisciplinary teams 
dedicated to stroke patients’ management at the study settings was a major barrier for 
stroke service improvement. Surgical intervention for ICH was also rarely performed 
despite the high proportion of hemorrhagic strokes (32% and 47% during the pre and post-
intervention phase respectively) and some promising evidence for its benefits (Dey et al., 
2014). Lack of positive change for brain imaging could be attributed to the fact that the 
CT-scan machine at one hospital was not functioning during the post-intervention patient 
recruitment period, and patients could only get the imaging services in other hospitals by 
travelling a distance of 135 km.  
Despite the significant improvements in the delivery of several KPIs, the absolute 
performance rates were low when compared to the quality standards according to which 
stroke patients should receive every KPI if they are eligible (Lindsay et al., 2014). I 
conducted my study in hospitals with support from the directors, and the educational 
seminar participants were convinced to improve their practice. Despite this common 
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willingness, there were challenges in terms of technical, material, financial and human 
resources that need to be addressed for implementing all key stroke unit care components.  
Given the results of improvements in stroke KPIs delivery and the evidence for the 
association of swallowing assessment and mobilisation with improved patient outcomes 
(Urimubenshi et al., 2017), one might also expect better outcomes from my intervention. I 
found a trend of improved patient outcomes in general and at both hospitals individually, 
although the improvements were only statistically significant for the survival with 
independence (mRS=0-2) and better quality of life. My results were consistent with the 
ones from a previous similar study (Middleton et al., 2011) which showed that a 
multidisciplinary intervention to support proactive evidence-based management of fever, 
hyper glycaemia, and swallowing was associated with 10% absolute increase in survival 
with independence at three months post stroke onset. The higher absolute increase of 14% 
found in my study could be due to having had a clinical intervention of 11 KPIs compared 
to three KPIs only in the other study while there is evidence of an association between 
achieving a greater number of KPIs and better patient outcomes (Urimubenshi et al., 2017). 
Additionally, the differences might be due to different baseline services (stroke units 
versus general medical wards). 
When looking at both sites combined, I found that my intervention was independently 
associated with improved survival in hospital (adjusted OR: 2.97; 1.25-7.05, p=0.014) and 
survival at three months post stroke (adjusted OR 2.30; 1.10-4.78, p=0.026). Patient 
outcomes for CHUB were not statistically significant probably due to a very small sample 
size, but I found a clear association between my intervention and the survival in hospital 
for CHUK (adjusted OR: 4.76; 1.33-17.03, p=0.016). The clinical significance of these 
results is more remarkable when compared against other established clinical interventions, 
namely swallowing assessment and mobilisation (Urimubenshi et al., 2017). Although not 
shown to be statistically significant, the promise of an increase in stroke survivors with 
independence (mRS=0-2) and also in those with better quality of life at three months post 
stroke could represent substantial benefits for patients.  
I did not find evidence for the association between my intervention and reduced LoS for 
each hospital individually and in general. However, previous similar studies also provided 
inconsistent results. A South African study (de Villiers et al., 2009) has shown that 
implementing multidisciplinary stroke care was significantly associated with an increase in 
LoS. By contrast, a Danish study (Svendsen et al., 2009) reported that any of several KPIs 
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including stroke unit admission, antiplatelets and anticoagulants for IS with AF, brain 
imaging, early mobilization, occupational therapy assessment, swallowing assessment or 
deep vein thrombosis prophylaxis was significantly associated with a decrease in LoS.   
Strengths and weaknesses 
To the best of my knowledge, this is the first study to provide evidence on the feasibility of 
implementing aspects of stroke unit care in two selected hospitals in Rwanda, a low-
income country with limited resources. The data suggest that using site champions, 
feedback on usual care and on-site training on stroke KPIs may facilitate stroke service 
delivery and better patient outcomes. The study, however, has several limitations. First, as 
I conducted the study in referral university teaching hospitals with better resources and 
services, my findings are not necessarily generalizable to all hospitals in Rwanda. Second, 
I achieved the desired sample size at CHUK, but not at CHUB because the recruitment was 
very slow while I had a time limit for the research project. This could have resulted to lack 
of power to provide evidence on the potential benefits associated with implementing stroke 
unit care KPIs at CHUB. Third, in-hospital data were obtained from patient medical files 
and there were considerable missing data. Specifically, as in my analysis I considered the 
undocumented KPIs as if they had not been implemented, there remains the possibility that 
my results do not reflect the real picture of stroke service delivery, and the intervention 
outcomes may have been influenced by improvements in documentation by the hospital 
staff. Fourth, I did not capture if the KPIs were delivered in accordance with the 
recommended quality standards. I hope future interventions to change practice could still 
further look at the quality of care received by the stroke patients. Fifth, my study was 
limited in that patients with severe strokes were relatively underrepresented. Although, I 
considered the six simple variables and stroke type for the casemix adjustment, my pre and 
post-intervention cohorts consisted of patients who survived for the first four and two days 
respectively. My results may therefore not represent the intervention benefits for patients 
with more severe strokes. 
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5.6 Conclusion 
My study indicated that several common KPIs for a stroke unit care can be implemented in 
two selected hospitals in Rwanda although there were limited resources, and some 
important KPIs such as geographic stroke unit and thrombolysis were not yet implemented. 
The data suggested that there may be improved patient outcomes in hospital and at three 
months post stroke. Policy makers and health care professionals should consider 
implementing the stroke unit care KPIs including those that are not yet initiated like a 
geographic stroke unit.  Future similar studies should consider assessing the quality of the 
delivery of the KPIs.   
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Chapter 6: Final discussion  
6.1 A summary of my research 
The aim of my thesis was to establish, for countries like Rwanda, how much stroke is a 
major problem (chapter 1), if services are well prepared (chapter 2) and then how to 
develop and implement a relevant service improvement (chapter 3-5).  
Epidemiology and impact of stroke in Africa 
An initial concern at the beginning was the relevance of the project and I aimed to explore 
to which extent stroke was a problem in Africa. As discussed in chapter 1, before my thesis 
there were several systematic reviews on the same topic. However, the literature searching 
methodologies of those previous systematic reviews may have resulted in them missing 
some relevant information on stroke in Africa. For example, the reviews were confined to 
studies published in English while some of the African researchers are more likely to 
publish in French. Additionally, the reviews included studies conducted in a small number 
of African countries. I therefore performed a systematic review of the literature on the 
epidemiology (incidence, prevalence, mortality, one month-case-fatality) and impact 
(disability, quality of life, and cost) of stroke in Africa. I searched many relevant databases 
including Medline, Embase, PubMed, and AJOL, with no language restriction. The review 
provided up-to-date and comprehensive results showing that stroke was common and 
important in Africa. I could not have achieved this by doing a simple narrative review. 
Since it is reported that adequate health services and strategies for stroke prevention in 
HICs have contributed to the decline in stroke mortality and disability rates, my findings 
raised a question on the availability, accessibility and quality of stroke services in Africa.  
Stroke care in Africa 
To develop and implement a relevant service improvement in countries like Rwanda, I had 
to gain a clearer understanding of the systems of stroke care in Africa and the areas for 
improvement. As shown in chapter 2, I performed a systematic review of the literature by 
searches of Ovid Medline, Embase, Amed, CINAHL, PubMed, and AJOL databases. 
There was no language restriction, but the search was limited to contemporary full-text 
publications (from January 1
st
, 2006 to June 20
th
, 2017). Previous similar reviews were 
confined to studies published in English while some of the African researchers are more 
likely to publish in French, and none of them focused of the delivery of stroke care in 
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Africa. Data from eligible publications were extracted and analysed based on the WSO 
Stroke services Framework (Lindsay et al., 2014). The findings showed that in the 
published reports the provision of stroke care in Africa was below the recommended 
standards with variations across and within counties, and they informed me about what I 
would include in the content of my stroke unit care intervention.  
First, I learned much from previous initiatives to start-up stroke units in African countries. 
Collectively, 23 stroke units were reported; 21 in South Africa, one in Ghana and the 
remaining one in Central African Republic. There were three main lessons from South 
Africa (Burton et al. 2016):  
i) Some stakeholders may not understand and support the idea immediately. For 
instance, the Ministry of Health in South Africa was unwilling to support a 
project to start stroke units, focusing on a single non-communicable disease;  
ii) Starting up a stroke unit does not necessarily make it compliant with accepted 
international standards. In South Africa, they started with the formation of 
stroke teams, distributing post stroke care protocol templates, and trainings on 
stroke care by led by international experts.  
iii) Finding champions for the cause, people enthusiastic about improving care who 
could help organise meetings and training sessions, was a key factor for the 
achievements made.  
With the experience in South Africa, it became clear that I would have to communicate 
with the study hospitals’ directors with enough information about the evidence on potential 
benefits of a stroke unit care. It also became clear that I had to consider the local context in 
developing the stroke unit care intervention, and use local champions as one of the 
implementation strategies.    
Regarding the reports from Ghana (Baatiema et al., 2017) and the Central African 
Republic (Ossou-Nguiet et al., 2016), beyond being a geographic hospital area dedicated to 
stroke patients, there was no clear information on the characteristics of the stroke unit care. 
This finding indicated the need for a model of stroke unit care KPIs applicable in LMIC 
settings. 
Second, the findings from several African countries suggested that implementing some 
interventions such as thrombolysis, intra-arterial interventions and ICH management in 
Rwanda may not be possible because of delays in arriving to hospital and the shortage of 
the resources required.  
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Third, the review showed that only a small proportion of patients with stroke arrived at a 
hospital within three hours from symptom onset and, consequently, less than 20% of 
patients were admitted within three hours of stroke onset. Such delays in presentation to 
hospital prevent patients from benefiting from some emergency interventions such as brain 
imaging and thrombolysis for IS among others. This finding implied a need for 
interventions in community and primary health care facilities to raise awareness of stroke 
signs and symptoms, and prompt referrals to hospitals. This issue was not addressed in this 
thesis because of limited time and financial resources. In my future plans I will consider 
this gap. 
Key performance indicators of quality stroke care and their association with patient 
outcomes 
I am convinced that initiatives to improve stroke care in any setting should focus on those 
stroke care elements that are relevant to the local context in terms of feasibility and 
effectiveness. As discussed in chapter 2, there is a need for determining the applicable key 
components to start up a stroke unit care in a given setting. I therefore aimed to identify the 
key elements of quality stroke care to inform the content of my stroke unit care 
intervention. As shown in chapter 3, I conducted a systematic literature review to identify 
the KPIs that have been described in stroke care and to summarise their association with 
patient outcomes. Searching sources were Ovid Medline, Embase and PubMed databases, 
and relevant references from screening the bibliographies of the initial articles included in 
the search. I included national or regional registers that recorded the independent 
association (after adjusting for at least age and a measure of stroke severity) between the 
KPIs and stroke patient outcomes. 
I found that the most frequently reported KPIs for stroke care were swallowing assessment, 
stroke unit admission, antiplatelets for IS, brain imaging, anticoagulants for IS with AF, 
lipid management, deep vein thrombosis prophylaxis, and early mobilization. Stroke unit 
admission and early interventions including swallowing assessment, antiplatelets for IS, 
anticoagulants for IS with AF, lipid management and mobilization were all associated with 
better patient outcomes. Achieving a combination of several KPIs was always associated 
with a better outcome. 
The studies that were included in my review involved large sample sizes in general, 
allowing sufficient statistical power and enhancing the external validity of the results. 
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However, the publications I reviewed were mainly from HICs. This raises a question of 
whether the KPIs in HICs are applicable to LMICs. As shown in chapter 4, I aimed to 
explore the examples of key stroke care elements outside high-income healthcare settings. 
I used the INTERSTROKE study data to identify the availability and delivery of stroke 
care services and their association with patient outcomes in LMICs generally and African 
countries in particular. I found that the commonly reported KPIs including early brain CT 
scan, access to a stroke unit or stroke specialist, antiplatelet therapy for IS, in-hospital and 
post-discharge rehabilitation, may have similar utility in LMICs as has been noted in HICs. 
Information on stroke KPIs in countries with different income levels was crucial in 
ensuring that the eventual intervention to implement stroke unit care in centres in Rwanda 
was going to be relevant and applicable in similar settings. 
Developing a stroke unit care intervention relevant to Rwandan and other LMIC 
settings 
The information that in Africa stroke was common and important (chapter 1), and that 
stroke services were below the recommended standards (chapter 2) suggested that 
interventions to improve stroke services and patient outcomes in Africa are necessary.  
My contribution to this objective was to develop a model of stroke unit care relevant to 
Rwandan and other LMIC settings. Stroke unit care has become established as the central 
component of a modern stroke service to reduce the risk of death and disability after 
stroke. A “stroke unit” is defined as is a complex intervention that entails a combination of 
medical and rehabilitation interventions that are delivered by a multidisciplinary team of 
stroke specialists who work in a focussed and coordinated way to provide care for patients 
with stroke in hospital (Stroke Unit Trialists’ Collaboration, 2013). In order to achieve my 
envisioned aim, I had to select the KPIs to include in my stroke unit care intervention. For 
this purpose, I used the results from my systematic review of the literature on stroke KPIs 
and analysis of INTERSTROKE study, the recommendations from the WSO stroke 
services framework (Lindsay et al., 2014) plus the Rwandan clinical guidelines (Ministry 
of Health, 2012; 2016). The Rwandan clinical guidelines included the clinical treatment 
guidelines for various conditions. However, the guidelines for stroke were limited to some 
aspects of investigations and management. Regarding the investigations, the guidelines 
included only blood tests, brain imaging, and investigations for the heart and carotid artery. 
For the management, the guidelines were limited to oxygen therapy, fever management, 
hydration and nutrition, antihypertensive therapy, pressure care, early mobilisation, drug 
  
152 
 
therapy for ischemic stroke, prevention of complications and secondary stroke, as well as 
counseling for patient and family. Several important aspects of stroke care such as 
swallowing assessment, speech and language therapy, and occupational therapy among 
others (Lindsay et al., 2014) were not included in the Rwandan guidelines. At present, no 
training in speech and language therapy is provided in Rwanda, and the 4-year training in 
OT started recently in 2015. Approximately, only five occupational therapists are 
employed in Rwanda, and none of them is at any of the two study hospitals. 
Considering several sources of evidence enabled me to design a stroke unit care 
intervention that is meaningful, likely to be feasible and fit for wider implementation. My 
intervention consisted of 11 key elements including acute stroke diagnosis (recognition of 
strokes and brain imaging), use of stroke severity assessment tools, admission to a 
geographic stroke unit, swallowing assessment, antithrombotic therapy for IS, management 
of ICH, early mobilization, blood sugar and pressure monitoring and treatment, secondary 
prevention, and multidisciplinary team meetings.  
Designing and testing a process of implementing stroke unit care in Rwanda  
Despite the current evidence for its benefits, stroke unit implementation requires a range of 
health professional resources, co-location of beds and clinical leadership. Therefore, a 
project to implement stroke units in Rwanda, a low-income country appeared to be 
ambitious. I did not have funds to supplement the existing hospital resources, and my aim 
was to test the feasibility of a stroke unit care using available resources and thus ensuring 
potential sustainability. In the “WSO Global Stroke Quality Action Plan” (Lindsay et al., 
2014, p. 2), it is stated that “even with the absolute minimal services available to you, at 
least something can be done for people with stroke that could make a difference to their 
recovery and outcomes”.  
Based on the available evidence on the effectiveness of various implementation 
interventions (Johnson and May, 2015) and the local context, I proposed to use a 
combination of several interventions including identification and preparation of site 
champions, provision of educational materials (soft and printed copies), face-to-face 
educational visit, feedback on usual care audit results, local consensus discussions, and 
discussions with the directors of the study hospitals. My supervisors have experience in 
conducting clinical trials. Their insights inspired me to consider several practical issues. 
For instance, it became clear to me that training the staff with different specialties together 
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was a good approach for each one to understand what others can do. This appeared as a 
strategy to enhance the multidisciplinary teamwork, and referrals between services. The 
site champions also advised me on a strategy to ensure that the educational seminar is 
attended from the beginning to the end. Lunch, transport fees to and from the training 
venue for all participants, and one-night accommodation fees for participants from CHUB 
were provided. The presence and contributions of two OSCAIL investigators during the 
educational seminar and meetings with the directors of the study hospitals was a strong 
support to show the importance of the study. 
I am convinced that using such combined behavior change interventions was the best 
approach to optimize the compliance with the stroke unit care KPIs. After adjustment for 
case mix and stroke onset-hospital arrival interval, I found a consistent trend of 
associations between the implementation intervention and an increase in participants who 
received the KPIs investigated and a probable increase in better patient outcomes. 
Limitations 
My thesis is subject to three main limitations. First, my entire thesis project was subject to 
a limitation for generalisability. Findings from my systematic reviews on stroke 
epidemiology, impact and care in Africa were from studies that were conducted in urban 
settings and therefore might not show the situation in rural areas. Findings from the 
INTERSTROKE data analysis may not indicate the real picture about stroke KPIs in 
LMICs because of 70 hospitals from LMICs assessed for the INTERSTROKE study, only 
three were from low-income countries (Mozambique and Uganda). Additionally, many of 
the participants may have been recruited from urban settings with better resources and 
services. Consequently, the results cannot be generalized within or across all LMICs. 
Finally, I conducted the stroke unit care implementation trial in referral university teaching 
hospitals with better resources and services, and the findings are not necessarily 
generalizable to all hospitals in Rwanda. Further studies involving rural and primary health 
care facilities are recommended. 
Second, my intervention did not result in the implementation of geographic stroke units 
despite the available evidence that they are associated with reduced risks of death and 
disability. The hospital directors and the educational seminar participants said that there 
were no resources to establish such units. Potential solutions to achieve this in future 
would be to have a collaboration partnership with the hospitals to further explore how 
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geographic stroke units can be established. This can be done in stages starting with at least 
a hospital area with dedicated beds and nursing staff as suggested by Langhorne et al. 
(2012).  
Third, I cannot exclude the possibility that my intervention results were influenced by 
unmeasured factors. For instance, my trial was a before and after study and the associations 
between the implementation intervention and patient outcomes may have been influenced 
by residual confounding factors. Additionally, the in-hospital data for the trial were 
obtained from patient medical files and there were considerable missing data. Specifically, 
as in my analysis I considered the undocumented KPIs as if they had not been 
implemented, there remains the possibility that my results do not reflect the real picture of 
stroke service delivery, and the intervention outcomes may have been influenced by 
improvements in documentation by the hospital staff. 
6.2 Future and wider implications for my thesis 
Developing and testing a process of implementing stroke unit care in Rwanda was in line 
with the call from the Government of Rwanda for relevant studies to generate evidence for 
the policy makers to respond efficiently to the growing burden of NCDs including stroke 
(Ministry of Health, 2015c). My thesis provides the policy makers and healthcare 
professionals in Rwanda and other LMICs with a strategy to improve stroke care and 
outcomes. The implementation approach may also be relevant for other similar NCD 
conditions.  
At present, it is not known if the study hospitals are maintaining the momentum for stroke 
service improvement. I am planning to have long-term collaborations with the two study 
hospitals and others in Rwanda for promoting quality stroke care. Specifically, in 
collaboration with the OSCAIL investigators, I have now developed a 3-year project 
entitled “Improving Stroke Care and Outcomes in Rwanda (ISCOR)”. The project is 
expected to start in January 2020 and will consist of four main activities:  
(i) To understand the burden of stroke in the community and health facilities, the 
ISCOR team will collect data on stroke prevalence and incidence, mortality, 
morbidity and stroke care practices (e.g. amount of physiotherapy provided, use 
of secondary prevention treatments) in selected settings depending on the 
budget that will be available;  
(ii) To collaborate with CHUK for establishing a geographic stroke unit; 
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(iii) To train multidisciplinary teams with expertise in stroke care. Physicians, nurses, 
physiotherapists, occupational therapists, speech therapists and community 
health care workers from Rwandan health care facilities (as many as possible) 
will be trained by local and international experts in stroke best practices, 
directly relevant to the needs of Rwandan stroke patients and with consideration 
of available resources. Specifically, as shown by the results in chapters 2 and 5, 
patients with stroke in Rwanda like in other African countries are late in 
arriving to hospital. Late presentation to hospital has been reported to be 
associated with poor awareness of stroke signs and symptoms, late referral from 
private hospitals, transportation problems, visit to traditional healers before 
coming to hospital, and treatment at home (Owolabi and Nagoda, 2012; Philip-
Ephraim et al., 2015). Therefore, interventions to raise awareness about stroke 
in community and primary health care facilities will be considered;    
(iv) To develop and test efficient and applicable stroke interventions, we will use the 
data on unmet stroke needs to determine intervention priorities. We will then 
determine current best practices and available evidence and assess applicability 
to the Rwandan setting. 
We have already identified the key stakeholders and submitted the project to the Ministry 
of Health of Rwanda for approval. 
Future well designed studies are recommended and should consider assessing the quality of 
the delivery of the KPIs.   
6.3 A final note 
The burden of stroke in LMICs has risen sharply in recent years and the rate of increase is 
set to accelerate. There is evidence that stroke unit care is associated with lower risks for 
death and disability, but it requires a range of health professional resources, co-location of 
beds and clinical leadership. My thesis addresses the strategies to implement stroke unit 
care in settings with limited resources. This thesis represents my first step in developing 
and implementing interventions to promote stroke unit care in hospitals in Rwanda and 
other under-resourced countries. 
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Appendices 
Appendix 1. 1: Details for search strategies for epidemiology and impact of stroke in 
Africa 
Medline 
1. Stroke/ 
 
2. Cerebrovascular Disorders/ 
 
3. Epidemiology/ 
 
4. burden.mp. 
 
5. Incidence/ 
 
6. Mortality/ 
 
7. Prevalence/ 
 
8. impact.mp. 
 
9. disability.mp. 
 
10. "Quality of Life"/ 
 
11. cost.mp. 
 
12. Africa, Western/ or Africa, Northern/ or South Africa/ or Africa, Eastern/ or Africa.mp. or "Africa 
South of the Sahara"/ or Africa, Central/ or Africa/ or Africa, Southern/  
13. 1 or 2 
 
14. 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 
 
15. 12 and 13 and 14 
 
16. limit 15 to (full text and yr="1980 - 2017") 
  
Embase 
1. stroke.mp. 
 
2. cerebrovascular accident/ 
 
3. cerebrovascular disease/ 
 
4. epidemiology/ 
 
5. burden.mp. 
 
6. incidence/ 
 
7. mortality/ or mortality rate/ 
 
8. case fatality.mp. or case fatality rate/ 
 
9. prevalence/ 
 
10. impact.mp. 
 
11. disability/ 
 
12. "quality of life"/ 
 
13. "health care cost"/ or "cost"/ or "hospital cost"/ or "hospitalization cost"/ 
 
14. "Africa south of the Sahara"/ or South Africa/ or Africa/ or North Africa/ or Central Africa/ or 
Africa.mp.  
15. 1 or 2 or 3 
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16. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
 
17. 14 and 15 and 16 
 
18. limit 17 to (full text and yr="1980 - 2017") 
 
 
Pubmed 
(((((stroke[MeSH Terms]) OR cerebrovascular accident[MeSH Terms]) OR cerebrovascular 
disease[MeSH Terms])) AND ((((((((((epidemiology[MeSH Terms]) OR burden[MeSH Terms]) 
OR incidence[MeSH Terms]) OR mortality[MeSH Terms]) OR case fatality[MeSH Terms]) OR 
prevalence[MeSH Terms]) OR impact[MeSH Terms]) OR disability[MeSH Terms]) OR quality of 
life[MeSH Terms]) OR cost[MeSH Terms])) AND Africa[MeSH Terms] Filters: Full text, From 
1980/01/01 to 2017/06/08 
 
AJOL 
Advanced search: stroke AND (epidemiology OR burden OR incidence OR mortality OR “case 
fatality” OR prevalence OR impact OR disability OR “quality of life” OR cost),  
“cerebrovascular accident” AND (epidemiology OR burden OR incidence OR mortality OR “case 
fatality” OR prevalence OR impact OR disability OR “quality of life” OR cost),  
“cerebrovascular disease” AND (epidemiology OR burden OR incidence OR mortality OR “case 
fatality” OR prevalence OR impact OR disability OR “quality of life” OR cost) 
Advanced filters: Until June 8
th
, 2017 
 
Appendix 2. 1: Details for search strategies for stroke care in Africa 
Ovid Medline  
1. exp Stroke/ 
 
2. exp Cerebrovascular Disorders/ 
 
3. exp Awareness/ 
 
4. exp "Delivery of Health Care"/ 
 
5. exp Health Services Accessibility/ 
 
6. exp Rehabilitation/ 
 
7. exp Therapeutics/ 
 
8. stroke unit.mp. 
 
9. (referral and consultation).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
10. exp Diagnosis/ 
 
11. exp Secondary Prevention/ 
 
12. exp Africa, Western/ or exp Africa, Central/ or exp "Africa South of the Sahara"/ or exp 
Africa/ or exp Africa, Northern/ or exp South Africa/ or exp Africa, Eastern/ or exp Africa, 
Southern/ 
 
13. 1 or 2 
 
14. 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 
 
15. 12 and 13 and 14 
 
16. limit 15 to (full text and yr="2006 - 2017") 
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Embase 
1. stroke.mp. or exp cerebrovascular accident/ 
 
2. exp cerebrovascular disease/ 
 
3. exp awareness/ 
 
4. exp health care delivery/ 
 
5. exp health care/ 
 
6. exp health care facility/ 
 
7. exp health care system/ 
 
8. exp health service/ 
 
9. exp health care access/ 
 
10. exp rehabilitation/ 
 
11. exp therapy/ 
 
12. exp stroke unit/ 
 
13. exp patient referral/ 
 
14. exp diagnosis/ 
 
15. exp secondary prevention/ 
 
16. exp "Africa south of the Sahara"/ or exp South Africa/ or exp Africa/ or exp North Africa/ or 
exp Central Africa/  
17. 1 or 2 
 
18. 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 
 
19. 16 and 17 and 18 
 
20. limit 19 to (full text and yr="2006 - 2017") 
 
Amed  
1. exp stroke/ 
 
2. exp Cerebrovascular disorders/ 
 
3. exp Cerebrovascular accident/ 
 
4. exp Awareness/ 
 
5. exp "Delivery of health care"/ 
 
6. exp Health facilities/ 
 
7. exp Health services accessibility/ 
 
8. exp Rehabilitation/ 
 
9. exp therapeutics/ 
 
10. exp Therapy/ 
 
11. stroke unit.mp. 
 
12. exp Diagnosis/ 
 
13. (referral and consultation).mp. [mp=abstract, heading words, title] 
 
14. secondary prevention.mp. 
 
15. exp Africa/ 
 
16. 1 or 2 or 3 
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17. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
 
18. 15 and 16 and 17 
 
19. limit 18 to yr="2006 - 2017" 
 
 
CINAHL 
http://search.ebscohost.com/login.aspx?direct=true&AuthType=athens,cookie,ip,url,uid&db=rzh&
bquery=((MH+stroke)+OR+(MH+cerebrovascular+disorders))+AND+((MH+%26quot%3bAfrica
%2b%26quot%3b)+OR+(MH+%26quot%3bAfrica+South+of+the+Sahara%2b%26quot%3b)+OR
+(MH+%26quot%3bAfrica%2c+Western%2b%26quot%3b)+OR+(MH+%26quot%3bDemocratic
+Nursing+Organisation+of+South+Africa%26quot%3b)+OR+(MH+%26quot%3bAfrica%2c+Sout
hern%2b%26quot%3b)+OR+(MH+%26quot%3bAfrica%2c+Northern%2b%26quot%3b)+OR+(M
H+%26quot%3bAfrica%2c+Eastern%2b%26quot%3b)+OR+(MH+%26quot%3bAfrica%2c+Centr
al%2b%26quot%3b)+OR+(MH+%26quot%3bSouth+Africa%26quot%3b)+OR+(MH+%26quot%
3bSouth+African+Nursing+Council%26quot%3b)+OR+(MH+%26quot%3bNamibia%26quot%3b)
)+AND+(((MH+awareness)+OR+(MH+health+care+delivery)+OR+(MH+health+care)+OR+(MH
+health+care+system)+OR+(MH+health+care+facility)+OR+(MH+health+service)+OR+(MH+he
alth+care+access)+OR+(MH+rehabilitation)+OR+(MH+therapy)+OR+(MH+stroke+units)+OR+(
MH+patient+referral)+OR+(MH+diagnosis))+OR+(%26quot%3bsecondary+prevention%26quot%
3b))&cli0=DT1&clv0=200601-201712&type=1&site=ehost-live 
Pubmed 
((("stroke"[MeSH Terms] OR "stroke"[MeSH Terms]) OR "cerebrovascular disorders"[MeSH 
Terms]) AND ((((((((((("awareness"[MeSH Terms] OR "delivery of health care"[MeSH Terms]) 
OR "delivery of health care"[MeSH Terms]) OR "delivery of health care"[MeSH Terms]) OR 
"health facilities"[MeSH Terms]) OR "health services"[MeSH Terms]) OR "health services 
accessibility"[MeSH Terms]) OR "rehabilitation"[MeSH Terms]) OR "therapeutics"[MeSH 
Terms]) OR "referral and consultation"[MeSH Terms]) OR "diagnosis"[MeSH Terms]) OR 
"secondary prevention"[MeSH Terms])) AND ("africa"[MeSH Terms] OR "africa"[All Fields]) 
AND ("loattrfull text"[sb] AND ("2006/01/01"[PDAT] : "2017/06/20"[PDAT])) 
 
AJOL 
(stroke OR "cerebrovascular accident" OR "cerebrovascular disease") AND awareness,  (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND health care, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND health service, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND diagnosis, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND treatment, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND management (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND rehabilitation, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND therapy , (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND stroke unit, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND referral, (stroke OR 
"cerebrovascular accident" OR "cerebrovascular disease") AND secondary prevention,  
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Appendix 2. 2: Form for extraction of data about stroke care in Africa 
Author(s)   
Publication year   
Study setting   
Was the setting rural or urban?   
Study design   
Sample size   
Participants   
Main findings  
 
 
 
Key stroke care element(s) investigated    
The reported findings were about which of the six phases of the continuum of stroke care? 
Tick the box  for Yes or No for each of the stroke care phases. 
 
Systems for stroke recognition and 
response 
Yes  No  
Hyperacute stroke care Yes  No  
Acute inpatient care Yes  No  
Stroke rehabilitation Yes  No  
Secondary stroke prevention Yes  No  
Longer-term stroke recovery Yes  No  
 
Appendix 3. 1: Details for search strategies for KPIs of quality stroke care and their 
association with patient outcomes 
Ovid Medline 
1. exp Stroke/ 
 
2. exp Cerebrovascular Disorders/ 
 
3. exp Intracranial Hemorrhages/ 
 
4. exp Brain Infarction/ 
 
5. exp Subarachnoid Hemorrhage/ 
 
6. exp "Quality of Health Care"/ 
 
7. exp Quality Indicators, Health Care/ 
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8. exp Quality Assurance, Health Care/ 
 
9. exp Quality Control/ 
 
10. performance indicator.mp. 
 
11. exp Registries/ 
 
12. exp Clinical Audit/ 
 
13. exp Treatment Outcome/ 
 
14. exp Mortality/ 
 
15. exp Survival/ 
 
16. disability.mp. 
 
17. functional status.mp. 
 
18. exp Hospitalization/ 
 
19. exp "Costs and Cost Analysis"/ 
 
20. exp "Quality of Life"/ 
 
21. complication.mp. 
 
22. stroke recurrence.mp. 
 
23. 1 or 2 or 3 or 4 or 5 
 
24. 6 or 7 or 8 or 9 or 10 
 
25. 11 or 12 
 
26. 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
 
27. 23 and 24 and 25 and 26 
 
28. limit 27 to (english language and full text and yr="2000 -Current") 
 
 
Embase 
1. stroke.mp. 
 
2. exp cerebrovascular accident/ 
 
3. exp cerebrovascular disease/ 
 
4. exp brain hemorrhage/ 
 
5. exp brain infarction/ 
 
6. exp subarachnoid hemorrhage/ 
 
7. exp health care quality/ 
 
8. exp quality control/ 
 
9. quality indicator.mp. 
 
10. performance indicator.mp. 
 
11. exp register/ 
 
12. exp clinical audit/ 
 
13. exp treatment outcome/ 
 
14. exp case fatality rate/ 
 
15. exp mortality/ 
 
16. exp survival/ 
 
17. exp disability/ 
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18. exp functional status/ 
 
19. exp hospitalization/ 
 
20. exp "cost"/ 
 
21. exp "quality of life"/ 
 
22. exp complication/ 
 
23. exp hospital discharge/ 
 
24. stroke recurrence.mp. 
 
25. 1 or 2 or 3 or 4 or 5 or 6 
 
26. 7 or 8 or 9 or 10 
 
27. 11 or 12 
 
28. 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
 
29. 25 and 26 and 27 and 28 
 
30. 29 and 2000:2017.(sa_year). 
 
 
Pubmed 
(((((((((stroke[MeSH Terms]) OR cerebrovascular accident[MeSH Terms]) OR cerebrovascular 
disease[MeSH Terms]) OR brain hemorrhage[MeSH Terms]) OR brain infarction[MeSH Terms]) 
OR subarachnoid hemorrhage[MeSH Terms])) AND ((((health care quality[MeSH Terms]) OR 
quality indicators, health care[MeSH Terms]) OR quality control[MeSH Terms]) OR performance 
indicator[MeSH Terms])) AND ((registries[MeSH Terms]) OR clinical audit[MeSH Terms])) 
AND ((((((((((((treatment outcome[MeSH Terms]) OR case fatality rate[MeSH Terms]) OR 
mortality[MeSH Terms]) OR survival[MeSH Terms]) OR disability[MeSH Terms]) OR functional 
status[MeSH Terms]) OR hospitalization[MeSH Terms]) OR cost[MeSH Terms]) OR quality of 
life[MeSH Terms]) OR complication[MeSH Terms]) OR hospital discharge[MeSH Terms]) OR 
stroke recurrence[MeSH Terms]) Filters: Full text, From 2000/01/01 to 2017/05/24, English 
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Appendix 4. 1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes 
All countries 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day case fatality 
5 Reference      
4 1.83(1.40-2.38); P<0.0001 Reference Reference Reference Reference Reference 
3 4.12(3.31-5.13); P<0.0001 3.44(2.77-4.26); P<0.0001 1.57(1.22-2.03); P<0.0001 2.59(2.09-3.20); P<0.0001 2.67(2.21-3.22); P<0.0001 1.86(1.43-2.43); P<0.0001 
2 4.81(3.84-6.04); P<0.0001 4.44(3.55-5.55); P<0.0001 3.95(3.25-4.80); P<0.0001 3.18(2.62-3.85); P<0.0001 4.62(3.85-5.56); P<0.0001 4.22(3.41-5.23); P<0.0001 
1 5.60(4.16-7.53); P<0.0001 5.47(4.08-7.34); P<0.0001 3.82(3.09-4.73); P<0.0001 4.12(3.25-5.22); P<0.0001 5.54(4.31-7.11); P<0.0001 5.36(4.30-6.68); P<0.0001 
0 5.30(3.09-9.10); P<0.0001 5.26(3.07-9.03); P<0.0001 5.92(4.30-8.15); P<0.0001 5.47(3.50-8.55); P<0.0001 5.03(3.04-8.34); P<0.0001 4.05(2.85-5.75); P<0.0001 
 Adjusted* ORs (95%CI) for 30-day case fatality 
5 Reference      
4 1.05(0.79-1.41); P=0.722 Reference Reference Reference Reference Reference 
3 2.50(1.96-3.18); P<0.0001 1.94(1.53-2.45); P<0.0001 0.90(0.69-1.19); P=0.465 1.74(1.38-2.20); P<0.0001 2.24(1.82-2.75); P<0.0001 1.00(0.75-1.33); P=0.988 
2 2.60(2.02-3.35); P<0.0001 2.44(1.90-3.12); P<0.0001 2.33(1.88-2.89); P<0.0001 2.70(2.18-3.35); P<0.0001 2.56(2.09-3.13); P<0.0001 2.50(1.97-3.16); P<0.0001 
1 3.02(2.16-4.24); P<0.0001 2.95(2.12-4.12); P<0.0001 2.15(1.70-2.73); P<0.0001 3.01(2.30-3.93); P<0.0001 3.03(2.28-4.02); P<0.0001 2.80(2.20-3.59); P<0.0001 
0 4.10(2.22-7.57); P<0.0001 4.02(2.18-7.43); P<0.0001 3.47(2.40-5.01); P<0.0001 4.09(2.43-6.87); P<0.0001 4.27(2.40-7.60); P<0.0001 2.66(1.79-3.96); P<0.0001 
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Appendix 4.1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes              Continued 
All countries 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 1.71(1.47-1.98); P<0.0001 Reference Reference Reference Reference Reference 
3 1.88(1.65-2.15); P<0.0001 1.91(1.69-2.17); P<0.0001 1.63(1.41-1.89); P<0.0001 1.51(1.32-1.73); P<0.0001 1.50(1.34-1.69); P<0.0001 1.71(1.47-1.98); P<0.0001 
2 2.12(1.84-2.45); P<0.0001 2.06(1.80-2.36); P<0.0001 1.97(1.74-2.23); P<0.0001 1.46(1.30-1.64); P<0.0001 1.96(1.74-2.20); P<0.0001 1.88(1.66-2.14); P<0.0001 
1 2.64(2.14-3.27); P<0.0001 2.70(2.20-3.33); P<0.0001 1.84(1.59-2.11); P<0.0001 2.14(1.82-2.51); P<0.0001 2.41(2.00-2.90); P<0.0001 2.25(1.96-2.58); P<0.0001 
0 2.31(1.50-3.57); P<0.0001 2.31(1.50-3.56); P<0.0001 2.96(2.31-3.80); P<0.0001 2.49(1.73-3.58); P<0.0001 2.10(1.38-3.19); P<0.0001 1.90(1.47-2.45); P<0.0001 
 Adjusted* ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 1.17(0.98-1.40); P=0.087 Reference Reference Reference Reference Reference 
3 1.24(1.05-1.45); P=0.010 1.22(1.04-1.41); P=0.012 1.15(0.96-1.37); P=0.135 1.03(0.88-1.21); P=0.707 1.32(1.15-1.52); P<0.0001 1.10(0.92-1.31); P=0.322 
2 1.27(1.07-1.51); P=0.007 1.27(1.07-1.50); P=0.006 1.25(1.08-1.46); P=0.003 1.35(1.16-1.56); P<0.0001 1.02(0.88-1.18); P=0.835 1.21(1.03-1.41); P=0.019 
1 1.66(1.28-2.17); P<0.0001 1.72(1.33-2.23); P<0.0001 1.18(0.99-1.41); P=0.062 1.75(1.43-2.14); P<0.0001 1.25(0.99-1.57); P=0.066 1.30(1.10-1.54); P=0.003 
0 1.68(1.02-2.78); P=0.043 1.69(1.02-2.79); P=0.042 1.84(1.37-2.49); P<0.0001 1.79(1.15-2.79); P=0.010 1.53(0.94-2.49); P=0.089 1.40(1.02-1.91); P=0.035 
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Appendix 4.1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes        Continued 
LMICs 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day case fatality 
5 Reference      
4 1.17(0.86-1.60), p=0.325 Reference Reference Reference Reference Reference 
3 2.40(1.84-3.13), P<0.0001 2.15(1.65-2.79), P<0.0001 0.98(0.74-1.31), P<0.0001 1.63(1.28-2.07), P<0.0001 2.01(1.63-2.47), P<0.0001 1.20(0.89-1.64), P=0.235 
2 3.04(2.31-3.99); P<0.0001 2.85(2.18-3.73), P<0.0001 2.31(1.83-2.93), P<0.0001 1.88(1.51-2.35), P<0.0001 3.53(2.88-4.33), P<0.0001 2.51(1.94-3.26), P<0.0001 
1 3.29(2.36-4.60); P<0.0001 3.28(2.36-4.56), P<0.0001 2.47(1.92-3.17), P<0.0001 2.35(1.81-3.05), P<0.0001 3.96(3.04-5.16), P<0.0001 3.47(2.66-4.53), P<0.0001 
0 3.07(1.75-5.37); P<0.0001 3.11(1.78-5.44), P<0.0001 3.50(2.48-4.94), P<0.0001 3.09(1.95-4.90), P<0.0001 3.55(2.12-5.92), P<0.0001 2.44(1.66-3.56), P<0.0001 
 Adjusted* ORs (95%CI) for 30-day case fatality 
5 Reference      
4 1.00(0.72-1.39), p=0.986 Reference Reference Reference Reference Reference 
3 2.44(1.83-3.25), P<0.0001 1.89(1.43-2.50), P<0.0001 0.88(0.65-1.20), p=0.415 1.74(1.34-2.26), P<0.0001 2.24(1.78-2.80), P<0.0001 0.97(0.70-1.35). P<0.0001 
2 2.64(1.96-3.55), P<0.0001 2.44(1.83-3.27), P<0.0001 2.28(1.77-2.91), P<0.0001 2.75(2.15-3.51), P<0.0001 2.62(2.10-3.27), P<0.0001 2.47(1.87-3.27), P<0.0001 
1 2.96(2.04-4.29), P<0.0001 2.87(1.99-4.14), P<0.0001 2.20(1.67-2.90), P<0.0001 2.99(2.23-4.00), P<0.0001 3.03(2.25-4.08), P<0.0001 2.89(2.16-3.85), P<0.0001 
0 3.95(2.10-7.43), P<0.0001 3.84(2.05-7.22), P<0.0001 3.39(2.29-5.01), P<0.0001 4.04(2.38-6.86), P<0.0001 4.18(2.34-7.48, P<0.0001 2.64(1.73-4.03), P<0.0001 
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Appendix 4.1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes       Continued 
LMICs 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 1.42(1.17-1.72), P<0.0001 Reference Reference Reference Reference Reference 
3 1.37(1.15-1.63), P<0.0001 1.50(1.27-1.77), P<0.0001 1.25(1.05-1.50), p=0.014 1.08(0.92-1.26), p=0.374 1.26(1.11-1.44), p=0.001 1.33(1.11-1.60), p=0.002 
2 1.66(1.39-1.99), P<0.0001 1.65(1.38-1.97), P<0.0001 1.39(1.19-1.63), P<0.0001 0.97(0.84-1.13), p=0.717 1.65(1.44-1.89), P<0.0001 1.33(1.12-1.56), p=0.001 
1 1.95(1.53-2.48), P<0.0001 2.05(1.62-2.59), P<0.0001 1.41(1.19-1.68), P<0.0001 1.39(1.16-1.66), P<0.0001 1.92(1.58-2.34), P<0.0001 1.71(1.44-2.03), P<0.0001 
0 1.67(1.07-2.62), P<0.0001 1.72(1.10-2.69), P=0.017 2.11(1.62-2.76), P<0.0001 1.60(1.10-2.32), p=0.014 1.65(1.08-2.52), p=0.020 1.35(1.03-1.78), p=0.031 
 Adjusted* ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 1.46(1.17-1.82), P<0.0001 Reference Reference Reference Reference Reference 
3 1.50(1.23-1.84), P<0.0001 1.50(1.23-1.81), P<0.0001 1.37(1.11-1.68), P=0.003 1.19(0.98-1.43), P=0.074 1.45(1.24-1.70), P<0.0001 1.28(1.04-1.59), p=0.021 
2 1.58(1.28-1.96), P<0.0001 1.58(1.29-1.94), P<0.0001 1.46(1.22-1.76), P<0.0001 1.54(1.29-1.84), P<0.0001 1.13(0.96-1.32), p=0.141 1.39(1.15-1.68), p=0.001 
1 2.03(1.52-2.70), P<0.0001 2.10(1.58-2.78), P<0.0001 1.41(1.15-1.73), P=0.001 1.97(1.58-2.47), P<0.0001 1.37(1.08-1.74), p=0.010 1.53(1.25-1.88), P<0.0001 
0 2.01(1.20-3.35), P<0.0001 2.01(1.21-3.36), P<0.0001 2.15(1.56-2.94), P<0.0001 2.02(1.29-3.16), P=0.002 1.63(1.00-2.65), p=0.050 1.60(1.15-2.22), P=0.005 
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Appendix 4.1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes        Continued 
African countries 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day case fatality 
5 Reference      
4 0.20(0.03-1.39); P=0.103 Reference Reference Reference Reference Reference 
3 1.25(0.26-6.04); P=0.784 1.07(0.22-5.18); P=0.932 0.21(0.03-1.44); P=0.112 0.21(0.03-1.34); P=0.098 3.68(1.10-12.32); P=0.035 0.25(0.03-2.35); P=0.225 
2 1.22(0.25-5.87); P=0.806 1.14(0.24-5.49); P=0.870 1.53(0.32-7.22); P=0.594 1.21(0.25-5.79); P=0.810 3.91(1.17-13.02); P=0.027 2.84(0.97-8.71); P=0.057 
1 1.16(0.24-5.63); P=0.853 1.15(0.24-5.57); P=0.863 1.25(0.26-5.90); P=0.783 1.23(0.26-5.93); P=0.796 3.77(1.12-12.69); P=0.032 2.79(0.97-8.02); P=0.056 
0 0.66(0.13-3.41); P=0.619 0.65(0.13-3.37); P=0.610 1.09(0.23-5.17); P=0.919 0.77(0.15-3.95); P=0.758 2.14(0.59-7.82); P=0.244 1.72(0.57-5.24); P=0.337 
 Adjusted* ORs (95%CI) for 30-day case fatality 
5 Reference      
4 0.46(0.06-3.62); P=0.461 Reference Reference Reference Reference Reference 
3 1.54(0.27-8.74); P=0.624 1.35(0.24-7.73); P=0.734 0.48(0.06-3.68); P=0.478 0.41(0.06-2.97); P=0.380 2.17(0.59-7.97); P=0.244 0.50(0.05-4.93); P=0.554 
2 1.35(0.24-7.56); P=0.731 1.19(0.21-6.74); P=0.843 1.83(0.33-10.07); P=0.490 1.42(0.26-7.90); P=0.686 2.08(0.55-7.37); P=0.289 2.30(0.71-7.45); P=0.165 
1 1.49(0.26-8.35); P=0.653 1.38(0.24-7.88); P=0.717 1.31(0.24-7.19); P=0.757 1.58(0.28-8.76); P=0.602 2.25(0.61-8.28); P=0.224 2.17(0.69-6.83); P=0.184 
0 1.16(0.19-6.97); P=0.870 1.11(0.18-6.76); P=0.913 1.49(0.27-8.20); P=0.645 1.32(0.22-7.78); P=0.761 1.78(0.45-7.10); P=0.416 1.75(0.53-5.82); P=0.359 
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Appendix 4.1: Details for the results from the logistic regression analysis for the association between stroke care bundle scores and 30-day patient 
outcomes        Continued 
African countries 
Bundle Score 
Analysis A Analysis B Analysis C Analysis D Analysis E Analysis F 
Crude ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 0.07(0.01-0.38); P=0.002 Reference Reference Reference Reference Reference 
3 0.12(0.03-0.60); P=0.009 0.12(0.02-0.56); P=0.007 0.10(0.02-0.42); P=0.002 0.08(0.02-0.40), p=0.002 1.44(0.69-3.00); P=0.329 0.10(0.03-0.37); P=0.001 
2 0.16(0.03-0.78); P=0.023 0.16(0.03-0.75); P=0.020 0.20(0.05-0.77); P=0.019 0.14(0.03-0.68), p=0.014 1.80(0.87-3.71); P=0.113 0.57(0.29-1.13); P=0.106 
1 0.14(0.03-0.66); P=0.013 0.14(0.03-0.65); P=0.013 0.23(0.06-0.90); P=0.034 0.14(0.03-0.67), p=0.014 1.55(0.74-3.23); P=0.247 0.69(0.36-1.32); P=0.264 
0 0.08(0.02-0.41), p=0.002 0.08(0.02-0.40), p=0.002 0.17(0.05-0.67); P=0.011 0.09(0.02-0.46), p=0.004 0.92(0.40-2.08), p=0.833 0.40(0.20-0.82); P=0.012 
 Adjusted* ORs (95%CI) for 30-day death or severe disability 
5 Reference      
4 0.13(0.02-0.70); P=0.018 Reference Reference Reference Reference Reference 
3 0.16(0.03-0.83); P=0.029 0.15(0.03-0.79); P=0.025 0.17(0.04-0.78); P=0.023 0.12(0.02-0.64), p=0.014 1.03(0.45-2.38); P=0.945 0.18(0.05-0.71); P=0.014 
2 0.20(0.04-1.06); P=0.058 0.18(0.04-0.95); P=0.043 0.24(0.06-1.04); P=0.056 0.19(0.04-0.98), p=0.047 1.26(0.54-2.90); P=0.595 0.58(0.27-1.28); P=0.179 
1 0.19(0.04-0.99); P=0.048 0.18(0.03-0.93); P=0.041 0.29(0.07-1.21); P=0.089 0.19(0.04-1.01), p=0.051 1.18(0.51-2.77); P=0.699 0.73(0.34-1.53); P=0.399 
0 0.13(0.02-0.72); P=0.019 0.13(0.02-0.70); P=0.017 0.25(0.06-1.03); P=0.055 0.15(0.03-0.82), p=0.029 0.83(0.33-2.09), p=0.697 0.48(0.22-1.07); P=0.073 
Abbreviations: LMICs, low and middle-income countries; OR, odds ratio 
*Adjusted for age, baseline stroke severity, baseline level of consciousness, and Oxfordshire Community Stroke Project (OCSP) classification of stroke.  
Analysis A: Logistic regression analysis for the association between patient outcomes and scores for the stroke care bundle of five components including brain CT scan by day 1, availability of stroke unit to at least (≥) 50% of stroke 
patients, availability of stroke specialist to at least (≥) 50% of stroke patients, antiplatelet therapy in hospital, and the availability of post-discharge rehabilitation 
Analysis B: Analysis A after excluding availability of post-discharge rehabilitation from the stroke care bundle 
Analysis C: Analysis A after excluding antiplatelet therapy in hospital from the stroke care bundle 
Analysis D: Analysis A after excluding availability of stroke specialist to at least (≥) 50% of stroke patients from the stroke care bundle 
Analysis E: Analysis A after excluding availability of stroke unit to at least (≥) 50% of stroke patients from the stroke care bundle 
Analysis F: Analysis A after excluding brain CT scan by day 1 from the stroke care bundle 
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Appendix 5. 1: Admission Case Report Form (CRF) 
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Appendix 5. 2: Discharge Case Report Form (CRF) 
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Appendix 5. 3: Three-month follow-up Case Report Form (CRF) 
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Appendix 5. 4: Ethics approval by the Committee of the College of Medical, 
Veterinary and Life Sciences (MVLS), University of Glasgow 
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Appendix 5. 5: Ethics approval by the Institutional Review Board of the College of 
Medicine and Health Sciences, the University of Rwanda 
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Appendix 5. 6: Ethics approval by CHUK ethics committee 
 
CENTRE HOSPITALIER UNIVERSITAIRE 
UNIVERSITY TEACHING HOSPITAL 
          Quality Health Care 
          Training & Research 
Ethics Committee / Comité d'éthique 
 
March 31 
st
, 2017 Ref.: EC/CHUK/341/2017 
Review Approval Notice 
 
Dear Gerard Urimubenshi, 
 
Your research project: "Feasibility of Implementing Stroke Care Units in selected 
Hospitals in Rwanda." 
During the meeting of the Ethics Committee of University Teaching Hospital of Kigali 
(CHUK) that was held on 31/03/2017 to evaluate your protocol of the above mentioned 
research project, we are pleased to inform you that the Ethics Committee/CHUK has 
approved your protocol. 
You are required to present the results of your study to CHUK Ethics Committee before 
publication. 
PS: Please note that the present approval is valid for 12 months. 
Yours sincerely, 
 
John   
The Secretary, Ethics Committee, 
University Teaching Hospital of Kigali 
<<University teaching hospital of Kigali Ethics committee operates according to standard operating 
procedures (Sops) which are updated on an annual basis and in compliance with GCP and Ethics guidelines 
and regulations>>. 
 
B.P. :655 Kigali- RWANDA www.chk.rw Tél. Fax : OO (250) 576638 E-mail :chu .hospital@chukigali.rw 
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CENTRE HOSPITALIER UNIVERSITAIRE UNIVERSITY TEACHING 
HOSPITAL 
          Quality Health Care 
          Training & Research 
Ethics Committee / Comité d'éthique 
 
March 16
th
, 2018                                                                 Ref.: EC/CHUK/552/2018 
  
Review Approval Notice 
 
Dear Gerard Urimubenshi, 
 
Your research project: "Feasibility of Implementing Stroke Care Units in selected 
Hospitals in Rwanda." 
During the meeting of the Ethics Committee of University Teaching Hospital of Kigali 
(CHUK) that Was held on 16/03/2018 to evaluate your protocol of the above mentioned 
research project, we are pleased to inform you that the Ethics Committee/CHUK has 
approved your protocol. 
You are required to present the results of your study to CHUK Ethics Committee before 
publication.  
PS: Please note that the present approval is valid for 12 months. 
Yours sincerely, 
 
Dr. Rusingiza Emmanuel 
The President, Ethics Committee, 
University Teaching Hospital of Kigali 
<<University teaching hospital of Kigali Ethics committee operates according to standard operating 
procedures (Sops) which are updated on an annual basis and in compliance with GCP and Ethics guidelines 
and regulations 
 
B.P.:655 Kigali- RWANDA www..chk.rw Tél. Fax : 00 (250) 576638  
E-mail :chuk.hospital@chukigali.rw 
 
 
Appendix 5. 7: Ethics approval by CHUB ethics committee 
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CENTRE HOSPITALIER UNIVERSEAIRE 
UNIVERSITY TEACHING HOSPITAL                                 
CENTRE HOSPITALIER UNIVERSITAIRE                   Huye, 06 APR 2017 
DE BUTARE (CHUB) 
OFFICE OF DIRECTOR GENERAL  N
O 
Ref: CHUB/DG/SA/04/642/2017 
Gerard Urimubenshi 
College of Medicine and Health Sciences 
University of Rwanda 
E-mail: ugerardus@gmail.com 
Phone: +250788871371 
Dear Urimubenshi, 
Re: Your request for data collection 
 
Reference made to your letter requesting for permission to collect the data within 
University Teaching Hospital of Butare, for your research proposal entitled "Feasibility of 
implementing Stroke care unity in selected Hospital in Rwanda", and based on approvals 
Notice: No 166/CMHS IRB/2017 from University of Rwanda and No 
RC/UTH/B/022/2017 from our research committee, we are pleased to inform you that your 
request was accepted. Please note that your final document will be submitted in our 
Research department. 
 
 
E-mail : info@chub.rw B.P : 254 BUTARE 
Website : www.chub.rw Hotline:2030 
Appendix 5. 8: Participant information sheet (English) 
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PARTICIPANT INFORMATION SHEET 
 
1. Study title:  Feasibility of implementing stroke care units in selected hospitals in 
Rwanda 
2. Invitation paragraph 
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss it with others if you wish. Ask us if there is anything 
that is not clear or if you would like more information. Take time to decide whether or not you 
wish to take part. 
3. What is the purpose of the study? 
Stroke is the second most common cause of death worldwide and the seventh leading cause of 
disability. In Rwanda, stroke is estimated to be one of the major causes of illness.  As the Rwandan 
economy grows, the burden of stroke will grow even more. Findings from clinical trials have 
shown that providing care in a stroke unit can increase the number of patients who survive, return 
home, and regain independence in daily activities.    A stroke care unit is an organized in-hospital 
facility that is devoted to care for patients with stroke, and that is staffed by a multidisciplinary 
team with special knowledge in stroke care. However, since stroke units are complex and costly, 
most developments have taken place in high income countries where most of the health service is 
publicly funded. We aim to explore the feasibility of implementing stroke care units in selected 
hospitals in Rwanda with the aim of developing a model of care suitable for countries like Rwanda. 
The study will be conducted between April 2017 and January 2018. 
4.    Why have I been chosen? 
All stroke patients attending two selected hospitals between April 2017 and January 2018 will be 
invited to take part in the study.  
5. Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, you will be given 
this information sheet to keep and be asked to sign a consent form. If you decide to take part, you 
are still free to withdraw at any time and without giving a reason. 
6. What will happen to me if I take part? 
If you agree to take part, some information from your medical file will be recorded, and 3 months 
after you got sick, you will be contacted on phone and be asked questions whether you got stroke 
again, whether you were readmitted to hospital, and your level of disability and quality of life.    
7. What do I have to do? 
This research is about collecting information about your care and outcome, and this does not 
recommend any restriction.   
8. What are the possible disadvantages and risks of taking part? 
No identifiable disadvantages or risks of taking part in this study. 
9. What are the possible benefits of taking part? 
You will not get any compensation as you will not have any extra financial expenses because of 
being research participants, and you will receive no direct benefit from taking part in this study. 
The information that is collected during this study will give us a better understanding of how to 
improve stroke care in Rwanda. 
10. Will my taking part in this study be kept confidential? 
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All information which is collected about you, or responses that you provide, during the course of 
the research will be kept strictly confidential. You will be identified by an ID number, and any 
information about you will have your name and address removed so that you cannot be recognized 
from it. 
11. What will happen to the results of the research study? 
The results of the study will be used for my thesis, and some information will be published. You 
will be able to get copy of the results from January 2020 at your hospital, and the Department of 
Physiotherapy, University of Rwanda. You will never be identified in any report or publication. 
12. Who is organising and funding the research? 
The study is being organized by Gerard Urimubenshi, a PhD student at the University of Glasgow, 
under the supervision by researchers from the University of Glasgow, the University of Rwanda, 
the McMaster University, and South Africa and it is funded by a grant from McMaster University, 
Population Health Research Institute (PHRI). 
 
13. Who has reviewed the study? 
The study project has been reviewed by the Ethics Committee of the College of Medical, 
Veterinary and Life Sciences at the University of Glasgow, and Institutional Review Board of the 
College of Medicine and Health Sciences (CMHS) at the University of Rwanda. 
14. Contact for Further Information 
If you have any questions about the research study itself, please contact:  
Gerard Urimubenshi, Cell phone number: 0788871371 in Rwanda or +447438930941 in United 
Kingdom (UK), E-mail: g.urimubenshi.1@research.gla.ac.uk. Should you have any questions 
regarding this study and your rights as a research participant or if you wish to report any problems 
you have experienced related to the study, please contact the Vice Chairperson of the Institutional 
Review Board of the College of Medicine and Health Sciences (CMHS) at the University of 
Rwanda:  
Prof. Jean Bosco Gahutu  
College of Medicine and Health Sciences  
University of Rwanda  
Kigali, Rwanda 
Phone: 0783340040, E-mail: jbgahutu@yahoo.com 
 
15. Thank you very much for taking part in this study! 
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Appendix 5. 9: Consent form (English) 
 
 
Centre Number: 101/102 
Project Number: 200160048 
Subject Identification Number for this study: 
 
 
CONSENT FORM 
 
Title of Project: Feasibility of implementing stroke care units in selected hospitals in Rwanda 
 
Name of Researcher(s): Gerard Urimubenshi 
 
                                                                      Please tick the box with “V” 
I confirm that I have read the information sheet dated __________(version _____ )  
for the above study, or it has been read to me, and understood it, and have had the  
opportunity to ask questions. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected. 
 
I agree to take part in the above study.       
 
          
Name of subject                                         Date                       Signature/Thumb print 
          
Name of witness for accurate reading        Date                      Signature 
(in case the forms were read to the subject) 
    
Name of person taking consent             Date                   Signature 
(if different from researcher) 
Gerard Urimubenshi   
Researcher                                                Date                        Signature 
 
(1 copy for subject; 1 copy for researcher) 
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Appendix 5. 10: Assent form (English) 
 
 
Centre Number: 101/102 
Project Number: 200160048 
Subject Identification Number for this study: 
 
 
ASSENT FORM 
 
Title of Project: Feasibility of implementing stroke care units in selected hospitals in Rwanda 
 
Name of Researcher(s): Gerard Urimubenshi 
                                                                                  Please tick the box with “V” 
I confirm that I have read the information sheet dated __________ (version _____ ) 
 for the above study, or it has been read to me, and understood it, and have had the opportunity to 
ask questions. 
 
I understand that the participation of the patient whose I am the guardian is voluntary          and that 
he/she is free to withdraw at any time, without giving any reason,  
without his/her legal rights being affected. 
 
I agree for him/her to take part in the above study.       
 
           
Name of guardian                                 Date                         Signature/Thumb print 
           
Name of witness for accurate reading    Date                      Signature 
(in case the forms were read to the guardian) 
   
Name of person taking assent              Date                      Signature 
(if different from researcher) 
Gerard Urimubenshi   
Researcher                                                    Date                       Signature 
 
(1 copy for guardian; 1 copy for researcher) 
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Appendix 5. 11: Consent to continue form (English) 
 
 
Centre Number: 101/102 
Project Number: 200160048 
Subject Identification Number for this study: 
 
 
CONSENT TO CONTINUE FORM 
 
Title of Project: Feasibility of implementing stroke care units in selected hospitals in Rwanda 
 
Name of Researcher(s): Gerard Urimubenshi 
                                                                                 Please tick the box with “V” 
I confirm that I have read the information sheet dated __________ (version _____)  
for the above study, or it has been read to me, and understood it, and have had the  
opportunity to ask questions. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected. 
 
I agree to continue to take part in the above study.       
           
Name of subject                                          Date                       Signature/Thumb print 
           
Name of witness for accurate reading      Date                      Signature 
(in case the forms were read to the subject) 
    
Name of person taking consent              Date                      Signature 
(if different from researcher) 
Gerard Urimubenshi   
Researcher                                                 Date                      Signature 
 
 
(1 copy for subject; 1 copy for researcher) 
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Appendix 5. 12: Participant information sheet (Kinyarwanda) 
 
IBISOBANURO BIGENEWE USABWA KUGIRA URUHARE MU 
BUSHAKASHATSI 
1. Izina ry’ubushakashatsi: Ishyirwa mu bikorwa ry’ubuvuzi bwihariye bwa sitoroke (paralizi 
iterwa no kuziba cyangwa guturika kw’imiyoboro y’amaraso mu bwonko) mu bitaro byo mu 
Rwanda 
2. Ubusabe bwo kugira uruhare mu bushakashatsi 
Turagusaba kugira uruhre mu bushakashatsi ku ishyirwa mu bikorwa ry’ubuvuzi bwihariye bwa 
sitoroke mu bitaro byo mu Rwanda. Ni ngombwa ko wumva impamvu ubu bushakashatsi bugiye 
gukorwa n’icyo uwemeye kubugiramo uruhare asabwa. Urasabwa rero gufata umwanya uhagije wo 
gusoma no kumva ibisobanuro bikurikira, ndetse ushobora no kubaza abandi uko ubyifuza mbere yo 
gufata umwanzuro wo kugira cyangwa kutagira uruhare muri ubu bushakashatsi. Wemerewe kutubaza 
ibyo udasobanukiwe neza cyangwa ibindi bisobanuro wakwifuza.  
3. Ubu bushakashatsi bugamije iki? 
Ku rwego rw’isi, sitoroke ni indwara iri ku mwanya wa kabiri mu gutera imfu nyinshi, ikaba ku 
mwanya wa karindwi mu mpamvu zitera ubumuga. No mu Rwanda, sitoroke ni mwe mu ndwara 
zikunda kwibasira abanyarwanda. Mu gihe u Rwanda rukataje mu iterambere, ibibazo biterwa na 
sitoroke byakomeza kwiyongera hadafashwe ingamba zo kubikumira. Ubushakashatsi bunyuranye 
bwagaragaje ko ubuvuzi bwihariye bwa sitoroke bugabanya umubare w’abapfa n’abagira ubumuga 
bitewe na sitoroke.  Ubuvuzi bwihariye bwa sitoroke ni ubuvuzi bukorerwa ahantu hihariye hagenewe 
abarwayi b’iyo ndwara, kandi hakaba hari abakozi bo mu mashami anyuranye bazobereye mu buvuzi 
bwayo, kandi bagakora nk’ikipe. Nyamara ariko, kubera ubuvuzi bwihariye bw sitoroke busaba ibintu 
byinshi kandi buhenze, ubu buvuzi bukorwa cyane cyane mu bihugu byateye imbere, aho ibikorwa 
byinshi by’ubuvuzi byishyurwa na za Leta. Intego yacu ni ugutegura no gushyira mu bikorwa ubuvuzi 
bwihariye bwa sitoroke muri bimwe mu bitaro byo mu Rwanda, tugamije gutegura no kugerageza 
uburyo bwihariye bw’ubuvuzi bwa sitoroke bubereye ibihugu biri ku rwego rumwe nk’u Rwanda. Ubu 
bushakashatsi buzakorwa guhera muri Mata 2017 kugeza muri Mutarama 2018. 
4.   Ese kuki nsabwa kugira uruhare muri ubu bushakashatsi? 
Abarwayi bose ba sitoroke bazivuriza mu bitaro byatoranyijwe hagati ya Mata 2017 kugeza muri 
Mutarama 2018 bazasabwa kugira uruhare muri ubu bushakashatsi. 
5.  Ese ngomba kugira uruhare muri ubu bushakashatsi? 
Ni wowe ubwawe wifatira icyemezo niba wemeye kugira cyangwa kutagira uruhare muri ubu 
bushakashatsi. Niwemera kugira uruhare muri ubu bushakashatsi, uzahabwa iyi nyandiko uyigumane, 
hanyuma usabwe gusinya ku nyandiko yo kwemera kugira uruhare muri ubu bushakashatsi. Niba 
wemeye kugira uruhare muri ubu bushakashatsi, ufite uburenganzira bwo kwisubiraho ukivanamo igihe 
cyose ushakiye utagombye gutanga ibisobanuro.   
6.  Ese bizangendekera gute ningira uruhare muri ubu bushakashatsi? 
Niwemera kugira uruhare muri ubu bushakashatsi, amwe mu makuru ari mu ifishi yawe yo kwa 
muganga azandukurwa, kandi nyuma yo gusezererwa mu bitaro, nyuma y’amezi atatu kuva urwaye 
sitoroke, tuzaguhamagara kuri telefoni tukubaze niba warongeye kurwara iyi ndwara bwa kabiri, niba 
warasubiye mu bitaro, tukubaze n’amakuru ajyanye n’ubumuga waba ufite ndetse n’ikigereranyo 
cy’uburyo uzaba ubayeho.  
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7.  Ese ndasabwa gukora iki? 
Ubu bushakashatsi bugamije gushaka amakuru yerekeye uko uzavurwa n’uburyo bizakugendekera 
nyuma yo kurwara no kuvurwa, kandi ntacyo usabwa kwigomwa cyangwa kwitondera kubera kugira 
uruhare muri ubu bushakashatsi.   
8. Ni izihe ngaruka zijyanye no kugira uruhare muri ubu bushakashatsi? 
      Nta ngaruka tubona zaterwa no kugira uruhare muri ubu bushakashatsi.  
9. Ni izihe nyungu zijyanye no kugira uruhare muri ubu bushakashatsi? 
Nta nyungu cyangwa igihembo uzahabwa wowe ubwawe kubera kugira uruhare muri ubu 
bushakashatsi. Amakuru azava muri ubu bushakashatsi azadufasha kumva neza uburyo ubuvuzi bwa 
sitoroke mu Rwanda bwatezwa imbere.  
10. Ese kugira uruhare muri ubu bushakashatsi bizagirwa ibanga? 
Amakuru yose tuzafata akwerekeye cyangwa ibisubizo uzaduha muri ubu bushakashatsi azagirwa 
ibanga rikomeye.  Uzahabwa nimero, naho amazina n’aho utuye ntibizagaragara muri raporo y’ubu 
bushakashatsi.  
11. Ese amakuru azava muri ubu bushakashatsi azakoreshwa iki? 
Amakuru azava muri ubu bushakashatsi azakoreshwa mu rwego rw’amasomo ndi kwiga, kandi amakuru 
amwe n’amwe azashyirwa ahagaragara binyuze mu binyamakuru by’ubumenyi. Uzashobora kubona 
kopi y’amakuru azava muri ubu bushakashatsi guhera muri Mutarama 2010 ku bitaro wivurijemo, 
n’agashami kigisha ubuvuzi bushingiye ku bugenge muri Kaminuza y’u Rwanda. Nta na rimwe uzigera 
umenyekana mu makuru azava muri ubu bushakashatsi.  
12. Ese ni nde uri gutegura ubu bushakashatsi? Use ni nde uzatera inkunga ubu bushakashatsi? 
Ubu busakashatsi buzakorwa na Gerard Urimubenshi, umunyeshuri muri Kaminuza ya “Glasgow” yo 
mu Bwongereza, akazaba ayobowe n’abashakashatsi banyuranye bo muri Kaminuza ya “Glasgow” yo 
mu Bwongereza, Kaminuza y’u Rwanda, Kaminuza ya “MacMaster”yo muri Kanada, na Afurika 
y’epfo.  Ubu bushakashatsi buzaterwa inkunga n’ikigo cyo muri Kanada cyita ku bushakashatsi ku 
buzima bw’abaturage ibinyujije muri Kaminuza ya “MacMaster”yo muri Kanada. 
13. Ese ni nde wasesenguye ubu bushakashatsi? 
Ubu bushakashatsi bwasesenguwe na Komite ishinzwe ubushakashatsi muri Kaminuza ya “Glasgow” 
mu Bwongereza, ndetse n’urwego rushinzwe ubushakashatsi muri Koleji y’ubuvuzi n’ubuzima muri 
Kaminuza y’u Rwanda.  
14. Uwo wakwiyambaza ugize ikibazo 
Ugize ikibazo kuri ubu bushakashatsi, wakwiyambaza Gerard Urimubenshi kuri telefoni nimero 
0788871371 mu Rwanda cyangwa +447438930941 mu Bwongereza, E-mail: 
g.urimubenshi.1@research.gla.ac.uk.  
Uramutse ushatse kumenyekanisha ibibazo watewe no kugira uruhare muri ubu bushakashatsi, 
wakwiyambaza Porofeseri Jean Bosco Gahutu, umuyobozi wungirije w’ urwego rushinzwe 
ubushakashatsi muri Koleji y’ubuvuzi n’ubuzima muri Kaminuza y’u Rwanda, kuri telefoni nimero 
0783340040, E-mail: jbgahutu@yahoo.com 
 
 
15. Uzaba ukoze cyane kwemera kugira uruhare muri ubu bushakashatsi! 
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Appendix 5. 13: Consent form (Kinyarwanda) 
 
Nimero y’ibitaro: 101/102 
Nimero y’ubushakashatsi: 200160048 
Nimero y’ugira uruhare mu bushakashatsi:  
 
INYANDIKO YO KWEMERA KUGIRA URUHARE MU BUSHAKASHATSI 
Izina ry’ubushakashatsi: Ishyirwa mu bikorwa ry’ubuvuzi bwihariye bwa sitoroke mu bitaro 
byo mu Rwanda 
 
Izina ry’ukora ubushakashatsi: Gerard Urimubenshi 
 
                                      Shyira akamenyetso “V” mu gasanduku ku byo wemera  
Ndemeza ko nasomye, cyangwa nasomewe kandi numvise ibikubiye mu nyandiko y’ibisobanuro 
bigenewe usabwa kugira uruhare mu bushakashatsi bwavuzwe hejuru yo ku wa________________ 
(kopi_______) kandi ndemeza ko nahawe umwanya wo kubaza ibibazo 
Numvise ko kugira urahare kwanjye muri ubu bushakashatsi ari ubushake kandi ko mfite 
uburenganzira bwo kwivanamo igihe icyo ari cyo cyose, ntabanje gutanga ibisobanuro, kandi 
uburenganzira bwanjye buteganywa n’amategeko ntibubangamirwe.   
 
Nemeye kugira uruhare muri ubu bushakashatsi       
            
Izina ry’ugira uruhare mu bushakashatsi                     Italiki                   Umukono/Igikumwe  
          
Izina ry’umuhamya w’uko ibyasomwe ari ukuri         Italiki                    Umukono 
(mu gihe inyandiko zasomewe usabwa 
Kugira uruhare mu bushakashatsi) 
                   
Izina ry’uwakiriye ukwemera kugira                          Italiki                     Umukono                
uruhare     mu bushakashatsi    
(niba atandukanye n’ukora ubushakashatsi) 
Gerard Urimubenshi   
Ukora ubushakashatsi                                               Italiki                   Umukono 
 
(Kopi 1 y’ugira uruhare mu bushakashatsi; Kopi 1 y’ukora ubushakashatsi) 
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Appendix 5. 14: Assent form (Kinyarwanda) 
 
 
Nimero y’ibitaro: 101/102 
Nimero y’ubushakashatsi: 200160048 
Nimero y’ugira uruhare mu bushakashatsi:  
 
INYANDIKO Y’UHAGARARIYE USABWA KUGIRA URUHARE MU 
BUSHAKASHATSI 
Izina ry’ubushakashatsi: Ishyirwa mu bikorwa ry’ubuvuzi bwihariye bwa sitoroke mu bitaro 
byo mu Rwanda  
 
Izina ry’ukora ubushakashatsi: Gerard Urimubenshi 
 
                                         Shyira akamenyetso “V” mu gasanduku ku byo wemera 
Ndemeza ko nasomye, cyangwa nasomewe kandi numvise ibikubiye mu nyandiko y’ibisobanuro 
bigenewe usabwa kugira uruhare mu bushakashatsi bwavuzwe hejuru yo ku wa_________ 
(kopi_______) kandi ndemeza ko nahawe umwanya wo kubaza ibibazo 
Numvise ko kugira uruhare k’uwo mpagarariye muri ubu bushakashatsi ari ubushake kandi ko afite 
uburenganzira bwo kwivanamo igihe icyo ari cyo cyose, atabanje gutanga ibisobanuro, kandi 
uburenganzira bwe buteganywa n’amategeko ntibubangamirwe.   
 
Nemeye ko uwo mpagarariye agira uruhare muri ubu bushakashatsi     
       
   
Izina ry’uhagarariye                                                   Italiki                  Umukono/Igikumwe 
ugira uruhare mu bushakashatsi 
           
Izina ry’umuhamya w’uko ibyasomwe ari ukuri      Italiki                     Umukono 
(mu gihe inyandiko zasomewe uhagarariye  
usabwa kugira uruhare mu bushakashati) 
                   
Izina ry’uwakiriye inyandiko                                   Italiki                           Umukono 
y’uhagarariye ugira uruhare mu bushakashatsi    
(niba atandukanye n’ukora ubushakashatsi) 
Gerard Urimubenshi   
Ukora ubushakashatsi                                             Italiki                 Umukono 
(Kopi 1 y’uhagarariye ugira uruhare mu bushakashatsi; Kopi 1 y’ukora ubushakashatsi) 
 
Appendix 5. 15: Consent to continue form (Kinyarwanda) 
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Nimero y’ibitaro: 101/102 
Nimero y’ubushakashatsi: 200160048 
Nimero y’ugira uruhare mu bushakashatsi:  
 
INYANDIKO YO KWEMERA GUKOMEZA KUGIRA URUHARE MU 
BUSHAKASHATSI 
Izina ry’ubushakashatsi: Ishyirwa mu bikorwa ry’ubuvuzi bwihariye bwa sitoroke mu bitaro byo mu 
Rwanda 
 
Izina ry’ukora ubushakashatsi: Gerard Urimubenshi 
 
                                        Shyira akamenyetso “V” mu gasanduku ku byo wemera 
Ndemeza ko nasomye, cyangwa nasomewe kandi numvise ibikubiye mu nyandiko y’ibisobanuro bigenewe 
usabwa kugira uruhare mu bushakashatsi bwavuzwe hejuru yo ku wa ____________ (kopi_______) kandi 
ndemeza ko nahawe umwanya wo kubaza ibibazo. 
 
Numvise ko kugira urahare kwanjye muri ubu bushakashatsi ari ubushake kandi ko mfite uburenganzira bwo 
kwivanamo igihe icyo ari cyo cyose, ntabanje gutanga ibisobanuro, kandi uburenganzira bwanjye 
buteganywa n’amategeko ntibubangamirwe.   
 
Nemeye gukomeza kugira uruhare muri ubu bushakashatsi       
              
Izina ry’uwemera gukomeza                               Italiki                   Umukono/Igikumwe 
kugira uruhare mu bushakashatsi 
           
Izina ry’umuhamya w’uko ibyasomwe ari ukuri     Italiki                   Umukono 
(mu gihe inyandiko zasomewe usabwa 
Kugira uruhare mu bushakashatsi) 
                   
Izina ry’uwakiriye ukwemera gukomeza                  Italiki                   Umukono 
kugira uruhare mu bushakashatsi    
(niba atandukanye n’ukora ubushakashatsi) 
Gerard Urimubenshi   
Ukora ubushakashatsi                                           Italiki                   Umukono 
(Kopi 1 y’uwemera gukomeza kugira uruhare mu bushakashatsi; Kopi 1 y’ukora ubushakashatsi) 
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